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1. Tissue engineering and regenerative medicine
During the last decennia, the field of biomaterials has shifted its emphasis 
from achieving exclusively a bioinert tissue response to developing bioactive 
materials that can elicit a controlled action and reaction in the physiological 
environment.[1] This shift has given rise to a new tissue repair strategy: tissue 
engineering and regenerative medicine. This strategy comprises the use of 
bioactive materials or scaffolds to guide or support endogenous or transplanted 
stem cells to regenerate the damaged tissues. Biomolecules are also added to 
scaffolds, promoting cellular growth and differentiation.[2]
2. Biodegradable polymers
Ceramic, metallic and polymer-based biomaterials have been developed and 
are regularly used for tissue engineering applications. Composites constituted 
from the combination of these materials have also been developed. Polymers 
are the most popular class of biomaterials used in the tissue engineering and 
regenerative medicine field due to their availability and ease to synthesize, process 
and modify, resulting in materials with diverse physicochemical properties.
[3] The development of degradable biocompatible polymers was an important 
breakthrough, as it allowed the creation of materials that can be implanted in the 
body and thereafter fully degrade.
Biodegradable polymers are widely used in the development of biomaterials 
for the most diverse clinical and biomedical applications. The main advantage 
related to the use of such materials is the fact that they degrade in the body, 
avoiding the need for a second surgical procedure to remove the implant.[4] 
Such polymers can be divided into two categories: degradable natural polymers 
and degradable synthetic polymers. Natural polymers, which include proteins 
(e.g. collagen, gelatin, and silk), polysaccharides (e.g. starch, cellulose, and 
chitosan) and deoxyribonucleic acid (DNA), have high biocompatibility, 
ability to initiate cellular adhesion and proliferation, and the degradation 
products are non-toxic.[5, 6] However, natural polymers might suffer from poor 
mechanical performance, fast and variable degradation rate, and ethical and 
safety concerns, the latter specifically when obtained from animal sources.
[7, 8] Degradable synthetic polymers, on the other hand, overcome these 
disadvantages. Their physicochemical properties and degradability can be easily 
tailored.[9] Synthetic polymers can be cost-effectively synthesized, processed 
or modified to present good mechanical properties, higher thermal stability, 
and desired degradability.[10, 11] The most widely used synthetic biocompatible 
polymers include polyanhydrides, polyacrylates, poly(α-hydroxy) acids (e.g. 
poly(lactic acid), PLA; poly(glycolic acid), PGA), poly(ε-caprolactone) (PCL), 
and polyhydroxyalkanoates (e.g. poly(β-hydroxybutyrate), PHB). However, 
synthetic polymers have a major limitation: they generally lack biofunctionality. 
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This limitation is related to their inherent hydrophobicity and lack of reactive 
functional groups, leading to lower levels of cellular adhesion, proliferation, and 
differentiation.
Figure 1. Structure of polymers commonly used in electrospinning.
3. Electrospinning: A leading technique in the processing of 
biomaterials
Biodegradable (synthetic) polymers can be processed using diverse techniques, 
enabling the development of scaffolds with different shapes, morphologies, and 
physicochemical properties. Commonly applied techniques include solvent 
casting[12, 13], thermally induced phase separation (TIPS)[14, 15], freeze-drying[16, 
17], lithography[18, 19], three-dimensional (3-D) printing[20, 21], and electrospinning.
[22] Studied and patented by Formhals in the 1930s[23, 24], electrospinning is an 
efficient technique to produce ultrafine polymeric fibers by applying an electric 
force to polymeric solutions.[25] A typical electrospinning setup consists of a 
pump to push the polymeric solution, a nozzle through which the solution is 
extruded, a high voltage power supply connected to the nozzle to generate the 
electric force, and a grounded collector onto which the fibers are deposited. 
Several parameters can affect the formation and properties of electrospun fibers, 
mainly the applied voltage, flow rate, the viscosity, and conductivity of the 
polymeric solution.[26, 27] 
Electrospun fibers have a diameter of 50 nanometers to a few microns, possessing 
a high surface area-to-volume ratio and a high porosity.[28, 29] Due to these proper-
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ties, electrospun scaffolds morphologically resemble the fibrous components of 
the native extracellular matrix (ECM). This feature makes electrospun mem-
branes extremely attractive to be used as tissue engineering scaffolds.
Figure 2. Schematic illustration of an electrospinning setup.
4. Biomedical applications of biodegradable synthetic 
electrospun membranes
Electrospun membranes can be used for tissue engineering purposes. Elec-
trospun non-woven membranes, which are considered to be two-dimensional 
(2-D) constructs, show potential as barrier membranes, keeping a soft tissue 
(skin, gingiva) wound clean and avoiding bacterial infiltration. Therefore, 2-D 
electrospun scaffolds seem specifically applicable in guided bone regeneration 
(GBR) and guided tissue regeneration (GTR) procedures.[4, 9, 30] Electrospun 
membranes can then be used as a physical barrier, preventing the migration of 
fibroblasts and the formation of fibrous tissue, and hence creating in such a way 
a secluded space around the bone defects, in which osteogenic cells can migrate 
and proliferate toward the formation of new bone.[11]
In addition, drugs can be incorporated in electrospun membranes. Due to their 
high surface area-to-volume ratio, electrospun membranes represent ideal drug 
carriers. Electrospun membranes can be produced or modified to achieve either 
an immediate release of the pharmaceutical compounds or a more sustained and 
slow release. Antibacterial and pharmaceutical compounds can be loaded in the 
electrospun fibers both by blending and coaxial electrospinning or incorporated 
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using post-spinning functionalization methodologies. Membranes containing 
tetracycline[31], gentamicin[32] or vancomycin[33] have been produced and their 
antibacterial activity has been evaluated. Pharmaceutical compounds as anti-
cancer drugs[34-37], osteoinductive compounds[38, 39] or anti-resorptive drugs[40-43] 
have also been incorporated. The delivery of DNA and gene therapy using elec-
trospun membranes as a carrier is currently under investigation.[44, 45]
A disadvantage of the use of biodegradable polymers for the manufacturing of 
electrospun membranes is the final mechanical properties of the membranes. 
Frequently, the membranes are not stiff enough to maintain the space to 
allow ingrowth of bone. Consequently, polymers are combined with ceramic 
components (e.g. calcium phosphate precursors[46, 47] or silicon-based 
components[48, 49]) in order to create composite materials with enhanced 
mechanical properties. Ceramics are inherently brittle, and by incorporating 
polymeric fibers in their matrix, an improvement of the tensile properties and 
toughness can be achieved, due to resistance to crack propagation. Further, 
surface mineralization of electrospun polymeric synthetic fibers has been 
studied. By this strategy, the polymeric fibers have been coated with a mineral 
layer, leading to an improvement of their strength[50, 51] and an increase in cellular 
adhesion and proliferation.[50]
Figure 3. Biomedical applications of electrospun fibers.
General Introduction
17
1
5. Functionalization of electrospun biodegradable synthetic 
fibers
Many types of biodegradable synthetic polymers can be used for electrospinning. 
However, due to the lack of bioactivity of these polymers, the electrospun fibers 
need to be modified to render them biological functionality and improve their 
performance.
The incorporation of relevant compounds by blending is a simple and popular 
strategy. As the name indicates, during blending the compounds are mixed with 
the polymeric solution before electrospinning. This strategy has the advantage 
of being simple and straightforward, enabling an easy incorporation of 
compounds in the electrospun fibers. However, the dissolution of the polymers 
is performed mostly by using strong organic solvents, limiting the incorporation 
of biomolecules.[52, 53] Additionally, a non-homogeneous distribution of the 
compounds in the polymeric fibers can occur, leading to unpredictable release 
phenomena.[25, 54] Coaxial electrospinning was developed to address such 
drawbacks. By this technique, fibers constituted of a core and a shell are formed. 
In the formation of the core, dissolution of biomolecules or pharmaceutical 
compounds is performed using mild organic solvents or aqueous solutions, 
while the shell is composed of the electrospun synthetic polymeric component.
[55] As such, the compounds are more homogeneously incorporated in the fibers 
and their release is limited by an initial diffusion from the core to the shell and 
lastly to the medium, leading to a more sustained and controlled release.[56, 57]
Post-electrospinning strategies are also largely applied. Adsorption is a common 
strategy used to render electrospun membranes biofunctionality, by their 
immersion in solutions containing the compounds of interest. The interaction 
between the electrospun fibers and the compounds is based on physical 
entrapment and Van der Waals bonding.[58, 59] Due to this weak interaction, 
this method is often not efficient, showing a low incorporation rate. Layer-
by-layer (LbL) deposition is a more refined adsorption technique, based on 
the sequential deposition of polyelectrolytes with an opposite charge. Due to 
electrostatic interactions and hydrogen bonding, polyelectrolyte multilayers 
(PEMs) can be deposited at the surface of the fibers.[60] Charged compounds 
can also be incorporated due to their electrostatic interaction with these 
polyelectrolytes.[61, 62] Several studies demonstrated a higher incorporation of 
compounds via this technique[62-64] and the possibility to control their deposition 
and release by altering several parameters including the pH, the ionic strength 
of the solutions, or the temperature.[65-67] Covalent functionalization is a more 
permanent strategy. Reactive molecular groups (e.g. amine[68, 69], hydroxyl 
and carboxylic groups[70, 71]) can be attached to the molecular structure of 
the polymers. The incorporation of peptides or proteins in the electrospun 
materials can be achieved by these methods.[72, 73] Covalent modifications can 
have a major effect on the physicochemical properties of the fibers, modifying 
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their hydrophilicity[74], degradability[75] or mechanical properties.[76] Further, 
cellular adhesion, proliferation, and differentiation can be directed with such 
modifications.[77, 78]
6. Objectives of this thesis
Polymer-based synthetic biodegradable electrospun fibers and devices are 
widely studied for biomedical applications. However, as highlighted in this 
introduction, functional limitations are still largely present. The main goal of 
the work described in this thesis was the development of synthetic electrospun 
fibers or matrices with new physicochemical properties, which could address 
and overcome the limited biofunctionality presented by the current synthetic 
electrospun materials. In this thesis, GBR electrospun membranes possessing 
new functional properties were developed and evaluated. Further, techniques 
of post-spinning functionalization were applied to create electrospun materials 
with new chemical attributes. Finally, electrospun fibers were used for the 
formation of micro-cylindrical building blocks for biomedical applications.
Taken into account the challenges previously described, this thesis focused on 
the following research questions:
1- What is the current state-of-the-art with respect to the functionalization of 
electrospun membranes for biomedical applications? (Chapter 2)
2- Can mechanical and biofunctional properties of PCL-based electrospun 
membranes be improved by the incorporation of silica nanoparticles? (Chapter 
3)
3- Can a thermal treatment lead to a more sustained release of the simvastatin 
incorporated in PLLA electrospun membranes, enabling their use as GBR 
electrospun membranes? (Chapter 4)
4- Can a layer-by-layer (LbL) strategy, based on the deposition of PAA and PLL, 
be used to functionalize PLLA electrospun fibers, facilitating the incorporation 
of small molecules? (Chapter 5)
5- Can functionalized microcylinders be developed by a top-down modification 
of electrospun fibers? (chapter 6)
6- Does the incorporation of PLLA microcylinders in calcium phosphate 
cements (CPCs) have a positive effect on their mechanical properties? (Chapter 
7)
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List of abbreviations
 BCNU   1,3-Bis(2-chloroethyl)-1-nitrosourea
 BMP    Bone Morphogenetic Protein
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 FGF    Fibroblast Growth Factor
 GRGDY   Glycine-arginine-glycine-aspartic acid-  
    tyrosine
 LbL    Layer-by-layer
 MSC    Mesenchymal Stem Cells
 NR4+    Quaternary Ammonium
 PDA    Polydopamine
 PDGF    Platelet-derived Growth Factor
 PEG    Poly(ethylene glycol)
 PLLA    Poly(L-lactic acid)
 PCL    Poly(ε-caprolactone)
 RGD    Arginine-glycine-aspartic acid
 TMCh    N,N,N-trimethylchitosan iodide
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1. Introduction
Nowadays nanotechnology is gaining increasing relevance in scientific research, 
given that nanomaterials have shown improved mechanical, conductive, opti-
cal and biofunctional properties.[1–3] In the field of tissue engineering, the de-
velopment of nanofibrous mats is one of the most promising approaches. The 
morphological resemblance to the structure of extracellular matrix (ECM) and 
high surface area-to-volume ratio make nanofibers very appealing to be used as 
scaffolds or drug carriers.[4–7]
Nanofibers can be produced using several techniques, such as template[8, 9], 
self-assembly[10, 11], melt-blown[12, 13], phase separation[14, 15], or electrospinning 
methods.[16, 17] Among these techniques, electrospinning is widely used as it is a 
low-cost process, the setup is simple and the technique can be applied to a broad 
range of materials, including polymers. In most of the cases, electrospun poly-
meric nanofibers are based on synthetic polymers rather than naturally derived 
polymers due to their well-controlled physiochemical properties, abundant 
resources, and relatively low cost. Such fibers are easily processed and present 
appropriate reproducibility.[18–20] However, they also present a hydrophobic na-
ture and lack cell recognition signals. Such characteristics can lead to rejection 
of the implanted material, low connection with the surrounding tissues, and 
abnormal tissue regeneration and growth.[5, 21–23] Functionalization can be used 
to improve biocompatibility, cellular adhesion, tissue connection, and bioactiv-
ity. Furthermore, functionalization of electrospun fibers with clinically relevant 
compounds, such as drugs or therapeutic agents for antibacterial or anticancer 
purposes, is also widely studied due to their high loading capacity and mild pro-
cess conditions.[19, 24] Figure 1 describes the electrospinning process and the dif-
ferent functionalization approaches that can be performed, considering co-elec-
trospinning techniques or post-spinning surface modification.
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2. Electrospinning Process
The apparatus used to generate electrospun fibers consists in its essence of a 
high-voltage generator, a nozzle through which a high voltage can be applied to 
the solution of interest, and a collector. When the voltage is applied to the poly-
meric solution and the consequent electrostatic charge overcomes the surface 
tension of the solution, a jet is created. This jet elongates (at the same moment 
solvent evaporation occurs) and the resulting fibers in a non-woven form are 
deposited in the collector.[7, 25, 26] Although the concept behind electrospinning 
is rather simple, the obtained fibrous structure can be controlled via several fac-
tors, including the viscosity/concentration of the solution, the applied voltage, 
the solution flow rate, the type of collector, and others.[26, 27] Solution viscosi-
ty/concentration is a major parameter that has to be taken into account when 
developing electrospun fibers. Polymer concentration determines the entangle-
ment between the polymer chains and consequently the viscosity of the solu-
tion. If the concentration is too low, a jet cannot be produced due to the lack 
of entanglement and only droplets are sprayed. Likewise, if the concentration 
is too high, the viscosity of the solution hinders the flow of the solution and a 
constant jet cannot be developed.[27, 28] Another important parameter is the ap-
plied voltage. Several authors observed a direct relation between the augment in 
fiber diameter and the increase of the voltage field.[7, 29] However, in some studies 
the opposite behavior has been reported.[30] It can be concluded that the voltage 
effect is closely related to the nature of the polymer used. The type of collector 
also affects the final structure of the fibers produced. Rotating collectors have 
Figure 1. Different electrospun fibers’ production and surface modification approaches.
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been employed to produce fibers with a higher alignment. Such fibers presented 
an improvement of mechanical and functional properties.[4, 31, 32]
There are other technical aspects, which can influence the electrospinning pro-
cess, not being addressed in this work. For a more detailed review of these sub-
jects, articles by Agarwal, Pham, Sill, Huang, and other authors can be consult-
ed.[3, 7, 19, 25, 28]
3. Functionalization of Electrospun Fibers
As aforementioned, electrospun fibers based on synthetic polymers can be func-
tionalized in order to improve their biocompatibility and obtain an appropriate 
biological response when implanted. Such functionalization, as summarized 
in Table 1, can be achieved either by co-electrospinning, meaning mixing the 
polymer with other compounds prior to/during electrospinning process, or by 
surface modification of already prepared electrospun fibers.
3.1. Co-electrospinning
An approach developed to functionalize electrospun fibers is the incorporation 
of compounds in the fiber structure. The main advantages of such procedures 
are twofold: allowing the modification of the structural properties of the fibers 
and a longer time of release of the compounds incorporated. Co-electrospinning 
can be performed by several ways, including blending, coaxial electrospinning, 
or emulsion-based methods.
Blending
Blending of compounds with the polymeric solution and posterior electrospin-
ning is a common strategy to perform functionalization.[36, 40, 71] Because most 
of the synthetic polymers are easily dissolved in organic solvents, this meth-
od is especially effective for the incorporation of hydrophobic compounds.[72, 73] 
However, some drugs and other compounds have to be dissolved in an aqueous 
medium in order to maintain their functionality, making their incorporation 
difficult only by blending methods. Another very common phenomenon ob-
served when blending is an initial burst release of the compounds, due to their 
presence on the surface of the fibers and diffusional aspects.[19, 72, 74] 
Coaxial electrospinning
In order to overcome the drawbacks present in blending, core-shell fibers have 
been developed. One of the main techniques used to produce such structures is 
coaxial electrospinning. Coaxial electrospinning is based on the simultaneous 
electrospinning of two separated solutions, using an inner and an outer nozzle. 
The resulting fibers are composed of a core, where commonly the compounds 
to be released are present, and a shell. In most cases, the core consists of a hy-
drophilic polymer, such as poly(ethylene glycol) (PEG)[75, 76], which allows a suc-
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cessful incorporation of hydrophilic compounds. The use of a polymeric shell 
not only provides mechanical stability but also results in a more sustained and 
prolonged release of the compounds, making their action more efficient.[77–79] 
However, some disadvantages are present using coaxial electrospinning, includ-
ing the complexity of the experimental setup and procedure, and a moderate 
burst release of the compounds.[53, 74] 
Emulsion-based fibers
An alternative approach to produce core-shell fibers is emulsion electrospin-
ning. As the name indicates, this method is based on the development of wa-
ter-in-oil or oil-in-water emulsions. Ideally, during the electrospinning process, 
micelles present in the solution elongate and unify, forming a core, while the 
dissolved polymer forms a surrounding shell.[20, 80] The main advantage of this 
method is that it is a one-step method, allowing the use of a single-needle appa-
ratus while still enables the incorporation of hydrophilic compounds difficult to 
spin or to blend with the polymeric solution.[81, 82] 
3.2. Surface Modification
In the previous section, the incorporation of compounds into the fiber structure 
was described. However, in some cases surface functionalization is desirable, 
allowing the maintenance of the structural properties of the fibers, avoiding the 
use of a second polymeric solution and allowing the immobilization of different 
compounds (ECM proteins, growth factors, DNA, or drugs) on the surface of 
the fibers.
3.2.1. Adsorption
Adsorption methods are a popular and straightforward way to modify the sur-
face of electrospun fibers, being a rapid, easy and versatile route. The fact that 
electrospun fibers have a high surface area-to-volume ratio makes their func-
tionalization by adsorption very efficient. Physical adsorption and layer-by-layer 
(LbL) techniques will be addressed next. 
Physical adsorption
Physical adsorption is performed by immersing the electrospun scaffolds in a 
solution or emulsion. Electrostatic forces, hydrophobic interactions, Van der 
Waals forces and physical entrapment all can lead to the attachment of mole-
cules on the surface of the fibers, which can be rapidly released at the implan-
tation site.[72, 83] Although this burst release can be an advantage, for example in 
the rapid release of antibiotics on wound sites, such weak interactions can also 
be disadvantageous when a more controlled and sustainable release is desirable.
Nowadays, more complex systems are under development, consisting of the at-
tachment of nanoparticles or electrolytes mainly through the establishment of 
electrostatic interactions, such as using the LbL technique. In the next section, 
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such a technique will be described in more detail, for reasons of its importance 
as an adsorption based surface modification method for tissue engineering ap-
plications.
Layer-by-layer surface functionalization
The LbL technique is widely used in the development of multilayer modifica-
tions, in an attempt to overcome the limitations present in single-layer modifi-
cations. Multilayer techniques enable the attachment of molecules with differ-
ent properties on the same substrate and allow the formation of more complex 
structures and the incorporation of different biomolecules, making it possible to 
mimic to some extent the complex structure of the ECM.[22, 60, 84]
Traditionally, the LbL technique is based on the electrostatic interactions be-
tween species with opposite charges, although Van der Waals and hydrophobic 
interactions can play an important role.[83, 85, 86] Covalent LbL methods have also 
been reported, being based on covalent bonding between carbonyl, aromatic, or 
organometallic groups present in the reactive molecules.[86] The LbL technique 
presents several advantages, including its simplicity, versatility, high efficiency, 
and low cost. However, there are also some disadvantages, including the need 
for intermediate washing steps to remove excess residues and the fact that due to 
weak interactions a high initial release of compounds might occur. 
3.2.2. Covalent functionalization
The establishment of covalent bonding is an important aspect when consider-
ing surface modification of electrospun fibers. Such bonds are stronger than the 
ones present in the techniques already described, resulting in a higher stability 
and immobilization of the compounds incorporated or in a more prolonged re-
lease of the same. In most of the cases, covalent functionalization of polymeric 
fibers with biological compounds cannot be performed immediately. The main 
reason for this is the lack of reactive groups, such as hydroxyls, carboxyl, car-
bonyl, amine, or sulfhydryl groups on the surface of the polymer with which 
new molecules can react and establish new covalent bonds. Next, some of the 
major techniques used to perform covalent-based surface functionalization will 
be addressed.
3.2.2.1. Energy-mediated surface modification
For several techniques, non-thermal energy is used in order to induce chemi-
cal reactions at the surface of the electrospun fibers. In such methods, reactive 
species are subject to high-energy exposure, which leads to the formation of 
radicals and others. These species react with the surface of the fibers, inducing 
the formation of functional groups. Plasma surface modification and photo-me-
diated modifications will be addressed next as examples of energy-based surface 
functionalization techniques. 
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Plasma surface modification
Plasma surface modification is widely used in the modification of metallic, ce-
ramic and polymeric materials. It consists of the incorporation of molecular 
groups (hydroxyl, carboxyl, carbonyl, or amine groups) at the material surface 
or of the cleavage of already present groups. During plasma treatment, a sample 
is inserted in a vacuum chamber, where a low-pressure gas is injected and ener-
gized.[87–89] Several types of gases are used for plasma treatments, being divided 
into non-polymerizing gases (argon, oxygen, nitrogen, or air) and polymerizing 
gases (fluorocarbons, silicon monomers, or hydrocarbons).[83, 87] Modification 
of the surface occurs when the created groups (e.g., ions, radicals, and inter-
mediate species) are accelerated and bombard the surface of the material, lead-
ing to etching, activation and/or crosslinking phenomena.[83, 90, 91] In the case of 
polymeric fibers, such modifications greatly affect their wettability, functional 
properties, and biocompatibility as well as enable the incorporation of relevant 
compounds.[92–94] Recently, atmospheric plasma has been studied as an advanta-
geous approach when compared to more traditional plasma techniques, because 
of its low cost, the non-use of toxic reagents, and high efficiency.[95, 96] 
Although plasma treatments are commonly used for the modification of poly-
meric surfaces, they also have some drawbacks, including the possibility of the 
materials degradation and a limited actuation depth.[21]
Photo-mediated modifications
Surface modification of polymers can also be obtained by employing light-based 
energy. The increased use of photo-based techniques is explained by the high 
selectivity of the chemical reactions, processing under mild conditions, no need 
for catalysts or special solvents, and high versatility.[97] UV light is widely used 
to modify the surface of fibers. In most cases, such processes involve the use of 
light-sensitive reagents called photo-initiators.[74, 98] Such compounds react with 
the UV radiation, creating reactive species that lead to reversible or irreversible 
chemical processes on the surface of the fibers, including photo-degradation, 
photo-functionalization, photo-initiated polymerization, and photo-isomeriza-
tion.[97]
Photo-initiated polymerization is used for the functionalization of biodegrad-
able polymers, as in the case of PEG[98], polyesters[99], and others.[100, 101] Although 
photo-induced reactions present several advantages, they are also associated 
with some drawbacks. For example, in photo-degradation reactions, a loss of 
polymer molar mass can occur.[97, 101, 102] For a more detailed description of these 
processes, the following reviews can be consulted.[85, 97, 100, 101, 103]
3.2.2.2. Immobilization of organic groups
Functionalization can be performed through the covalent immobilization of 
organic groups. In such cases, the covalent attachment of a reaction product 
or the chemical scission of the polymer molecular chains occurs, allowing the 
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generation of functional groups. Hydrolysis and aminolysis are the most com-
mon chemical reactions performed for the functionalization of electrospun fiber 
surfaces with organic residues.
Hydrolysis
Hydrolysis is based on the cleavage of chemical bonds exposed at the surface 
of the polymers, resulting in the creation of new hydroxyl and carboxyl reac-
tive groups. Hydrolysis can occur at acidic or alkaline pH. Acidic conditions, 
although used during hydrolytic surface modification, require a very low pH, 
leading to a high degree of polymer degradation and resulting in a more difficult 
control over the chemical process. Alkaline conditions, on the other hand, are 
commonly performed using sodium hydroxide and are preferred due to relative-
ly mild conditions, allowing superior control over functionalization and reduc-
ing the degradation of the fibers.[29, 104–106]
Aminolysis
Aminolysis is a known technique to modify the wettability and adhesion prop-
erties of polymeric materials. By this technique, the amine precursors used in-
duce chain scission reactions and the attachment of amine groups. Such amine 
groups can further act as linking points for the incorporation of other com-
pounds, for example proteins, peptides and polysaccharides.[61, 107] Aminolysis 
can also be used to alter the structure of electrospun fibers, making it possible to 
obtain a controlled degradation of the fibers.[108, 109]
3.2.2.3. Functionalization with polymeric linkers
Covalent functionalization can be achieved by the incorporation of macromol-
ecules. In such cases, the structural properties of the fibers are extensively mod-
ified affecting their wettability, adhesion properties, and cellular proliferation 
or differentiation. In this section, surface graft techniques for the attachment of 
macromolecules and the use of polydopamines for covalent immobilization will 
be described as examples.
Surface graft polymerization
A common technique to surface functionalize fibers with polymeric linkers is 
graft polymerization. Through this method, macromolecular branches are co-
valently attached to the end groups of polymeric fiber chains, functioning as 
anchor points for the attachment of biomolecules and active agents present in 
the ECM or cellular membrane.[62, 110–113]
The most common methods used to perform graft polymerization are known as 
grafting-to, grafting-from, and grafting-through. Grafting-to consists of the di-
rect attachment of macromolecules to the surface of the polymer backbone. This 
method, although being widely used, has some disadvantages, for example, the 
occurrence of steric hindrance phenomena. An alternative approach is the graft-
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ing-from technique, which consists of the initiation of the branching polymer-
ization from the reactive sites present at the surface of the polymer backbone. 
Through this method, it is possible to achieve a higher extension of the branches 
during the grafting process. Grafting-through starts with a combination of reac-
tive monomers and acrylate functionalized macromolecules. The monomers re-
act with each other, forming the polymeric backbone, and attach to the acrylate 
branches, which can then be further functionalized.[114–116] 
Polydopamines
A recent approach to modify electrospun fibers is the functionalization of their 
surface with polydopamines (PDAs). PDAs result from the polymerization of 
dopamine at neutral to alkaline pH, due to oxidation of the catechol group pres-
ent in the dopamine molecule.[117–119] PDAs present strong adhesive properties, 
attaching to glass, metals or polymeric surfaces due to the establishment of co-
valent or coordination bonds.[120] PDAs, besides granting a hydrophilic charac-
ter to the materials where immobilized can also be used for the attachment of 
proteins or peptides.[121, 122]
Table 1 - Compounds and methods used in the functionalization of electrospun fibers for tissue 
engineering applications
Functionalization methods Compounds
Co-electrospinning
Blending
Gelatin[33]
Hyaluronic acid[34]
Chitosan[35]
Silk fibroin[36]
Collagen[36]
Laminin[37]
Elastin[38]
VEGF[39]
BCNU[40]
Paclitaxel[41]
Chlorhexidine[42]
Tetracycline hydrochloride[43]
Coaxial electrospinning
Gelatin[44]
Hyaluronic acid[45]
Chitosan[46]
Collagen[47]
Laminin[48]
VEGF[46]
Doxorubicin[49]
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4. Applications
In this section, some of the current applications in the field of tissue engineer-
ing and drug delivery for functionalized electrospun fibers will be summarized 
(Table 2).
4.1. Cell Adhesion
As already mentioned, many of the polymeric fibers produced by electrospin-
ning techniques are based on synthetic polymers, which lack specific cell rec-
ognition and binding sites. A common approach to improve the cellular ad-
Emulsion 
electrospinning
Hyaluronic acid[50]
Silk fibroin[50]
VEGF[46]
PDGF[51]
Paclitaxel[52]
Doxorubicin[53]
Physical adsorption
Laminin[37]
FGF[54]
Fibronectin[55]
BMP-2; BMP-7[56]
Paclitaxel[57]
Layer-by-layer
Gelatin[58]
Chitosan[59]
Collagen[60]
Laminin[22]
Covalent immobilization
Gelatin[21]
Heparin[33]
Chitosan[61]
Collagen[62]
Laminin[37]
Fibronectin[63]
BMP-2; BMP-7[64]
VEGF[65]
FGF[66]
Surface grafting
Collagen[67]
Elastin[68]
BMP-2; BMP-7[69]
Doxorubicin[70]
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hesion to synthetic polymeric fibers is the incorporation of natural polymers, 
for example, gelatin, heparin, hyaluronic acid or chitosan.[59,123–125] A more tar-
get-controlled approach is the functionalization of fibers with components of 
the ECM, for example, collagen, fibronectin, or laminin, which are recognized 
by receptors present on the cellular membrane and can trigger signaling path-
ways activated upon cellular adhesion.[55, 63, 67, 126, 127] Recently, peptide sequences 
have been used to improve the adhesive properties of electrospun fibers as well. 
The use of these short sequences has as main advantage that they can be incor-
porated in a higher number, presenting a lower steric hindrance when compared 
to larger macromolecules. Also, an optimal molecular orientation can be more 
easily achieved and peptides present a higher resistance to degradation. A wide-
ly studied peptide sequence to enhance cellular adhesion is the RGD sequence.
[128–131] Other sequences, such as GRGDY or E7, have also been studied.[129, 132, 133]
Inorganic compounds can be incorporated on the surface of polymeric fibers 
in order to improve the adhesion of cells. A common class of inorganic com-
pounds is represented by calcium phosphate minerals. PLLA fibers covered with 
hydroxyapatite particles have shown an increase in hydrophilicity.[134, 135] The 
surface mineralization of PCL fibers with hydroxyapatite has further shown to 
enhance the immobilization of fibronectin-osteocalcin fusion protein and con-
sequently to improve the adhesion and proliferation of mesenchymal stem cells 
(MSCs).[136]
The development of fibers with magnetic properties for tissue engineering ap-
plications is a new research topic. Magnetic fibers are commonly prepared using 
cobalt (Co), nickel (Ni), iron (Fe), or metal oxides, for example, Fe3O4. Elec-
trospinning techniques can help to overcome some of the problems regarding 
the use of such compounds, including cytotoxicity or particle aggregation.[137, 
138] The development of magnetic fibers for bone regeneration has been recently 
undertaken. It is anticipated that by subjecting bone cells to oriented magnet-
ic fields, it becomes possible to enhance cell proliferation and differentiation. 
In vitro tests performed by seeding osteoblasts in magnetic electrospun fibers 
showed reduced cytotoxicity, increased adhesion, and increased proliferation 
rates.[137, 139] 
4.2. Growth Factors and Gene Delivery Systems
Growth factors play an essential role in tissue regeneration. These proteins di-
rectly modulate cell behavior by attaching to receptors present on the cellular 
membrane, affecting cell proliferation, adhesion, migration, differentiation, 
metabolic functions, and survival. The application of growth factors to induce 
in vivo tissue regeneration or physiological responses can be simply achieved 
by local injection. However, the direct injection of these biomolecules has not 
shown a high efficiency and when applied in high concentrations resulted in ad-
verse effects. Therefore, the incorporation of such compounds within a carrier, 
for example electrospun fibers, allowing a more localized and controlled release, 
Chapter 2 Biofunctionalization of electrospun fibers for tissue engineering and regenerative medicine
40
is desirable for certain cases.[67, 127, 140] Bone morphogenetic proteins (BMP-2, 
BMP-7, or their derivates) have been successfully immobilized on the surface 
of electrospun fibers, showing to induce osteogenic differentiation of human 
mesenchymal stem cells and in vivo bone regeneration.[56, 69, 121] Vascular endo-
thelial growth factor (VEGF) and platelet-derived growth factor (PDGF) have 
also been studied in order to induce blood vessels formation and regeneration. 
An effective proliferation and adhesion of vascular endothelial cells and vascular 
smooth muscle cells in in vitro cell culture with the electrospun fibers and in vivo 
implantation of vascular grafts was achieved.[46]
Although the use of growth factors has shown great potential, many challenges 
still exist due to the complexity of the cellular signaling pathways involved in 
their action, and the absence, in most cases, of a single mechanism of action for 
these biomolecules.
A similar approach is the immobilization and release of nucleic acid sequenc-
es (i.e. containing genetic information). These biomolecules present some ad-
vantages compared to proteins, being more stable and less susceptible to deg-
radation from enzymes when released. Also, the genes being taken up by the 
cells are integrated into their genome, leading to more prolonged and higher 
protein expression levels.[141–143] An interesting approach is the possibility to in-
corporate genes, which lead to the expression of growth factors. Poly(D,L-lac-
tide)–poly(ethylene glycol) electrospun fibers have been functionalized with the 
plasmids pVEGF and pFGF in order to enhance vascularization. Higher cell 
viability, a sustained release of the plasmids, and a high density of mature blood 
vessels was achieved.[144, 145] 
4.3. Drug Delivery Applications
Another important application for electrospun fibers is the development of drug 
delivery systems. Nanofibrous systems allow not only a high load of these com-
pounds but also, due to the fact that such biomaterials are locally implanted, a 
more localized action of the therapeutic agent with high efficiency. In the fol-
lowing sections, the most recent developments in antibacterial and anticancer 
therapies are addressed.
Antibacterial strategies
Infections due to bacterial proliferation are a serious concern when considering 
the implantation of biomedical devices, especially orthopedic implants. Bacte-
ria can develop biofilms on the surface of these devices, being in many cases 
resistant to the traditional topic or intravenous treatments. Electrospun fibers 
are preferred candidates for the development of more efficient strategies, being 
the incorporation of antibacterial compounds currently under investigation.[42, 
110, 146, 147] An interesting approach is the surface functionalization of electrospun 
fibers with quaternary ammonium (NR4+) compounds. These molecules pres-
ent strong antimicrobial properties, binding to the bacterial cell membrane and 
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causing its disruption. Surface modification of polyurethane electrospun fibers 
with NR4+ has shown an efficient reduction in the number of viable Staphylo-
coccus aureus (S. aureus) and Escherichia coli (E. coli) bacteria.[148] PCL fibers 
surface-functionalized with N,N,N-trimethylchitosan iodide (TMCh) have also 
shown antibacterial activity, inhibiting the proliferation of E. coli and S. aureus 
bacteria and also the suppression of S. aureus adhesion to the fiber’s surface.[149]
Anticancer therapy
Electrospun fibers loaded with anticancer drugs are under investigation in order 
to achieve a more efficient release, diminish side effects, and prolong the half-life 
of the used drugs. Traditionally, blending or emulsion-based techniques were 
developed in order to incorporate anticancer drugs in polymeric fibers. Doxoru-
bicin, BCNU, and paclitaxel were incorporated by these methods showing anti-
tumor activity.[40, 52, 53, 150] However, non-uniform distribution of the drugs in the 
fibers and burst release profiles were observed. A very recent and target-oriented 
approach is the stimuli-dependent functionalization of polymeric fibers. By this 
method, drug release is dependent on an external stimulus, such as pH, tem-
perature, or enzyme activity.[151, 152] Jiang et al. successfully incorporated doxoru-
bicin in PCL fibers by a polydopamine-mediated surface modification method. 
The authors managed to obtain a pH-dependent release of the drug into the 
medium and an effective reduction of the number of H1299 cancer cells.[70]
Table 2 - Tissue engineering and drug delivery applications of electrospun fibers
Electrospun fiber application Compound
Improvement of cellular adhesion
Gelatin
Hyaluronic acid
Silk Fibroin
Collagen
Fibronectin
PDGF
Cellular proliferation
Heparin
Hyaluronic acid
Collagen
Fibronectin
FGF
PDGF
Cellular migration
Hyaluronic acid
Fibronectin
VEGF
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5. Conclusion
Electrospun fibers present characteristics that make them ideal for tissue engi-
neering applications. However, some challenges are still present. Issues concern-
ing mass production, reproducibility, and the use of toxic solvents are still major 
challenges for the successful development of electrospun fiber-based materials. 
Nowadays, the development of multi-nozzle systems, melt electrospinning, and 
computer-assisted electrospinning are underway in order to allow an effective 
up-scaling of the technique. The so-called green electrospinning techniques, 
which consist of the use of non-toxic solvents (e.g., water), are currently possible 
and show very promising results.
Another important aspect that is under development and certainly will be ad-
dressed in the future is the production of biodegradable three-dimensional 
systems incorporating electrospun fibers. Such materials could be a great im-
provement for the development of ECM-mimicking structures, allowing a more 
efficient attachment of macromolecules, for example, proteins and growth fac-
tors, and helping to improve tissue regeneration.
Functionalization of fibers with drugs presents some further challenges, includ-
Osteoblast proliferation and differentiation Chitosan
BMP-2; BMP-7
Neuronal differentiation and 
neurite outgrowth
Laminin
Fibronectin
FGF-2
Vascular regeneration Elastin
VEGF
Induction of angiogenesis
VEGF
FGF
PDGF
Growth factor immobilization Heparin
Antitumor activity BCNU
Inhibition of cancer cells growth and in-
duction of apoptosis
Paclitaxel
Doxorubicin
Bactericide activity Chlorhexidine
Tetracycline hydroxide
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ing uniform distribution of the drug, bioactivity maintenance, or controlled 
release profiles. The development of hybrid particle-fiber systems or physical, 
chemical, and biological stimuli-based release systems is under investigation 
and can help to realize such challenges.
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1. Introduction
 Guided Bone Regeneration (GBR) is a common therapy used for the treatment 
of lesions in the alveolar or mandible bone caused by infections or trauma. The 
principle underlying GBR is to create a secluded space in the wound site, which 
favors the proliferation of bone-forming cells and consequently results in new 
bone formation. An essential step in such a strategy is the use of a physical barrier, 
mainly in the form of a membrane, preventing the fast-growing fibroblasts from 
migrating into the wound site and keeping a space for the slow-growing bone 
tissue to regenerate.[1, 2]
Electrospinning is an ideal technique to produce polymeric GBR membranes. 
The application of an electric current to the polymeric solution leads to the 
creation of a jet and consequently to the production of polymeric fibers, due to 
the evaporation of the solvent.[3, 4] Electrospun membranes share the advantages 
of possessing a high surface area-to-volume ratio and a microstructure which 
resembles the extracellular matrix structure (ECM).[5, 6] Electrospun GBR 
membranes are made of natural or synthetic polymers.[7, 8] The use of natural 
polymers is justified by their great biocompatibility, possessing protein motifs 
that enhance cell adhesion and proliferation. However, these natural materials 
lack the ideal tensile properties for GBR applications and present a high 
degradation rate.[9, 10] Synthetic membranes are often made of polyesters, e.g. 
polyglycolide (PGA) and polylactide (PLA), which possess easily controllable 
and tunable physicochemical properties. However, PGA or PLA release acidic 
degradation products, potentially leading to local inflammatory reactions.[11] 
Poly(ε-caprolactone) (PCL) is a known biocompatible polyester, having the 
advantage that its degradation products are not acidic. A major disadvantage 
of synthetic membranes is their lack of osteoconductive capacity to allow bone 
growth along their surface and promote bone healing or regeneration.[12–14] 
A known strategy for introducing functional properties in synthetic GBR 
membranes is the incorporation of compounds that lead to improved mechanical 
properties and/or trigger an osteogenic response. These additives can be organic, 
for example, proteins and peptides[15, 16], or inorganic, such as calcium phosphate 
(e.g. hydroxyapatite) or silicate bioceramic particles.[17–19] The conjugation 
of inorganic particles and polymeric components: polymeric hydrogels[20], 
polymeric membranes[21] and polymeric molecular branches[22, 23] are a current 
strategy used in the development of materials with new functional properties. 
Such new hybrid materials are used in the most diversified areas[24], including 
in the biomedical field: cancer therapy[25–27], gene therapy[28], development 
of new antibacterial therapies[29, 30], optogenetics[31], drug delivery systems[23] 
among others. Previously, we prepared GBR membranes based on PCL and 
nano-apatite rod-like particles.[18] The addition of nano-apatite particles led 
to improved mechanical properties and osteoblast-like cells differentiation. 
However, uncontrollable aggregation of the particles inside the fibers occurred, 
Chapter 3 Development of a PCL-silica nanoparticles composite membrane for guided bone regeneration
60
which negatively affected the mechanical properties of the membranes. Calcium 
biosilicates have shown in the past to induce osteogenic cellular differentiation 
and bone tissue formation.[32, 33] More recently has been shown that silica 
nanoparticles (Si-NPs) can be an alternative type of bioceramic particles for 
osteoconductive purposes. Their application is based on their reported positive 
effect on the mechanical properties of polymeric membranes[34–36] and promotion 
of an osteogenic response from osteoblastic progenitor cells.[37, 38] However, 
despite promising results, Si-NPs weight percentages above 30 wt% frequently 
result in adverse effects, e.g. particle aggregation[39, 40], poor interaction between 
the polymeric components and the silica particles[34] or non-ideal mechanical 
properties.[41]
The aim of this study was to develop a PCL-based GBR membrane, in which Si-
NPs are more homogeneously dispersed inside the electrospun fibers at amounts 
above 30 wt%. To this end, Si-NPs were produced by a sol–gel Stöber method to 
achieve mono-sized nanoparticles.
Membranes with a series of PCL : silica weight ratios (100:0, 100:25, 100:50 
and 100:75) were fabricated by an electrospinning methodology. Morphology, 
structure, and chemical composition were analyzed via scanning electron 
microscopy (SEM), transmission electron microscopy (TEM), attenuated 
reflectance-infrared spectroscopy (ATR-IR) and X-ray diffraction (XRD). 
Mechanical properties were evaluated using a tensile test. Stability of the 
membranes in wet conditions was evaluated by immersion in phosphate buffered 
saline (PBS) solution at 37 °C. Osteoblastic cell response was determined by in 
vitro culture of MC3T3-E1 cells on the membranes and by assessing cellular 
morphology, proliferation, and osteogenic differentiation.
2. Materials and methods
2.1. Preparation of silica nanoparticles
Si-NPs were prepared using a Stöber method.[42] Briefly, a 6% v/v mixture of 
ammonia (ammonia solution 25%; Merck; Germany) in ethanol was prepared. 
Afterward, tetraethyl orthosilicate (TEOS; reagent grade, 98%; Sigma-Aldrich; 
USA), was added to the mixture, under continuous stirring, and left to react 
at room temperature for 30 minutes. The solution was kept at 4 °C overnight. 
Finally, the nanoparticles were washed first with ethanol, second a mixture of 
ethanol-ddwater (50:50) and third ddwater, with intermediate centrifugation and 
redispersion steps.
2.2. Preparation of the polymeric solutions and fabrication of the membranes
Four solutions were prepared by firstly dissolving PCL (average Mn 80,000; 
Sigma-Aldrich; USA) in a 80% v/v 2,2,2-trifluoroethanol (TFE; Sigma-Aldrich; 
USA)/ ddwater mixture with sodium dodecyl sulfate (SDS; Fluka; Germany) 
(Table 1). Afterward, a specific amount of Si-NPs was added and the dispersion 
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Table 1. Si-NPs : PCL membranes composition
Membrane Si-NPs : PCL weight ratio Si-NPs weight / % SDS / %
S0 0 : 100 0 0.05
S25 25 : 100 20 0.05
S50 50 : 100 33 0.05
S75 75 : 100 43 0.05
A commercially available electrospinning setup was used for the fabrication of 
the membranes (Advanced Surface Technology, The Netherlands). The prepared 
solutions were fed into a glass syringe, controlled by a pump (KD Scientific Inc.; 
USA), and connected by a Teflon tube to a blunt-end nozzle with an inner di-
ameter of 0.5 mm. The electrospinning process was performed with a distance 
between the nozzle and a roll-drum collector of 20 cm, a voltage between 18–22 
kV and a feeding rate of 2.0 mL h−1.
2.3. Morphological and structural evaluation
The morphology of the membranes was observed using scanning electron mi-
croscopy (SEM; Zeiss, SIGMA 300; The Netherlands) and transmission electron 
microscopy (TEM; 1101, JEOL; Japan). Images were taken at 1,000× magnifica-
tion and 10,000× magnification for SEM and 20,000× for TEM.
The chemical profile of the membranes was determined by attenuated total re-
flectance-infrared spectroscopy (ATR-IR; UATR two, PerkinElmer, The Nether-
lands) with a resolution of 4.0 cm−1 and a scanning range from 400 cm−1 to 4000 
cm−1.
X-ray diffraction (XRD; pw1830, Philips; The Netherlands) was performed to 
determine the crystallographic profile of the samples. Electrospun membranes 
as a thin planar layer were placed in a glass holder and scanned. XRD spectra 
were registered at 40 kV, 30 mA (Cu-Kα radiation with a wavelength of 1.54 Å) 
and a 2θ between 10 and 40°, at a step size of 0.005°.
2.4. Mechanical evaluation
To determine the effect of silica nanoparticles on the mechanical performance 
of the membranes, 6 samples of 10 mm in width and 50 mm in length were 
cut with a scalpel and tested for each group. The thickness of the membranes 
was left to mix overnight. Table 1 describes the Si-NPs : PCL weight ratio and 
silica weight percentages.
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was measured with a caliper having a precision of 0.01 mm. The samples were 
attached to a tensile test machine (LS1; Lloyd instruments; Ametek; USA) using 
10 mm of the sample on both ends. The tensile properties of the membrane were 
tested with a 100 N load cell under a cross-head speed of 10 mm min−1. The fol-
lowing mechanical properties were recorded or calculated from the stress–strain 
(σ–ε) curves: (1) the tensile modulus was calculated from the slope of the initial 
linear part of the curve, consisting of 10% of the initial strain values (2) the max-
imum strain at break was defined as the maximum strain that the samples could 
reach immediately before break and (3) the tensile strength was defined as the 
maximum stress at break.[43]
2.5. Stability of the membranes in a wet environment
Circular membranes with a diameter of 15 mm were punched from the electro-
spun sheets. Each sample was immersed in 10 mL of phosphate buffered saline 
(PBS) solution in a test tube. All tubes (n=3) were placed in a water bath at 37 °C 
under continuous shaking. After immersion periods of 14, 21 and 28 days the 
membranes were washed with ddwater and freeze-dried. The membranes, before 
and after PBS immersion, were examined by SEM.
2.6. In vitro cell culture
MC3T3-E1 cells (ATCC, USA) were maintained in α-MEM medium (Gibco®, 
Life Technologies; USA) supplemented with 10% v/v fetal bovine serum (FBS; 
Gibco®) and a mixture of penicillin (100 Units ml-1) /streptomycin (100 μg ml-1) 
(Gibco®) in an incubator with 5% CO2 at 37 °C.
Electrospun membranes were disinfected using a plasma cleaning procedure, 
consisting of exposing the membranes for 5 minutes to charged argon and 
followed by immersion in ethanol 70% v/v for 1 hour. Afterward, the membranes 
were washed with PBS three times and incubated with non-osteogenic culture 
medium overnight. Cells were seeded at a density of 10,000 cells cm−2 on top of 
the membranes and cultured with osteogenic medium: α-MEM supplemented 
with 10% FBS, 0.2 mM ascorbic acid, 10 mM sodium β-glycerophosphate and 10 
nM dexamethasone (supplements were purchased from Sigma-Aldrich).
Samples used for cellular morphology evaluation were collected at 3, 14 and 
28 days. A 2% v/v solution of glutaraldehyde (glutaraldehyde solution 25%; 
Merck; Germany) was used to fixate the cells and a series of dehydration steps, 
using ethanol at different concentrations, (70%, 80%, 90%, 96% and 100% v/v) 
were performed. Lastly, samples were covered with tetramethylsilane (TMS; 
≥99.0% GC; Sigma-Aldrich; USA). Afterward, samples were prepared for SEM 
observation.
DNA quantification and ALP (alkaline phosphatase) activity measurements 
were performed as described in previous studies.[44] Membranes cultured 
with cells were collected and immersed in 1 mL of ddwater. Afterward, three 
freeze-thaw cycles were performed, in order for cellular lysis to occur. Cellular 
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DNA content was measured at 3, 7, 14, 21 and 28 days using a Quant-IT™ 
PicoGreen® ds-DNA Assay Kit (Invitrogen; The Netherlands) according to the 
manufacturer’s instructions. In a 96-well plate 100 μl of sample or standard were 
added to a working solution. The plates were incubated at room temperature in 
the dark for 5 minutes and fluorescence read (excitation: 485/20 nm; emission: 
530/25 nm). ALP activity was analyzed at 3, 7, 14, 21 and 28 days of culture. ALP 
activity was measured by a p-nitrophenyl phosphate (4-NP; Sigma-Aldrich, 
USA) colorimetric assay, according to the manufacturer’s instructions. 80 μL 
of samples or standards were added to 20 μL of buffer and 100 μL of substrate. 
The mixture was incubated for 60 minutes at 37 °C. Afterward, 100 μL of 0.5 M 
NaOH was added, in order to stop the reaction. Absorbance at 405 nm was read 
and ALP activity normalized according to the DNA content for each sample.
2.7. Statistical analysis
Measurement of fiber diameter was performed based on SEM images (n = 100 for 
each composition) and diameter distribution was calculated using Origin Pro 8.0 
software (OriginLab Corporation, USA). Analysis of the mechanical properties 
of the membranes was performed using Prism 6.01 software (GraphPad Software, 
Inc., USA). Data were reported as mean ± standard deviation (SD). Significance 
was evaluated using a one-way ANOVA significance test combined with a post-
hoc Tukey’s multiple comparison test. Differences were considered significant at 
p < 0.05. DNA quantification and ALP activity values (n= 6) were analyzed using 
Prism 6.01 software performing a two-way ANOVA significance test combined 
with a post-hoc Tukey’s multiple comparison test. Differences were considered 
significant at p < 0.05.
3. Results
3.1. Morphological evaluation of the membranes
The SEM images in Figures 1a–d show that the PCL membranes with different 
amounts of Si-NPs consisted of smooth fibers. For membranes S50 and S75, 
noticeable nanoparticle agglomerates were present in between the fibers as 
indicated by the yellow arrows (Figures 1c and 1d). Figures 1e–h present the 
fibers diameter and size distribution and show that with increasing amounts of 
Si-NPs, the diameter of the fibers and the fiber size distribution decreased (1.4 
± 1.68 μm for S0, 0.4 ± 0.25 μm for S25; 0.1 ± 0.04 μm for S50 and 0.2 ± 0.05 μm 
for S75).
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Figure 2 presents TEM images for the different electrospun fibers. S0, the pure 
PCL fiber, presented a uniform morphology. Dark dots were observed in the 
fibers of S25, S50, and S75 compositions, indicating that the Si-NPs were incor-
porated inside of the electrospun fibers. No signs of aggregation were observed 
for S25 and S50 fibers. However, for S75 fibers, a low degree of aggregation of 
the Si-NPs seemed to occur.
Figure 1. SEM images of membranes prepared by electrospinning; 10,000× magnification a) S0 
b) S25 c) S50 d) S75. Images highlighted in red 1,000× magnification. Yellow arrows indicate 
nanoparticles agglomerates. Fibers diameter and size distribution for e) S0 f) S25 g) S50 h) S75.
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Figure 2. TEM images of fibers prepared by electrospinning; 20,000× magnification a) S0 b) S25 
c) S50 d) S75.
3.2. Structural characterization
ATR-IR and XRD were performed and the results are shown in Figures S1 and 
S2 in Supplementary Information. ATR-IR spectra display peaks at 1725 cm−1 
and 1185 cm−1 for all compositions, associated with C=O and C-O-C groups in 
PCL (blue lines in Figure S1). For the compositions containing Si-NPs, peaks 
related to Si-O-Si stretching were also detected at 475 cm−1, 807 cm−1 and 1070 
cm−1 (red lines in Figure S1). With increasing amounts of Si-NPs, a decrease in 
intensity for the peak at 1185 cm−1 was observed. XRD spectra were similar for 
all compositions, presenting a first peak at 21.25° and another peak at 23.70°; 
both peaks are assigned to PCL lattice planes, i.e. (110) and (200) respectively 
(Figure S2).
3.3. Mechanical evaluation
Membranes were subjected to a tensile test. Figure 3a presents a typical stress 
(σ) - strain (ε) curve for each group. Tensile modulus, strain at break and tensile 
strength were calculated based on the stress-strain curves. A significant increase 
in tensile modulus was observed for S50 when compared with S0, with the val-
ues of 13.5 ± 1.27 MPa and 9.5 ± 1.75 MPa respectively. However, when higher 
amounts of Si-NPs were incorporated (S75) a decrease in tensile modulus oc-
curred (8.9 ± 1.32 MPa). The incorporation of Si-NPs also had an effect on the 
strain at break. Figure 3c demonstrates that with increasing amounts of silica 
the strain at break decreased. S25 and S50 presented a significant increase in 
tensile strength compared to pure PCL membranes (2.9 ± 0.31 MPa for S0, 6.5 ± 
1.55 MPa for S25 and 5.8 ± 0.19 MPa for S50). However, S75 presented a tensile 
strength similar to S0 membranes (3.7 ± 0.99 MPa).
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3.4. Stability of the membranes in a wet environment
In order to evaluate the stability of the electrospun fibers in a wet environment 
and silica release, the membranes were immersed in PBS at 37 °C for 14, 21 and 
28 days. Figure 4 shows the SEM images for the immersed membranes after 14 
days. S0 electrospun fibers did not show significant signs of degradation, as fis-
sures or cracks (Figure 4a). Membranes containing Si-NPs presented spherical 
holes (Figures 4b–d, red arrows) in the surface of the electrospun fibers, indicat-
ing release of Si-NPs present in the outer regions of the fibers.
Figure 3. a) Stress-strain curves of the electrospun membranes. Tensile test results b) tensile mod-
ulus c) maximum strain at break d) tensile strength. *p < 0.05, **p < 0.01, ***p=0.0001, ****p < 
0.0001.
a)
c)b) d)
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Figure 4. SEM images of membranes immersed in PBS for 14 days; 10,000× a) S0 b) S25 c) S50 d) 
S75. Red arrows indicate holes in the surface of electrospun fibers.
3.5. In vitro cell culture
Figure 5 presents the membranes after in vitro culture with MC3T3-E1 cells. Af-
ter 3 days of culture, cells were observed on the surface of all membranes. Cells 
possessed a “star-shaped” morphology, indicating adherence to the electrospun 
fibers.
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Figure 6. a) DNA quantification of MC3T3-E1 cells cultured with membranes. b) ALP activity of 
MC3T3-E1 cells cultured with membranes. *p < 0.05, **p < 0.01, ****p < 0.0001.
Figure 5. SEM images of membranes after in vitro culture with MC3T3-E1 cells; 1,000× magnifica-
tion. Images highlighted in red 10,000× magnification a) S0 3 days b) S0 28 days c) S25 3 days d) 
S25 28 days e) S50 3 days f) S50 28 days g) S75 3 days h) S75 28 days.
DNA quantification demonstrated an increase in DNA content with time for all 
groups. For S0 higher amounts of DNA were measured compared to membranes 
with Si-NPs from 14 days of culture (Figure 6a). ALP-activity was evaluated at 
day 3, 7, 14, 21 and 28. Figure 6b shows that ALP activity was only detected after 
14 days of culture. 
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4. Discussion
The addition of bioceramic nanoparticles in electrospun membranes is a 
straightforward strategy for the fabrication of functional GBR membranes with 
improved properties. However, aggregation of nanoparticles and a weak inter-
action between the ceramic and polymeric components can occur during the 
fabrication process, which in turn weakens the mechanical properties of such 
materials. Here, we developed a composite GBR membrane with significantly 
enhanced mechanical properties by incorporating high amounts of Si-NPs (i.e.> 
30 wt %) without substantial aggregation. A Stöber method was selected to pre-
pare the Si-NPs, since previous studies have shown that the physical and chem-
ical properties of the nanoparticles could be precisely tuned by this method. 
Nanometric particles were successfully produced and adequate control over size 
and shape of the nanoparticles was achieved. The nanoparticles presented a clear 
spherical shape and homogenous dimensions. Our results showed that Si-NPs 
were successfully incorporated in the electrospun fibers and aggregation starts 
to occur for composition S50, although being only substantial for composition 
S75 (Si-NPs content of 43 wt %). Mechanical properties of the membranes were 
highly affected by the incorporation of Si-NPs. Tensile strength for composition 
S25 and S50 and tensile modulus for composition S50 increased significantly 
with the incorporation of the nanoparticles. In vitro cell culture with MC3T3-E1 
osteoblastic cells demonstrated that none of the compositions were cytotoxic, 
allowing cell adhesion and proliferation. Osteogenic differentiation occurred for 
cells cultured on all the membranes.
The major goal of this work was to incorporate a high number of nanoparticles 
in the electrospun fibers, achieving a more homogeneous distribution of the 
nanoparticles and averting aggregation. A major cause for such aggregation 
are the particles concentration in solution, particles diameter and attractive 
interactions between the particles, being these stronger when considering 
anisotropic particles.[45–47] In order to overcome this issue, two strategies were 
adopted. First, Si-NPs were developed using a Stöber sol–gel method[42], which 
enabled adequate control over nanoparticle diameter and size distribution. A 
second strategy was the use of a mixture of TFE and water, conjugated with a 
surfactant, as already described by Yang et al.[18] TFE is a fluorinated alcohol 
commonly used for the dissolution of polypeptides and polymers, such as PCL. 
Water was added to increase the dielectric constant of the solution, enabling 
the production of electrospun fibers without beads or defects. Homogenous 
electrospun fibers with a smooth surface were produced and, as observed by 
TEM, Si-NPs are well dispersed in the interior of the fibers up to a Si-NPs weight 
content of 43 wt%, which is remarkable, especially when compared with similar 
recent studies.[39, 48–50] TFE interacts strongly with the PCL polymeric chains, 
resulting in their swelling and a looser polymeric matrix.[51, 52] This effect allows 
for an improved dispersion of the silica nanoparticles in the solution. Addition of 
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the anionic surfactant SDS likely also contributed to the appropriate dispersion 
of the nanoparticles in the solution. SDS is an amphiphilic molecule, interacting 
with both hydrophobic and hydrophilic compounds. Karlson et al. explain such 
effect by a surrounding of the nanoparticles by the hydrophilic group of the 
surfactant molecules, exposing at the same time their hydrophobic region to 
the polymeric chains. This way, the surfactant worked as a “bridge” between 
PCL and Si-NPs.[53, 54] The presence of a high number of particles in composition 
S75, combined with their hydrophilic nature led to the hindrance of their 
dispersion in the PCL solution, resulting in phase separation between silica-rich 
and PCL-rich regions within the fibers and the formation of aggregates in the 
interior of the PCL fibers.[40, 55] Incorporation of Si-NPs had a significant effect 
on the morphology of the electrospun fibers. When comparing the diameter 
of the electrospun fibers for the different compositions, a decrease in fiber 
diameter with increasing Si-NPs content was observed (Figure 1). As apparent 
from Tables S1 and S2 in the Supplementary Information, the addition of Si-
NPs resulted in an increase of the conductivity and viscosity of the solutions. 
As postulated previously, an increase in conductivity leads to a greater tension 
in the polymeric jet during electrospinning, resulting in an easier formation of 
fibers and hence in a decrease in fiber diameter.[3, 5] According to several studies, 
an increase in viscosity leads to an increase in fiber diameter.[56, 57] However, this 
effect was not observed in our work. A possible explanation is that when Si-
NPs were incorporated the increase in conductivity overbalanced the increase 
in viscosity, leading to the rapid formation of the fiber jet and the production of 
fibers with a smaller diameter.
The mechanical properties of the membranes were significantly affected by the 
incorporation of Si-NPs. The tensile modulus of S50 membranes was significantly 
higher than pure PCL membranes (S0), showing that the incorporation of the 
Si-NPs was beneficial up to this amount. The actual values of tensile moduli 
can be explained by the properties of PCL and silica. PCL presents a glass 
transition temperature (Tg) of approximately -60 °C and polymers subjected 
to electrospinning have shown to present a lower crystallinity.[58] The reduction 
in crystallinity can affect the elastic behavior of the membranes, making them 
become easily deformed when subjected to tensile forces. S0 membranes are 
composed solely by PCL, presenting the lowest value of tensile modulus. The 
incorporation of Si-NPs compensated the low modulus of PCL for compositions 
S25 and S50. The homogeneous distribution of the nanoparticles inside the 
electrospun fibers can explain the increase in tensile modulus. Allo et al. claim 
that the presence of silica could promote cross-linking phenomena among the 
PCL fibers, due to the bonding between the silanol groups (Si-OH) present in 
the Si-NPs and the carbonyl groups (C=O) present in PCL.[59] In our study, the 
formation of these bonds could not be confirmed by ATR-IR, although specific 
peaks attributed both to PCL and Si-NPs were detected. When membranes S25 
and S50 were subjected to tension, the Si-NPs inside the electrospun fibers likely 
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“hold” the polymeric chains, hindering fiber deformation and increasing the 
elastic behavior of these membranes.[60]
The addition of Si-NPs led to a significant increase of the tensile strength, 
achieving more than double the value of S0 for S25 and S50 membranes. 
Furthermore, compared to several studies focused on the development of PCL-
silica based composite membranes, it is noticeable that the values obtained in this 
study are superior or equal to those reported previously.[34, 40, 61–63] This increase in 
tensile strength can be explained by the fact that Si-NPs were distributed along 
the electrospun fibers for compositions S25 and S50, being mostly separated 
from each other. Such dispersion of the nanoparticles inside the electrospun 
fibers resulted in an alignment of the nanoparticles in the interior of the fibers, 
when these were subjected to tensile forces.
Upon immersion of the membranes in PBS the presence of holes in the fibers 
from S25, S50, and S75 membranes was observed (Figure 4). Such results 
demonstrate that dissolution of the Si-NPs occurs through time.[34, 37] The release 
of Si-NPs in the PBS potentiates the clinical relevance of such membranes by the 
increase of silica levels in the medium.[64, 65] To obtain better insight into the effect 
of PCL : Si-NP membranes on osteoblastic differentiation, an in vitro culture 
with osteoblastic MC3T3-E1 cells was performed. An increase in DNA content 
could be observed for all compositions when comparing earlier times of in vitro 
culture (3 and 7 days) and later time points (14, 21 and 28 days). Cells were 
cultured in osteogenic medium and consequently, osteogenic differentiation was 
expected for all groups. In this study, it was intended to evaluate if the presence 
of membranes containing silica would affect the osteogenic differentiation rate 
and levels. ALP levels and activity could be detected for all the compositions. 
However, a direct effect from the Si-NPs on osteoblastic differentiation could 
not be determined.
5. Conclusion
The present study aimed to develop electrospun membranes for GBR with 
improved mechanical and biofunctional properties. Nanometric spherical Si-
NPs were produced and successfully incorporated in the PCL fibers, being the 
nanoparticles well dispersed in their interior up to a PCL : Si-NPs ratio of 100:75 
(43 wt%). Tensile modulus and tensile strength improved when Si-NPs were 
added. Membranes have shown to be cytocompatible although a direct action of 
the membranes on osteoblastic differentiation could not be observed.
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Supplementary Information
Table S1. Conductivity of the prepared compositions
Composition Conductivity / μS cm-1
S0 5.7±0.28
S25 34.1±0.73
S50 31.4±0.26
S75 23.4±0.05
Table S2. Viscosity of the prepared compositions
Composition Viscosity / cP
S0 891±28.1
S25 1400±16.7
S50 2227±20.6
S75 5693±66.0
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3Figure S1. ATR-IR spectra for electrospun membranes. Blue lines delimit the bands assigned to PCL groups. Red lines delimit the bands assigned to silica groups.
Figure S2. XRD spectra for electrospun membranes. a describes the peaks assigned to PCL.
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1. Introduction
 Dental implants are a common treatment option for replacing missing teeth due 
to diseases, like periodontitis, or trauma. Successful implant placement requires 
adequate alveolar ridge dimensions, which are essential to house the implant 
and provide esthetics and function.[1] Unfortunately, this is usually not the case 
due to bone resorption or damage. Therefore, a ridge augmentation technique 
is oen required to regenerate enough bone for successful implant placement. 
Guided bone regeneration (GBR) is an established strategy for this purpose and 
is based on the creation of a secluded space, in which pluripotent and osteogenic 
cells are allowed to proliferate and form new bone, whilst so tissue formation 
(by e.g fibroblasts and epithelial cells) is inhibited.[1] This can be achieved by a 
physical barrier, mainly in the form of a membrane.[2, 3]
Electrospinning is an optimal technique to create polymeric membranes. Via 
electrospinning, polymer solutions are ejected under an electrical force; the 
fluid jet is elongated and solidifies to ultrafine fibers before reaching a collector; 
those randomly deposited ultrafine fibers form non-woven membranes.[4] The 
electrospun membranes have a high porosity and surface area-to-volume ratio, 
resembling the extracellular matrix (ECM) structure. More importantly, the 
pore size of the electrospun membranes, in general, is less than the average cell 
size and previous studies have shown that such small pores do not allow cell 
penetration.[5]
GBR membranes do not possess an active role in local bone regeneration, and 
specifically synthetic membranes are inherently hydrophobic[6, 7] and biologically 
inert.[8]Different strategies can be adopted to overcome these drawbacks. The 
development of new materials based on polymeric composites[5, 9] or graphene/
graphene oxide composites[10, 11] are promising approaches, leading to the 
proliferation and osteogenic differentiation of osteoblastic cells. An alternative 
strategy is the incorporation of osteostimulatory compounds. The incorporation 
of growth factors, such as bone morphogenetic proteins (BMPs) is a first choice 
due to their potent osteoinductive effect.[12, 13] However, their incorporation 
is limited by their inactivity when in contact with organic solvents or at 
physiological conditions, uncontrolled release which can lead to supraphysiologic 
concentrations and high cost.[14, 15] Small osteogenic pharmaceutical drugs have 
shown to be a promising alternative, showing higher chemical stability and 
a lower cost.[16] Simvastatin (SV) is used to treat hypercholesterolemia and 
hyperlipidemia.[17, 18] Recently, it has also been reported that SV directly promotes 
osteoblastic differentiation and improves new bone formation by increasing the 
expression of bone morphogenetic protein-2 (BMP-2), alkaline phosphatase 
(ALP), osteocalcin and collagen type 1 (COL1) mRNAs in osteoblast-like cells 
and stem cells. The mechanism associated with the influence of simvastatin on 
the osteogenic differentiation is not fully understood. However, recent studies 
point out to a direct action of simvastatin in the activation of the Wnt/β-catenin 
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signaling pathway, which is involved in the differentiation of mesenchymal stem 
cells (MSCs) and the proliferation, differentiation, mineralization and apoptosis 
of osteoblastic cells.[19] Promotion of angiogenesis by SV has also been reported.
[20] SV has been incorporated in different materials, including calcium-phosphate 
particles and granules,[20, 21] metallic substrates[22, 23] and polymeric particles,[24] 
micelles[25] and scaffolds.[26, 27] Electrospun polymeric membranes containing 
SV have been previously developed,[28, 29] but SV release from these membranes 
occurred as fast as within 8 days,[20, 21, 24, 26] which does not match the pace of bone
regeneration ( ~12 weeks).[30] Consequently, the need for a system achieving 
prolonged SV release is apparent.
Thermal treatments such as annealing,[31] quenching,[32] or aging[33] are commonly 
used to modify the physicochemical properties of polymers. By heating a polymer 
to a temperature slightly above its cold crystallization temperature (Tcc), it is 
possible to increase its overall crystallinity. Here, our goal was to develop an 
electrospun poly(L-lactic acid) (PLLA) membrane for prolonged SV release. 
PLLA was chosen due to its biocompatibility, biodegradability, and appropriate 
mechanical and physicochemical properties. More specifically, PLLA showed no
obvious degradation within 3 months, which ensures the mechanical stability 
of the GBR membranes during the treatment period.[34, 35] PLLA is a semi-
crystalline polymer and it has been reported that the change of crystallinity 
of a polymeric drug carrier significantly affects the release of drugs.[36–40] 
Consequently, we utilized thermal treatment of the electrospun PLLA 
membranes to increase its crystallinity and control the drug release. The 
morphological properties of the membranes were evaluated by scanning electron 
microscopy (SEM), physicochemical properties were analyzed by attenuated 
total reflectance-infrared spectroscopy (ATR-IR), X-ray diffraction (XRD) and 
differential scanning calorimetry (DSC). The release profile of simvastatin from 
the membranes with or without thermal treatment was evaluated by in vitro 
incubation in near-physiological conditions at 37 °C. The cellular osteogenic 
response to the membranes and biological activity of SV was determined by 
in vitro culture of the different membranes with rat bone marrow stromal 
cells (rBMSCs) and evaluating cell morphology, proliferation, and osteogenic 
differentiation over culture time. 
2. Materials and methods
2.1. Preparation of polymeric solutions and fabrication of electrospun 
membranes
Poly(L-lactic acid) (PLLA; Purasorb PL65®; Corbion, The Netherlands) solutions 
were prepared by dissolving the polymer in 1,1,1,3,3,3-hexafluoroisopropanol 
(HFIP; Fluorochem, UK) to a concentration of 3% w/v. Solutions containing 
simvastatin (SV; Sigma-Aldrich, USA) were prepared by dissolving the SV (5% 
w/w to PLLA) and PLLA in HFIP and le to be stirred overnight. Membranes 
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were prepared by electrospinning (Advanced Surface Technology BV, The 
Netherlands) and the following parameters were applied: needle diameter = 1.2 
mm, feeding rate = 2.0 ml h-1; distance between the needle and the collector = 
20 cm; voltage = 19.25 kV.
Thermal treatment of the membranes was performed in an oven at 80 °C for 16 
hours.
Four different membranes were produced: pure PLLA membranes (PLLA); 
PLLA membranes subjected to the thermal treatment (PLLA HT); PLLA 
membranes containing simvastatin (PLLA + SV); PLLA membranes containing 
simvastatin and subjected to the thermal treatment (PLLA + SV HT). 
2.2. Morphological and structural evaluation
The morphology of the membranes was observed using scanning electron 
microscopy (SEM; SIGMA 300; Zeiss, The Netherlands). Samples were fixed into 
aluminum stubs with carbon tape and sputter coated with chromium (thickness 
of 20 nm).
The chemical profile of the membranes was assessed by attenuated total 
reflectance-infrared spectroscopy (ATR-IR; UATR two; PerkinElmer, The 
Netherlands) with a resolution of 4.0 cm-1 and a scanning range from 400 cm-1 
to 4000 cm-1.
X-ray diffraction (XRD; X’pert3 powder; PANalytical, The Netherlands) 
was performed to determine the crystallographic profile of the membranes. 
Electrospun membranes as a thin planar layer were placed on a glass holder and 
scanned. XRD spectra were registered at 40 kV, 30 mA (Cu-Kα radiation with 
a wavelength of 1.54 Å) and a 2θ between 10° and 40°, at a step size of 0.005°.
Crystallinity was determined by modulated differential scanning calorimetry 
(DSC; Discovery®; TA instruments, The Netherlands). For DSC analysis, samples 
were placed in perforated aluminum pans, to avoid overpressure, and scanned 
from 20 to 200 °C at a heating rate of 2 °C min-1. The degree of crystallinity (χc%) 
was calculated considering the ratio between the experimental heat of melting 
(ΔHm) minus the cold crystallization heat (ΔHcc) and the heat of melting 
of 100% crystalline PLLA (ΔH°m = 93.6 J g-1),[41] according to the following 
equation:
χc% = [ΔHm -ΔHcc]/ ΔH°m x 100
2.3. Release of simvastatin (SV) in an aqueous medium
Membranes containing SV with or without thermal treatment (≈ 0.8 mg each 
sample) were immersed in 1 ml of PBS at 37 °C. The supernatant was collected 
at predetermined time points, being the medium renewed with 1 ml of PBS. 
The amounts of SV released were determined by liquid chromatography-mass 
spectrometry (LC-MS). The conditions of analysis were the following:
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LC-MS was performed with a mobile phase that consisted of acetonitrile (ACN) 
+ 0.1% v/v formic acid and water (H2O) + 0.1% v/v formic acid, with a gradient 
of acetonitrile from 5 to 100% for 30 minutes and a flow rate of 0.2 ml min-1. 
Charged ions ([simvastatin + H]+ at m/z = 420.57 and [simvastatin acid + H]+ 
at m/z = 437.59) were analyzed in order to determine the amount of simvastatin 
present in the samples.
The release of SV was fitted according to the Higuchi and Korsmeyer–Peppas 
mathematical kinetic models.
2.4. In vitro cell culture
rBMSCs were cultured with the membranes and their osteostimulatory potential 
evaluated. rBMSCs were isolated from healthy male Wistar rats with Radboud 
UMC Animal Ethics Committee approval (RU-DEC 2014-157). Cell culture 
medium and all supplements were purchased from Gibco (Gibco®, Life
Technologies, USA), except the fetal bovine serum (FBS; Sigma-Aldrich, USA). 
rBMSCs were isolated and cultured using a method adapted from Maniatopoulos 
et al.[42] The tibia of male Wistar rats were extracted, and epiphyses were cut off. 
Cells were flushed out of the remaining diaphyses using cell culture medium 
consisting of α-MEM supplemented with 10% v/v fetal calf serum, 50 mg ml-1 
ascorbic acid, 10-8 M dexamethasone, 50 mg ml-1 gentamycin and 10 mM sodium 
β-glycerophosphate. The flush-out of the two tibias was cultured for one day in 
three 75 cm2 culture flasks in a humidified incubator (5% CO2; 37 °C), aer 
which the medium was refreshed to remove non-adherent cells. The osteogenic 
potential of the cells was assessed by culturing rBMSCs with an osteogenic 
medium for 28 days, presenting the cells mineralization capability.
A preliminary study was firstly performed to evaluate the cytotoxicity of 
simvastatin. Briefly, rBMSCs were cultured in a growth medium (α-MEM 
supplemented with 10% v/v FBS, 100 units per ml penicillin, and 100 mg ml-1 
streptomycin) containing different concentrations of simvastatin (4200 ng ml-1 
or ≈10-5 M, 420 ng ml-1 or ≈10-6 M, 42 ng ml-1 or ≈10-7 M, and 4.2 ng ml-1 or ≈10-8 
M) at a cell density equal to 2 x 104 cm-2 and incubated in a humidified incubator 
(37 °C, 5% CO2). Cytotoxicity was evaluated both by visual examination with an 
optical microscope (DM IL LED, Leica, The Netherlands), for the cells cultured 
at 3 days, 14 days and 28 days, and by an AlamarBlue® viability test (Molecular 
Probes™, Invitrogen®, Thermo Fisher Scientific, The Netherlands) aer 3, 7, 14, 21 
and 28 days, according to the manufacturer's instructions to obtain quantitative 
data on cellular activity. Viability percentages are relative to a positive control, 
where rBMSCs were cultured in an osteogenic medium (α-MEM supplemented 
with 10% v/v FBS, 50 mg ml-1 ascorbic acid, 10-8 M dexamethasone, 10 mM 
sodium β-glycerophosphate and 100 units per ml penicillin + 100 mg ml-1 
streptomycin).
For the cell culture experiments, electrospun membranes were first disinfected 
with Argon plasma for 5 minutes (plasma cleaner/sterilizer PDC-001; Harrick, 
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USA). rBMSCs were statically seeded in 24-well adherent culture plates 
with growth medium at a cell density equal to 2 x 104 cm-2 and incubated in 
a humidified incubator (37 °C, 5% CO2), allowing the cells to adhere to the 
bottom of the wells. Aer 24 hours, membranes were placed in cell culture 
inserts (Thincert™, Greiner Bio-one, The Netherlands) and indirectly cultured 
with the cells. The different groups and conditions of culture are described in 
more detail in Table 1.
rBMSCs DNA quantification and ALP (alkaline phosphatase) activity 
measurements (n = 3) were performed at 3 days, 7 days, 14 days, 21 days and 
28 days of co-culture as described previously.[43] Briefly, cells were washed with 
PBS twice, collected and immersed in 1 ml of ddwater. Aerward, sonication 
and three freeze–thaw cycles were performed. DNA content in the supernatant 
was measured using a Quant-IT™ PicoGreen® ds-DNA assay kit (Invitrogen; The 
Netherlands) according to the manufacturer's instructions. In a 96-well plate, 
100 ml of sample or standard were added to a working solution. The plates were
incubated at room temperature in the dark for 5 minutes and fluorescence 
read (excitation: 485/20 nm; emission: 530/25 nm). ALP activity of the same 
sample was measured by a p-nitrophenylphosphate (4-NP; Sigma-Aldrich, 
USA) colorimetric assay, according to the manufacturer's instructions. 80 ml of 
samples or standards were added to 20 ml of buffer and 100 ml of the substrate. 
The mixture was incubated for 60 minutes at 37 °C. Aerward, 100 ml of 0.5 M 
NaOH solution was added to stop the reaction. Absorbance at 405 nm was read 
and ALP activity normalized according to the DNA content for each sample.
To observe the cellular morphology, cells were directly cultured on the 
membranes with the specific medium indicated in Table 1. Samples were 
collected at 3 days, 14 days and 28 days. A 2% v/v solution of glutaraldehyde 
(glutaraldehyde solution 25%; Merck; Germany) was used to fixate the cells 
and ethanol at graded concentrations (70%, 80%, 90%, 96% and 100% v/v) was 
used for dehydration. Finally, samples were covered with tetramethylsilane 
(TMS; ≥99.0% GC; Sigma-Aldrich; USA) and prepared for SEM observation as 
referred previously.
Table 1 Groups for in vitro cell culture experiments
Group Composition
PLLA Membrane + growth medium+ 10 mM β-GP
PLLA+SV Membrane + growth medium+ 10 mM β-GP
PLLA+SV HT Membrane + growth medium+ 10 mM β-GP
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2.5.Statistical analysis
Fiber diameter was estimated from the corresponding SEM images using ImageJ 
soware (National Institutes of Health, USA). Twenty different measurements 
were taken from 5 different regions of each electrospun membrane (n = 100). Data 
were reported as mean ± standard deviation (SD). Statistical analysis was carried 
out by using one-way analysis of variance (ANOVA) combined with a Tukey's 
multiple comparison post-hoc test. Differences were considered significant at p 
< 0.05. Statistical differences in crystallinity of the different samples (n = 3) were 
analyzed using an unpaired t-test with Welch's correction, calculated with Prism 
6.01 soware (GraphPad Soware, Inc., USA). Data were reported as mean ± 
standard deviation (SD). Differences were considered significant at p < 0.05. 
DNA content and ALP activity (n = 3) were analyzed using Prism 6.01 soware 
and performing a two-way ANOVA significance test combined with a post-
hoc Tukey's multiple comparison test. Data were reported as mean ± standard 
deviation (SD). Differences were considered significant at p < 0.05.
3. Results
3.1. Morphological and structural evaluation of electrospun membranes 
containing SV
Figure 1 shows the morphology of the electrospun PLLA membranes with 
and without SV before and aer thermal treatment (HT). All membranes are 
composed of micrometric fibers, with a small decrease of the diameter of the 
fibers when the drug was incorporated (1.4 ± 0.14 μm for PLLA; 1.3 ± 0.11 μm 
for PLLA HT; 1.0 ± 0.10 μm for PLLA+SV; 0.9 ± 0.07 μm for PLLA+SV HT). No 
noticeable changes in the morphology of the fibers were detected when SV was 
incorporated (Figure 1c and Figure 1d). Membranes subjected to the thermal 
treatment (PLLA HT and PLLA + SV HT) presented a similar morphology when 
compared with their non-thermal treated counterparts (PLLA and PLLA + SV), 
although some deformation of the fibers was visible (Figure 1b-red square and 
Figure 1d-red square).
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Figure 1. SEM images of electrospun fibers 5,000x (red squares) and 50,000.x (a) PLLA (b) PLLA 
HT (c) PLLA + SV (d) PLLA + SV HT.
The chemical profile of the membranes was analyzed by ATR-IR (Figure 2). The 
spectra were similar for all membranes, showing the characteristic peaks of PLLA 
highlighted with red lines: 1751 cm-1 (carbonyl group); 1000–1450 cm-1 (ether 
groups) and 870 cm-1 (alkyl groups).[32, 44, 45] No characteristic peaks related to the 
presence of SV were detected, either before or aer thermal treatment. Further, 
thermal treatment did not affect the chemical composition of the membranes, 
with no significant changes in the polymeric backbone.
Figure 2. ATR-IR spectra of electrospun membranes. Red lines represent the main peaks belonging 
to PLLA.
Figure 3 presents the XRD profiles for the different membranes. Samples with-
out thermal treatment showed no sharp peaks on the XRD spectra. Membranes 
with thermal treatment showed a peak at approximately 2θ = 16° (red arrows, 
Figure 3), representing the characteristic peak of the crystal structure of the α 
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Figure 3. XRD spectra of electrospun membranes. Red arrows indicate the peak of the α form of 
PLLA.
Figure 4 shows the crystallinity percentage of the different electrospun mem-
branes. As expected, crystallinity increased aer the membranes were subjected 
to thermal treatment, shown by XRD (42 ± 7.8 % vs. 58 ± 4.4 % for PLLA with-
out SV and 38 ± 3.0 % vs. 62 ± 1.1% for PLLA with SV). On the other hand, the 
incorporation of SV did not affect the crystallinity of PLLA. The representative 
DSC spectra of each group are shown in Figure S1 and the correlated thermal 
properties are summarized in Table S1. The glass transition temperature (Tg) 
decreased when SV was incorporated (54 ± 1.1 °C vs. 46 ± 0.1 °C for PLLA and 
PLLA + SV, respectively). Tg of membranes subjected to thermal treatment was 
not detectable considering the total heat flow (Figure S1). However, when exam-
ining the data obtained with the reversing heat flow, the Tg for these membranes 
was determined (Figure S2). A substantial increase of the Tg values due to ther-
mal treatment was detected (73 ± 0.3 °C and 73 ± 1.0 °C for PLLA HT and PLLA 
+ SV HT respectively). The melting temperature (Tm) was not affected by the 
incorporation of SV or by the thermal treatment.
Figure 4. Crystallinity of electrospun membranes. * p < 0.05; ** p < 0.01.
form of PLLA.[46]
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3.2. Drug release from PLLA membranes
The release profiles of the membranes containing SV are presented in Figure 5. 
No initial burst release of SV was detected for both membranes. A higher SV 
release from PLLA without thermal treatment was detected. SV released at a fast 
speed within the first 5 days and continued to release at a constant slow speed 
up to 28 days, except that PLLA + SV showed a sudden increase in the amount 
of SV released at week 4. Not all the incorporated SV was released from PLLA 
membranes aer 4 weeks: 11 ± 1.9% SV released from PLLA+SV and 3 ± 0.8 % 
from PLLA+SV HT.
SV release data were fitted according to two well-established drug release mod-
els: the Higuchi model and the Korsmeyer–Peppas model. As shown in Figure 
S3, SV release correlated highly with both models, although the Korsmeyer–
Peppas model presented a higher correlation for both membranes (R2 = 0.98 vs. 
R2 = 0.97 for Higuchi model). The Korsmeyer–Peppas model fitting showed dif-
ferent release exponents (n): n = 0.56 for PLLA+SV and n = 0.47 for PLLA+SV 
HT.
Figure 5. Cumulative release of simvastatin in PBS at 37 °C (a) cumulative mass (b) cumulative 
percentage.
3.3. In vitro study with rBMSCs
rBMSCs were cultured in a proliferative medium containing simvastatin at dif-
ferent concentrations for 28 days, and cytotoxicity was evaluated using light 
microscopy and AlamarBlue assays (Figures S4 and S5). Cellular proliferation 
occurred mainly for the cells cultured with simvastatin concentrations of 42 ng 
ml-1 (10-7 M) and 4.2 ng ml-1 (10-8 M). Simvastatin concentrations above 420 ng 
ml-1 (10-6 M) resulted in substantial cytotoxicity, leading to cellular death (Figure 
S4) and low viability percentages (Figure S5).
rBMSCs were directly seeded on the different electrospun membranes with 
the purpose to analyze the cellular morphology and response. Figure 6 shows 
the images obtained by SEM aer 3, 14 and 28 days of culture. Aer 3 days of 
culture, cells showed adherence to the membranes. At 14 days of culture, the 
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Figure 6. SEM images of rBMSCs cultured on the membranes at 150x (red squares) and 1,000x.
Figure 7 shows the DNA amount and ALP-activity obtained upon indirect in 
vitro culture experiments. An increase in the DNA amount with time was ob-
served for all groups. At individual time points, no significant differences be-
tween groups were observed. PLLA + SV HT membranes evoked an increase in
ALP-activity up to 7 days followed by a decrease. Further, PLLA + SV HT mem-
branes induced the highest ALP-activity levels among all groups (Figure 7b).
number of cells increased significantly, covering almost the entire surface of the 
membranes. At 28 days, the membranes were completely covered by the cells 
and a thick cell layer on top of the membranes was observed.
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Figure 7. In vitro culture of rBMSCs. (a) DNA concentration (b) ALP activity. * p < 0.05; **** p < 
0.0001.
4. Discussion
We here aimed to incorporate an osteostimulatory drug, simvastatin (SV), in a 
PLLA electrospun membrane and prolong its release, with the ultimate objective 
of creating a membrane with suitable biological properties for GBR applications. 
SV was chosen not only due to its well documented promotion of in vitro osteo-
genic differentiation[47,  48] and bone regeneration, both in vivo[49,  50] and in clin-
ical studies,[51] but also because it possesses a high thermal stability (Tm of 139 
°C), and good solubility in organic solvents.[52, 53] The effect of PLLA crystallinity
on the release of SV was investigated. In order to increase PLLA crystallinity, 
membranes were treated at 80 °C for 16 hours. SV release kinetics showed that 
variations in PLLA crystallinity can be used to control SV release. In vitro cell 
culture assays demonstrated a continuous proliferation of cells over time for all 
compositions, with a significant increase in ALP-activity levels of osteogenic 
cells by membranes containing SV.
PLLA membranes containing SV were produced by electrospinning. Morpho-
logical evaluation of the membranes showed the formation of micrometric elec-
trospun fibers with a smooth surface and a decrease of the diameter of the fibers 
when SV was incorporated. The decrease in fiber diameter is probably related to 
an increase in the conductivity of the polymeric solution for the compositions 
containing SV, leading to a decrease in fiber diameter during electrospinning.[54] 
Thermal treatment did not affect the surface morphology or the diameter of the 
fibers, although limited fiber deformation could be noticed.
Similar ATR-IR spectra were obtained for all the membranes due to the over-
lap of characteristic infrared bands of SV with those of PLLA.[52, 55] Further, the 
similar spectra of membranes with or without thermal treatment indicate that 
the thermal treatment did not change the chemical structure of the electrospun
membranes.
XRD and DSC results confirmed that the thermal treatment used in this study 
increased the crystallinity of PLLA membranes. It has been shown previously 
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that an increase in polymer crystallinity due to thermal exposure leads to a slow-
er diffusion of the drugs because the crystalline domains function as a physical 
barrier and reduce polymeric degradation.[56, 57] The results from our study cor-
roborate these data. The amount of SV released from PLLA + SV membranes 
was approximately 2 times higher than the membranes subjected to the thermal 
treatment (PLLA + SV HT), demonstrating the primary role of crystallinity in 
controlling the release of SV. Release data of both membranes were fitted accord-
ing to two kinetic models (i.e. the Higuchi model and the Korsmeyer–Peppas 
model) in order to understand the drug release mechanism(s).[58,  59] The Higuchi
kinetic model is an ideal model, which considers the release of a drug from 
a homogeneous solid matrix, where the diffusion of the drug is constant and 
phenomena like polymer swelling and dissolution are negligible. The Korsmey-
er–Peppas kinetic model is more complex and different release mechanisms are
considered. According to the Korsmeyer–Peppas model, for cylindrical struc-
tures an n ≤ 0.45 corresponds to Fickian-based diffusion, an 0.45 < n < 0.89 to 
non-Fickian (anomalous) diffusion, an n = 0.89 to case II (relaxational) trans-
port, and an n > 0.89 to super case II transport, the two last mechanisms being 
related to polymer swelling and erosion. For both models, the correlation coeffi-
cient was high, although slightly higher for the Korsmeyer–Peppas kinetic mod-
el. The Korsmeyer–Peppas model was considered as more accurate to explain 
the mechanism(s) related to the in vitro release of SV. Considering that ideally 
the electrospun fibers possess a cylindrical geometry, the  determined n values 
demonstrate that PLLA + SV membranes exert an anomalous non-Fickian dif-
fusion of SV to the medium (n > 0.45), likely due to fiber erosion phenomena. 
PLLA + SV HT membranes, on the other hand, present an n value very close to
0.45, suggesting a diffusion of SV that follows the Fick's law.[60]
rBMSCs were cultured with pure and SV-loaded PLLA membranes with or 
without thermal treatment (PLLA, PLLA + SV and PLLA + SV HT). The mass 
of the membranes utilized in culture was calculated based on the SV release 
profile so that the concentration of SV in the medium was within the reported
range capable of inducing an osteogenic response.[20, 25, 61, 62] Should be mentioned 
that the potential cytotoxicity of simvastatin was also considered. Viability tests, 
where rBMSCs were cultured in medium containing different concentrations of
simvastatin, were performed on an early phase of this study (Figures S4 and S5) 
and the following assays were performed taking into account the viability results 
obtained.
The purpose of these experiments was to evaluate if (i) the membranes could 
induce an osteogenic response from the rBMSCs, and (ii) the differences in the 
amount of drug released from the membranes with or without thermal treat-
ment would affect osteogenic differentiation. Morphological observations indi-
cated that rBMSCs adhered and proliferated on all membranes over time. The 
results of the DNA assay were consistent with this finding. The DNA results 
further demonstrated that the tested membranes did not evoke a cytotoxic ef-
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fect. Moreover, SV incorporation followed by thermal treatment induced an 
increased osteogenic response from rBMSCs, demonstrated by a significantly 
increased ALP-activity for the cells cultured on such membranes (PLLA + SV 
HT). A suppression of an initial burst-release, combined with the significantly 
lower amounts of SV present in the medium, due to its more sustained release
from these membranes, appeared to be beneficial for the osteogenic differenti-
ation of pre-osteoblastic cells.[25, 60] In this study a non-osteogenic medium sup-
plemented with β-glycerophosphate was used to solely evaluate the effect of SV 
on the osteogenic differentiation of rBMSCs, without the influence of known 
osteoinductive compounds as ascorbic acid or dexamethasone. Also, we focused 
on analyzing the ALP-activity levels, since SV is known to have a major effect 
in the expression of this protein and a significant impact on the early stages of 
the osteogenic differentiation of osteoblastic cells.[50] Further studies should be 
performed in order to evaluate the effect of the systems developed on the min-
eralization capability of rBMSCs.
5. Conclusion
We developed electrospun PLLA membranes with enhanced osteostimulatory 
properties by incorporating simvastatin (SV) and modified the SV release pro-
file by varying the PLLA crystallinity. Thermal treatment successfully increased 
the PLLA crystallinity for all compositions without significantly changing the 
chemical properties and morphology of the electrospun fibers. A markedly 
more sustained release of SV was observed upon the thermal treatment to in-
crease the PLLA crystallinity. In vitro culture of PLLA membranes with rBMSCs 
demonstrated that the membranes are cytocompatible, with an increase in cell
proliferation over time. PLLA + SV HT induced an osteogenic response from 
rBMSCs, with significantly increased ALP-activity levels demonstrating both a 
preservation of biological activity of SV and an appropriate SV release profile. 
Thermal treatment to increase PLLA crystallinity in electrospun membranes can 
be used to control SV release and render these membranes biologically active.
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Supplementary Information
Figure S1. Modulated DSC spectra for the different electrospun membranes.
Figure S2. Modulated DSC spectra (reversing signal) for PLLA HT and PLLA + SV HT membranes.
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As described in Table S1, SV incorporation led to a small decrease in the values 
of glass transition temperature (Tg) and cold crystallization temperature (Tcc), 
related to a plasticizing effect common when drugs are added to polymeric ma-
terials.[1, 2] Membranes subjected to the thermal treatment showed an increase in 
Tg values, which is related to a higher organization and rigidity of the polymeric 
chains, a consequence of the higher crystallinity present on these membranes.
Group Crystallinity / % Tg / °C Tcc / °C Tm / °C
PLLA 42.0 ± 7.76 53.6 ± 1.07 66.2 ± 0.62 185.8 ± 0.15
PLLA HT 58.3 ± 4.40 73.1 ± 0.32 -------- 184.8 ± 0.21
PLLA + SV 38.4 ± 3.04 46.3 ± 0.12 60.6 ± 0.15 182.1 ± 0.06
PLLA + SV HT 61.5±1.06 73.3±1.04 -------- 178.8±0.10
Table S1. Thermal properties of the electrospun membranes
Figure S3. Fitting of the drug percentage released for both membranes according to a) Higuchi 
model b) Korsmeyer-Peppas model.
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Figure S4. Optical microscope images of rat bone marrow stromal cells (rBMSCs) cultured with 
a proliferation medium containing different concentrations of simvastatin, aer 3, 14 and 28 days 
of culture.
Figure S5. AlamarBlue test for rBMSCs cultured with proliferative medium containing different 
concentrations of simvastatin. * p<0.05, ** p<0.01, **** p<0.0001. Viability percentages (%) are 
relative to the positive control (rBMSCs cultured in an osteogenic medium).
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1. Introduction
 Electrospinning is a technique to produce ultrafine polymeric fibers that 
enables the development of non-woven membranes with a high porosity and 
surface area-to-volume ratio, allowing their use for a wide range of applications, 
including filtration systems[1, 2] textile industry[3, 4] and biological or clinical 
applications.[5-7] Biomedical applications require the electrospun membranes to 
be not only biocompatible but also bioactive. In the case of synthetic membranes, 
bioactivity is a major issue since most of the synthetic polymers possess a high 
degree of hydrophobicity and do not have the chemical moieties to induce a 
positive biological response, having a passive role in the tissue healing and 
regeneration. Such obstacles led to the development of several strategies to 
chemically modify the surface of synthetic membranes, including adsorption,[8] 
covalent functionalization,[9] and surface grafting[10].
Among adsorption techniques, layer-by-layer (LbL) is a popular strategy 
to functionalize inert substrates of irregular geometry. LbL techniques use 
adsorption of polyelectrolytes (surface charged oligomers or polymers) with 
opposite charges to the surface of substrates.[11] The interaction between the 
polyelectrolytes results in the creation of a layered structure on the surface of 
the substrate, i.e. polyelectrolyte multilayers (PEMs). Interactions between the 
polyelectrolytes and between the polyelectrolytes and the substrate are mainly 
governed by electrostatic forces due to the opposite charges present, although 
hydrogen bonding, covalent bonding, and hydrophobic interactions also might 
have a contribution. Despite of such interactions being normally weak, LbL 
possesses several features that makes it a desirable functionalization strategy: 
a wide range of polyelectrolytes are available[12]; functionalization can be 
controlled by changes in pH, ionic strength or temperature; the majority of the 
systems can be developed in aqueous environments and at room temperature.
[11, 13, 14] These features allow the incorporation of a wide range of compounds. 
Substrates containing antibiotics[15, 16], peptides[17, 18] and growth factors[19, 20] have 
been developed, showing an improved sustained release compared to traditional 
strategies (e.g. physical adsorption or blending).
Although LbL has been proposed in the early 90s by Decher et al.[21] as a promising 
surface functionalization technique, to the best of our knowledge, only a few 
studies focused on the functionalization of electrospun membranes by LbL for 
drug delivery purpose.[22-24] The aim of this study was to explore the possibility 
to functionalize poly(L-lactic acid) (PLLA) electrospun membranes by an LbL 
methodology. Furthermore, we intended to investigate the influence of drug 
charge on the incorporation process during LbL and subsequent release profiles. 
In order to achieve these goals, poly(L-lysine) (PLL) and poly(acrylic acid) 
(PAA) were chosen as polyelectrolytes. PLL and PAA have ideal properties that 
make them suitable to be used for the surface functionalization of electrospun 
membranes for biological purposes. PLL is positively charged at physiological 
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pH (polycation; pKa = 10.5).[25] It is not only biocompatible but also supports 
high levels of cellular adhesion and proliferation.[26, 27] Moreover, PLL molecular 
chains have a flexible structure, which contributes to the increased mobility of 
the compounds incorporated in the LbL system.[25] On the other hand, PAA 
is negatively charged at physiological pH (polyanion; pKa = 5).[28] It is also 
biocompatible and has been widely used for LbL applications.[28, 29] Rhodamine 
B and clindamycin were chosen as two model drugs for this study, due to their 
close molecular weight but distinct surface charge. Rhodamine B has a small 
molecular weight (M.W = 479.02 g mol-1), and is a “zwitterion”, having a neutral 
charge at physiological pH (pKa = 3.1).[30] On the other hand, clindamycin, a 
widely used antibiotic, has a similar molecular weight (M.W = 424.98 g mol-1) 
but presents a positive charge at physiological pH (pKa = 7.79).[31]
PLLA electrospun membranes were produced and subjected to different 
LbL experimental procedures. The membranes were then characterized 
morphologically by scanning electron microscopy (SEM), fluorescence 
microscopy and confocal microscopy. PEM growth was quantified by solid-
state elemental analysis of nitrogen, an element only present in PLL. Drug 
immobilization and release profile were analyzed both by high-performance 
liquid chromatography (HPLC) and liquid chromatography-mass spectrometry 
(LC-MS). 
2. Materials and methods
2.1. Preparation of electrospun membranes
Poly(L-lactic acid) (PLLA; Purasorb PL65®; Corbion, The Netherlands) was 
dissolved in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP; Fluorochem, UK) to 
a concentration of 3% w/v. Electrospun membranes were prepared by an 
electrospinning method. Electrospinning was performed using a commercially 
available electrospinning apparatus (Advanced Surface Technology BV, The 
Netherlands) according to the following parameters: needle diameter = 1.2 mm, 
feeding rate = 2.0 mL h-1; distance between the needle and the collector = 20 cm; 
voltage = 19.25 kV.
2.2. Layer-by-layer assembly
Electrospun membranes were functionalized by a layer-by-layer methodology. 
Prior to the development of the double-layers, the surface of the membranes was 
activated according to two different strategies: 1) the use of poly(ethyleneimine) 
(PEI, M.W = 25,000 g mol-1, Sigma-Aldrich, USA) to produce a basal reactive 
layer; or 2) by the incorporation of reactive amine groups using an aminolysis 
approach (Figure 1).
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2.2.1. Layer-by-layer using PEI
PLLA membranes were first treated with argon plasma for 5 minutes to increase 
their hydrophilicity. Afterward, the membranes were immersed in a solution 
of PEI (5 mg ml-1 in 10mM Tris Buffer with 150 mM sodium chloride; pH 
=7.4) for 30 minutes at room temperature, followed by immersion in a solution 
of poly(acrylic acid) (PAA; M.W = 60,000 g mol-1; Polysciences Inc., USA; 1 
mg ml-1 in 150 mM sodium chloride solution; pH =5.5) for 10 minutes and 
subsequently by immersion in a poly(L-lysine) solution (PLL; M.W= 30,000-
70,000 g mol-1; Sigma-Aldrich, USA; 1 mg ml-1 in 10 mM Tris Buffer with 150 
mM sodium chloride; pH =7.4). Washing steps of 1 minute with ddwater were 
performed between the immersion of the membranes on the polyelectrolyte 
solutions to remove the non-bonded PAA and PLL. To build up multi-layers, 
PAA-PLL immersion steps were repeated as shown in Figure 1. The created LbL 
system was named as PEI-[PAA-PLL]n with n representing the number of multi-
layers.
2.2.2. Layer-by-layer of aminolyzed samples
PLLA membranes were subjected to an aminolysis procedure prior to LbL 
assembly. Briefly, samples were incubated at 37 °C in a solution of ethylenediamine 
(EtDA; Sigma-Aldrich, USA) with different concentrations (0.1M, 0.5M, 0.75M 
EtDA in isopropanol and 0.75M in ddwater) and for different incubation periods. 
Afterward, samples were alternatively immersed in PAA and PLL solutions as 
described in the previous section.
Figure 1. Layer-by-layer methodologies.
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2.3. Incorporation of rhodamine B and clindamycin
Rhodamine B and clindamycin were added drop-wise to the membranes after 
the creation of a first PAA-PLL-PAA multilayer. Different amounts of rhodamine 
B or clindamycin (25 μg, 250 μg, and 2500 μg) were loaded onto the membranes 
according to the LbL methodology depicted in Figure 2. Membranes modified 
by aminolysis followed by LbL were loaded solely with 250 μg of clindamycin. 
The created systems were denoted as PAA-PLL-[PAA-Rhod.B-PAA-PLL]n and 
PAA-PLL-[PAA-Clind.-PAA-PLL]n.
Figure 2. Rhodamine B and clindamycin incorporation in LbL functionalized membranes.
2.4. Morphological evaluation
Morphology of the membranes was observed using scanning electron microscopy 
(SEM; SIGMA 300; Zeiss, The Netherlands). Samples were fixed into aluminum 
stubs with carbon tape and sputter coated with chromium (thickness of 20 nm).
2.5. Energy-dispersive X-ray Spectroscopy
Elemental analysis of the membranes was performed by Energy-dispersive 
X-ray Spectroscopy (EDS). Samples used for morphological evaluation by SEM 
were exposed to a voltage of 10 kV at a working distance of ≈ 10 mm and a 
magnification of 50,000x. Elemental analysis was performed considering the 
coating of chromium.
2.6. Fluorescence and confocal microscopy
For fluorescence assays, a fluorescein isothiocyanate (FITC) tagged PLL 
(M.W = 30,000-70,000 g mol-1; Sigma-Aldrich, USA) was used to replace the 
pristine PLL during the LbL process. Membranes were posteriorly visualized 
by fluorescence microscopy and confocal microscopy. Fluorescence microscopy 
images were taken using an Alexa Fluor 488 (AF488) filter, with a magnification 
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of 20x and a 4 milliseconds exposition. Confocal microscopy images were taken 
also using an AF488 filter and a magnification of 63x. Three-dimensional (3-D) 
reconstruction was performed using Fiji software (National Institute of Health, 
USA).
2.7. Solid-state elemental analysis of nitrogen
Elemental analysis was performed using a carbon and nitrogen analyzer (NA1500; 
Carlo Erba - Thermo Fisher Scientific, The Netherlands). Briefly, membranes 
were ground, weighted in tin containers (≈ 3 mg for each sample) and loaded 
into an automatic sampler. A combustion occurs in the presence of oxygen at a 
temperature of 1800 °C. The gaseous combustion products are carried to a Cu-
column where nitrogen oxides are reduced to elementary nitrogen. A thermal 
conductivity detector (TCD) produces an electrical signal proportional to the 
concentration of nitrogen. The amount of nitrogen was normalized according to 
the weight of the samples.
2.8. Determination of amine groups present in aminolyzed membranes
Quantification of amine groups density on the surface of the membranes 
subjected to aminolysis was performed using a TNBS colorimetric assay. Briefly, 
a known amount of sample (≈ 3 mg for each sample) was incubated with 400 
μL of a 0.5% w/v picrylsulfonic acid solution (Sigma Aldrich, USA) for 2 hours 
at 40 °C. Samples were digested using 700 μL of HCl (37% w/v, 12.1M) and 
incubated at 60 °C until the solution was completely clear. Absorbance at λ = 
405 nm was read with a UV-VIS microplate reader (Synergy® HTX; Biotek, The 
Netherlands). A 1:1 stoichiometry for the complex formed between the amine 
group and the dye was considered. Values were normalized according to the 
weight of each sample.
2.9. Release of rhodamine B and clindamycin in an aqueous medium
Membranes functionalized by LbL and containing rhodamine B and clindamycin 
(≈ 3 mg each sample) were immersed in 1 mL of PBS at 37 °C. The supernatant 
was collected at predetermined time points. The amount of rhodamine B 
released was determined by high-performance liquid chromatography (HPLC) 
and the amount of clindamycin released determined by liquid chromatography-
mass spectrometry (LC-MS).
HPLC was performed according to the following method:
A reversed-phase hydrophilic column (AQ-C18; 2.1 by 150 mm; 3 μm particle 
size; GL Sciences, Japan) was used. Two eluents, acetonitrile (ACN) and ddwater 
(H2O), were used as the mobile phase in a gradient method. Assays were 
performed with a gradient of 60% to 100% ACN in H2O over 10 minutes. A flow 
of 0.5 mL min-1 was chosen. Rhodamine B detection was performed with a λ = 
550nm.
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LC-MS was performed following the described conditions:
LC-MS was performed with a mobile phase consisting of acetonitrile (ACN) + 
0.1% v/v formic acid and water (H2O) + 0.1% v/v formic acid, with a gradient 
of acetonitrile from 5 to 100% in 30 minutes and a flow rate of 0.2 ml min-
1. Charged ions ([clindamycin+H]+) at m/z 425.98 were analyzed in order to 
determine the amount of clindamycin present in the samples.
2.10. Statistical analysis
Statistical significance of TNBS assay was performed using an unpaired t-test 
with Welch’s correction, calculated with Prism 6.01software (GraphPad Software, 
Inc., USA). Data were reported as the mean ± standard deviation (SD) and n = 3. 
Differences were considered significant at p < 0.05.
3. Results
Figure 3 presents the SEM results of the electrospun PLLA membranes 
subjected to the LbL technique with a PEI basal layer. Untreated electrospun 
fibers presented a homogeneous and smooth surface (Figure 3a). After the LbL 
treatment, the surface of the fibers became rough (Figure 3b and Figure 3c). 
The EDS analysis showed that nitrogen appeared in the membranes after LbL 
treatment and the amount was proportional to the number of double-layers: 
3.94% for PLLA-PEI-[PAA-PLL]5 and 7.96% for PLLA-PEI-[PAA-PLL]10 (Figure 
3b and 3c and, table S1).
Figure 3. SEM-EDS results of PLLA membranes, 20,000x. a) PLLA membrane b) PLLA-PEI-[PAA-
PLL]5 c) PLLA-PEI-[PAA-PLL]10.
Figure 4 and Figure 5 show the results obtained with fluorescence and confocal 
microscopy, respectively. In Figure 4, an increase in fluorescence with the 
number of double-layers is noticeable, and the pristine PLLA membrane was 
not fluorescent, as expected (Figure 4a).
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5Figure 4. Fluorescence microscopy images of PLLA membranes. a) PLLA membrane b) PLLA-PEI-[PAA-PLL]3 c) PLLA-PEI-[PAA-PLL]5 d) PLLA-PEI-[PAA-PLL]10.
By confocal microscopy was created a three-dimensional morphology of the 
functionalized membranes (Figure 5). Fluorescent PLL (PLL-FITC) could be 
detected in all membranes subjected to the LbL technique. It can also be seen 
that the amount of PLL increases with the number of double-layers.
Figure 5. 3-D reconstruction of PLLA membranes based on confocal microscopy images. a) PLLA-
PEI-[PAA-PLL]3 b) PLLA-PEI-[PAA-PLL]5 c) PLLA-PEI-[PAA-PLL]10.
In order to obtain quantitative data concerning the development of the dou-
ble-layers, the nitrogen content present in the membranes was quantified by sol-
id-state elemental analysis and the results are shown in Figure 6. It is clear that 
the nitrogen percentage (%) is almost directly proportional to the number of 
deposited double-layers. A higher increase rate of the nitrogen % up to 5 dou-
ble-layers was observed and afterward a lower increase rate from 5 double-layers 
to 20 double-layers.
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Figure 6. Nitrogen content for samples subject to LbL functionalization.
Figure 7. Amounts and percentage of rhodamine B incorporated in the membranes after LbL.
Figure 7 represents the amount and percentage (%) of rhodamine B incorporat-
ed in the membranes subjected to the LbL procedure with a PEI basal layer. As 
expected, a higher amount of rhodamine B was detected in the membranes when 
a higher initial amount of drug was used. It can also be seen that the amount of 
incorporated rhodamine B was significantly lower than the amount used in the 
experimental procedure. In other words, the drug incorporation efficiency was 
extremely low (< 0.014%).
Figure 8 shows the release profile of rhodamine B for the prepared membranes. 
The amount of rhodamine B released from the membrane loaded with 25 μg was 
below the detection limit of HPLC. For the membranes loaded with 250 μg and 
2500 μg of rhodamine B, ~ 40 to 50% of the drug was released within 8 hours of 
incubation. After that, no release could be detected.
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Clindamycin was not detected by this first methodology both for the loading 
and release experiments.
Considering the results described above, a second functionalization strategy, 
based on an initial aminolysis procedure was adopted. The membranes were 
first subjected to a preliminary study with different aminolysis experimental 
conditions, in order to evaluate the optimal time of incubation for the different 
concentrations of EtDA (data not shown). Figure 9 shows the SEM images of the 
membranes subjected to the optimal aminolysis conditions for the EtDA con-
centrations tested. All the electrospun fibers showed a similar morphology un-
der all the tested aminolysis conditions, presenting a smooth and homogenous 
surface. No fissures or cracks in the fibers were observed for all the conditions 
tested. 
Figure 8. Release profiles for membranes loaded with 250 μg and 2500μg of rhodamine B. a) 
amount of rhodamine B released b) cumulative percentage of rhodamine B released
Figure 9. SEM images of membranes aminolyzed, 10,000x. a) 0.1 M EtDA-2.5 hours b) 0.5 M EtDA-
2 hours c) 0.75 M EtDA-1 hour d) 0.75 M EtDA+ddH2O-1.5 hours.
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Figure 10. Amine groups density on electrospun membranes subjected to different conditions of 
aminolysis.
Figure 10 presents the density of amine groups for the membranes subjected to 
aminolysis, determined by a TNBS assay. The membranes subjected to an ami-
nolysis process using an aqueous solution of 0.75 M EtDA and an incubation 
period of 1.5 hours presented the highest average amines density (3.7 x 10-4 NH2 
cm-2). This condition was selected for further experiments.
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An LbL procedure was performed on the aminolyzed membranes using the 
PLL/PAA system. Figure 11 presents a morphological comparison between 
the membranes aminolyzed with the aqueous solution of 0.75 M EtDA and the 
membranes subsequently subjected to the LbL procedure. Unlike the amino-
lyzed membranes, the membranes subjected to a later LbL process presented 
fibers with a rough surface. EDS analysis also showed that the nitrogen content 
in the membranes increased from 4.27 % for aminolyzed membranes to 6.30 % 
after 10 LbL double-layer coatings (Table S2).
Figure 11. SEM-EDS results of aminolyzed PLLA membranes, 10,000x and 50,000x (red square). a) 
aminolyzed PLLA membrane b) aminolyzed PLLA-[PAA-PLL]10.
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Clindamycin was loaded on the membranes and subjected to the aminoly-
sis-based second methodology. The in vitro release is shown in Figure 12. After 
24 hours, 0.101 μg (0.004%) clindamycin was released. Furthermore, no clinda-
mycin could be detected after 48 hours.
Figure 12. Cumulative release of clindamycin from functionalized PLLA membranes.
4. Discussion
An LbL methodology using two polyelectrolytes, poly(acrylic acid) and 
poly(L-lysine), was used for PLLA electrospun membrane functionalization and 
drug loading. This strategy was followed to create electrospun membranes with 
high biocompatibility that could additionally function as a drug delivery res-
ervoir for the incorporation of small molecular weight compounds. The influ-
ence of drug charge on their loading and release was studied. Two model drugs 
were used, i.e. rhodamine B (neutrally charged) and clindamycin (positively 
charged). The results showed that the LbL process was successful for polyelec-
trolyte deposition. However, the drug-delivery capacity was compromised due 
to low loading efficacies and/or limited release.
Polyelectrolyte multilayer deposition on the electrospun PLLA membranes was 
successfully achieved by the LbL procedure. The deposition of the first 5 dou-
ble-layers was more efficient than the later ones since the nitrogen percentage 
increment was higher during the first 5 double immersion steps. Previous stud-
ies have shown that the number of deposited layers influences the dissociation 
constant (pKa) of the polyelectrolytes, showing for PLL a decrease in its pKa 
value. A decrease in the base strength of PLL is related with the adoption of a 
secondary conformational order by the polymeric chains and formation of hy-
drogen bonds, resulting in a decrease of the number of functional groups avail-
able to interact with the polyelectrolytes in solution.[32]
The other goal of this study was to improve our understanding of how the charge 
of small drugs influences their loading and release upon incorporation in the 
LbL systems. Two model drugs, rhodamine B and clindamycin, were selected 
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due to their similarity in molecular weight (479.02 g mol-1 for rhodamine B 
and 424.98 g mol-1 for clindamycin) but distinct charge at physiological pH (i.e. 
rhodamine B neutral and clindamycin slightly positive). We tested the loading 
efficiency of rhodamine B and found it was lower than 0.014%. The poor in-
corporation of rhodamine B was expected due to its neutral charge at physio-
logical pH, which likely compromised the interactions between rhodamine B 
and the polyelectrolytes. The incorporation of rhodamine B was only governed 
by non-specific adsorption phenomena. Furthermore, the loading efficiency of 
rhodamine B decreased with increasing initial amounts of rhodamine B used. 
This inverse correlation is probably due to steric repulsion when a large amount 
of rhodamine B is present; thus, rhodamine B molecules could only be adsorbed 
to the surface of the electrospun fibers up to a certain amount. After a certain 
threshold, there was a saturation of the rhodamine B adsorbed on the surface of 
the fibers and most of the compound was washed out during the washing steps. 
Clindamycin was also used as a model drug in this study. Due to a higher pKa, 
clindamycin presents positive charge at the physiological pH. Therefore, it was 
hypothesized that clindamycin would have a higher affinity to the polyanion 
PAA present in the LbL system. Surprisingly, no clindamycin was detected when 
the membranes functionalized by our first LbL strategy were immersed in PBS. 
A possible explanation for this result is a competitive effect between PLL (highly 
positive) and clindamycin to interact with PAA.[25, 33] Further, the LbL interme-
diate washing steps were performed using ddwater, which could lead to some 
level of deprotonation of the bound clindamycin, due to an increase in the pH of 
the solution and diffusion of the drug to the water.
A second strategy was attempted to enhance clindamycin incorporation. In this 
case, the LbL process was not initiated using a reactive basal layer of PEI. Instead, 
the electrospun membranes were initially functionalized by an aminolysis pro-
cess. Several studies demonstrated that aminolysis can be used to incorporate 
amine groups on the polymer surface.[34, 35] Ethylenediamine (EtDA) was chosen 
as the amine donor; different concentrations of the reagent in isopropanol (IPA) 
at different times of incubation were prepared (0.1M EtDa-2.5 hours; 0.5M EtDa 
-2 hours and 0.75M EtDa -1 hour) according to preliminary experiments (data 
not shown). Furthermore, aminolysis using a solution of 0.75M EtDA in ddH2O 
for 1.5 hours instead of IPA was included. Electrospun fibers presented a simi-
lar morphology for all the different conditions tested, suggesting that the used 
approach was mild and does not lead to chemical scission of the fibers. In order 
to select the optimal condition for further experiments, a TNBS test was per-
formed in the aminolyzed samples and the density of amine groups calculated. 
The membranes incubated in a solution of 0.75 M EtDA in ddH2O presented the 
highest number of amine groups per cm2. As described in a previous study from 
our group the dissolution of EtDA in IPA has a synergistic effect, promoting 
the chemical scission of the fibers.[36] By using an aqueous solution the chem-
ical scission activity of EtDA is controlled, allowing the incorporation of the 
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amine groups from the amine donor but avoiding the chemical degradation of 
the membranes.
Membranes aminolyzed using the optimal conditions of 0.75M EtDA in ddH2O 
for 1.5 hours were subjected to the same LbL protocol as before. Polyelectro-
lytes deposition occurred on the fibers. The percentage of nitrogen present after 
LbL was similar to the percentage measured on the membranes functionalized 
by the first strategy (Table S2). Clindamycin was loaded, and its release profile 
evaluated. Incorporation of clindamycin by the second approach was achieved, 
although the released amount was very limited, and no further release was de-
tected after 2 days. A possible explanation for a higher incorporation of clinda-
mycin using the aminolysis-based LbL is that the distribution of the polyelec-
trolytes is more efficient by this method, creating a double layer system where 
the PAA carboxylate groups are more exposed and can interact electrostatically 
with the positively charged clindamycin.[16, 37] The fast release of clindamycin is 
in accordance with other studies where small compounds were incorporated in 
LbL functionalized substrates.[15, 16, 23-25, 38] These results are related with the weak 
interaction between the drug and the multilayers at the pH of PBS, since clinda-
mycin has a pKa value only slightly higher than the physiological pH. Further, 
PBS contain salts which compete with clindamycin for the interaction with PAA.
[15, 16] When incorporated, clindamycin presented a more prolonged release than 
rhodamine B, which was released from the membranes in the first 8 hours of 
incubation. Although these results demonstrate that the interaction between the 
compounds and the multilayer systems is dependent on the methodology used, 
a clear understanding of the mechanisms involved in the loading and release 
of the compounds is still not established. Further studies are needed to have a 
clear understanding of the PEM build-up and how the interaction between the 
polyelectrolytes and the drugs occurs. 
5. Conclusion
In the present study, two layer-by-layer (LbL) methodologies were attempted 
in order to successfully functionalize PLLA electrospun membranes. A first 
strategy using a basal layer of PEI and a PAA-PLL double-layer build-up was 
followed. A second strategy, in which the membranes were first functionalized 
by aminolysis followed by the same PAA-PLL double-layer build-up was used. 
LbL functionalization was achieved with both strategies and an increase in PAA-
PLL double-layer build-up was observed. Two model drugs (rhodamine B and 
clindamycin), with a different charge at physiological pH were tested, presenting 
low loading efficiency and limited release within a short (i.e. hours to days) time 
span.
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Supplementary Information
Table S1 – Elemental analysis by EDS for pristine and functionalized PLLA membranes (first meth-
odology)
Sample C / % N / % O / %
PLLA membrane 80.49 3.00 14.92
PLLA membrane + 5 double-layers 80.99 3.94 13.27
PLLA membrane + 10 double-layers 74.13 7.96 15.25
Sample C / % N / % O / %
PLLA membrane 80.49 3.00 14.92
PLLA membrane + 5 double-layers 74.79 4.27 19.57
PLLA membrane + 10 double-layers 76.70 6.30 16.38
Table S2 – Elemental analysis by EDS for pristine and functionalized PLLA membranes (second 
methodology)
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1. Introduction
 Microsized particles have been widely used in the development of drug 
delivery systems. These particles can be fabricated from organic compounds like 
natural and synthetic polymers or inorganic minerals and metallic oxides. Each 
composition presents unique characteristics and opportunities to create particles 
of different sizes and shapes. Particles with a spherical geometry have been most 
commonly studied, especially in the development of systems that require high 
levels of cellular internalization and long circulation times in vivo.[1, 2] Compared 
to spherical structures, non-spherical particles such as micron-sized cylinders 
present several advantages for the development of drug or biomolecule delivery 
systems. First, higher drug loading levels can be achieved using non-spherical 
particles due to a higher surface area-to-volume ratio for particles with similar 
dimensions.[3] Second, non-spherical particles are cleared less rapidly from the 
body.[2, 4] This property is related to the different hydrodynamic forces to which 
these non-spherical particles are subjected in the body, leading them to stumble 
and move across the vessel walls and to adhere to endothelial cells, rather than 
following the more linear pattern in the circulatory system shown by spherical 
analogs.[1, 4] Finally, non-spherical micrometric particles have shown to be 
less susceptible to phagocytosis in vitro because their internalization is highly 
dependent on the particles’ geometry and length-normalized curvature (Ω).[5, 6]
Although several physical methods have been developed to fabricate non-
spherical structures, such as lithography[7], stretching techniques[8], and 
sectioning[9], chemical-based strategies present appealing advantages, including 
lower costs and mild experimental conditions. Also, when compared, for 
example, to mechanical drawing techniques, a better control of the fiber diameter 
is achieved.[10] In 2008, Kim and Park showed that poly(L-lactic acid) (PLLA) 
electrospun fibers could be shortened by a chemical transverse fragmentation 
method, leading to the development of cylindrical microstructures.[11] A 
wet-chemical process called aminolysis was used to induce this transverse 
fragmentation. Aminolysis comprises a reaction between a reactive species and 
an amine or ammonia group donor, resulting in chemical scission of the reactive 
species and the incorporation of amine or amide groups to its molecular structure.
[12, 13] Alternatively, aminolysis is commonly used for the functionalization of 
polymers with amine groups, which can increase the material’s biocompatibility 
or facilitate the conjugation of other compounds to the polymer.[13−15]
PLLA is one of the most extensively studied polymers for the development of new 
biomaterials, which is justified by its high biocompatibility, biodegradability, good 
mechanical properties, and typical degradation rates, which are compatible with 
clinical applications and result in lactic acid, a nontoxic degradation by-product.
[16, 17] However, as other polyesters, PLLA is in its pristine form hydrophobic, 
having a reduced wettability and consequently cellular adhesion. This drawback 
can be overcome by chemically modifying the surface or the molecular backbone 
Chapter 6
130
of the polymer with specific functional groups, for example, amine groups, 
hydroxyl groups, or peptidic sequences.[18, 19] As mentioned above, aminolysis 
renders the polymer with amine groups and can be used to functionalize PLLA.
The use of electrospinning has been well established in the production of fibers 
with micro- and nanoscale diameters.[20] Established by Formhals, this technique 
produces polymeric fibers by the application of an electric current to a polymeric 
solution. An electrospinning apparatus is essentially constituted by an electrical 
power source, a nozzle, and a collector. When an electrical potential between 
the nozzle and the collector is generated, the polymeric solution’s droplet is 
stretched, creating a jet. Due to solvent evaporation, polymeric fibers are then 
generated and collected.[21, 22] Electrospun scaffolds of biodegradable polymers, 
such as polylactic acid (PLA), poly(ε-caprolactone) (PCL), polyglycolic acid 
(PGA), and their copolymers have found widespread applications in various 
biomedical fields.[23−25] Furthermore, the high surface area-to-volume ratio and 
the possibility to incorporate biomolecules within and/or on the surface of the 
electrospun fibers encourages the use of these structures as a platform for the 
delivery of therapeutic drugs and growth factors.[26] Importantly, electrospun 
fibers with different morphologies and surface porosity can be obtained in a 
simple manner using solvents with different volatilities.[27−29] Surface porosity 
has an important effect on the functional properties of microsized particles, 
especially in the development of drug delivery systems. Porous particles have 
shown higher loading efficiencies compared to dense particles, largely due to 
their increased surface area-to-volume ratio.[30] Further, the porosity of a particle 
affects the drug release kinetics; by creating macroporosity, a higher initial 
release can be achieved[31, 32], while the presence of interconnected micropores 
leads to larger diffusion pathways, resulting in a more sustained release and 
diminished burst release profile.[33, 34]
Considering the advantages of electrospinning and aminolysis for the 
preparation of microsized particles, we combined both techniques in a top-
down approach for (i) production of PLLA-based electrospun fibers and (ii) 
generation of PLLA based microsized cylinders that feature high specific surface 
area and with or without surface porosity. To this end, PLLA polymeric fibers 
were electrospun and subsequently subjected to an aminolysis-based scission 
procedure. The morphology and chemical composition of the resulting dense 
or porous microcylinders were characterized by scanning electron microscopy 
(SEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC), 
thermogravimetric analysis (TGA), and infrared spectroscopy. Additionally, 
their biocompatibility was assessed by evaluation of the viability levels of human 
fibroblasts cultured in vitro. 
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2. Materials and methods
2.1. Electrospinning of PLLA
Medical-grade poly(L-lactic acid) (Purasorb PL65®; Corbion, The Netherlands) 
was dissolved at a concentration of 3% w/v in 1,1,1,3,3,3-hexafluoroisopropanol 
(HFIP; Fluorochem, UK) or in a 4:1 v/v mixture of dichloromethane (DCM; 
Merck, Germany) and trichloromethane (TCM; Merck). A commercially 
available electrospinning apparatus (Advanced Surface Technology BV, The 
Netherlands) was used for the preparation of PLLA membranes. Electrospinning 
of PLLA in HFIP was performed using the following parameters: volume = 8 
mL; needle diameter = 1.2 mm; feeding rate = 2.0 mL h−1; distance between the 
needle and the collector = 35 cm; and voltage = 19.25 kV. Electrospinning of 
PLLA in a DCM/TCM mixture was performed using the following parameters: 
volume = 8 mL; needle diameter = 1.2 mm; feeding rate = 2.0 mL h−1; distance 
between the needle and the collector = 35 cm; and voltage = 35.00 kV. Fibers 
were collected in a stationary flat collector, covered with aluminum foil. 
Electrospinning terminated after 4 hours. The obtained membranes of about 
0.2 mm thick were left overnight in a fume hood and freeze-dried for 3 days to 
remove the residual solvent. 
2.2. Preparation of PLLA microcylinders
PLLA membranes were subjected to an aminolysis process based on a previously 
described method, with some modifications.[11] Briefly, electrospun fibers were 
immersed in a 5% v/v solution of ethylenediamine (EtDA; Sigma-Aldrich, USA) 
in isopropanol (IPA; Merck) for two different time points (3 and 5 hours). EtDA 
was chosen as a reactive amine donor, and IPA was used in order to promote the 
aminolysis reaction.[12] After aminolysis, four cycles of centrifugation/washing 
with ddwater were performed to remove the diamine solution in excess. Samples 
were finally resuspended in ddwater, subjected to 40 seconds of ultrasonication 
at 100% amplitude (UP50H; Hielscher - Ultrasound Technology, Germany) to 
prevent aggregation of the microcylinders, freeze-dried, and stored at room 
temperature for further use. 
2.3. Characterization of PLLA microcylinders
The morphology of the electrospun membranes and microcylinders was 
observed by SEM (SM3010; JEOL, Japan) under an acceleration voltage of 5 
kV. Electrospun fibers as a mat and microcylinders as powder were fixed with 
carbon tape on aluminum holders and sputter-coated with gold (thickness ≈ 10 
nm).
XRD (pw1830; Philips, The Netherlands) was performed to determine the 
crystallographic profile of the samples. Electrospun membranes as a thin planar 
layer or microcylinders in powder form were placed in a copper holder and 
scanned. XRD spectra were registered at 40 kV, 30 mA (Cu−Kα radiation with 
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a wavelength of 1.54 Å), and 2θ between 10 and 30°, at a step size of 0.005°. 
The crystallite sizes of PLLA for the main (110) and (203) reflections were 
determined according to the Scherrer equation:[35] 
D = K λ/(βc cosθ)
where K is a dimensionless shape factor (0.9 for the spherulite structure), λ the 
wavelength of Cu−Kα radiation, and βc the full width at half-maximum value of 
the diffraction peak at 16.7° for PLLA, given in radians. Accordingly, θ is 16.7° 
for all calculations in this study.
The degree of crystallinity (χc) of the PLLA as received and after electrospinning 
and aminolysis processes was determined by DSC (Discovery®; TA Instruments, 
The Netherlands). For DSC analysis, samples were sealed in an aluminum pan 
and scanned from 20 to 200 °C at a heating rate of 5 °C min−1. The degree of 
crystallinity (χc) was calculated considering the ratio between the experimental 
heat of melting (ΔHm) minus the cold crystallization heat (ΔHcc) and the 
heat of melting of 100% crystalline PLLA (ΔH°m = 93.7 J g−1), according to the 
following equation:[35]
χc% = [ΔHm -ΔHcc]/ ΔH°m x 100
TGA (TA Instruments, The Netherlands) was carried out in a nitrogen 
atmosphere with a temperature range from 20 to 400 °C and a heating rate of 5 
°C min−1.
The specific surface area of the different samples was determined by nitrogen gas 
adsorption/desorption isotherms (Gemini V, Micrometrics; USA) and based on 
the Brunauer−Emmett−Teller (BET) model:[36]
1/(W((P0/P) − 1)) = 1/WmC + (C − 1)/WmC(P/P0)
where W is the weight of the gas adsorbed, Wm is the weight of the adsorbate as a 
monolayer, P0/P is the relative pressure, and C is the BET constant. The specific 
surface area (S) can be obtained from the following equation:[36]
S = WmNAcs/MW
where N is the Avogadro’s number, Acs is the adsorbate cross-sectional area (16.2 
Å2/ molecule for N2), and M is the weight of the sample.
The presence of amine groups was determined by attenuated total reflectance-
infrared spectroscopy (ATR-IR; UATR two; PerkinElmer, The Netherlands) 
with a resolution of 4.0 cm−1 and a scanning range from 400 to 4000 cm−1.
A fluorescamine assay was used in order to qualitatively detect the presence of 
amine groups. Briefly, the materials were incubated for 1 hour in a 1:1 (v/v) 
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mixture of ddwater and a 1 mg mL−1 fluorescamine (Sigma-Aldrich) solution in 
acetone (Lab-Scan, Poland) at room temperature. Afterward, three centrifugation 
steps with ddwater were performed to remove the excess dye. Fluorescence was 
assessed by confocal microscopy. Fluorescence intensity heat maps were created 
using ImageJ software (National Institutes of Health, USA).
In order to quantify the amount of amine groups in the samples, a 
2,4,6-trinitrobenzenesulfonic acid (TNBS) colorimetric assay was performed. 
Briefly, a known amount of sample was incubated with 400 μL of a 0.5% 
w/v picrylsulfonic acid solution (Sigma-Aldrich, USA) for 2 hours at 40 °C. 
Afterward, 700 μL of pure hydrochloric acid (HCl, 37% w/v, 12.1M) was added 
in order to dissolve the samples, and the samples were incubated at 60 °C until 
the solution was completely clear. Absorbance at λ = 405 nm was determined 
with a UV−vis microplate reader (Synergy HTX; Biotek, The Netherlands). 
The amines concentration was calculated assuming a 1:1 stoichiometry of the 
complex between the amine groups and the dye. Values were normalized for the 
weight of each sample. 
2.4. In Vitro cytotoxicity of PLLA microcylinders
Adherent human foreskin fibroblasts were grown and maintained in DMEM 
medium (Gibco®, Life Technologies, USA) with 10% fetal bovine serum (FBS; 
Sigma-Aldrich, USA) and a mixture of penicillin (100 Units mg-1) / streptomycin 
(100 μg ml-1) (Gibco®). Cells were cultured in an incubator with 5% CO2 at 37 °C. 
For cytotoxicity analyses, fibroblasts were seeded at a density of 30,000 cells cm−2. 
A LIVE/DEAD assay (Molecular Probes, Invitrogen, Thermo Fisher Scientific, 
The Netherlands) was performed at 72 hours, according to the instructions of 
the manufacturer. A suspension of porous microcylinders in culture medium 
was prepared (0.5 mg mL−1) and added to the cells 24 hours after seeding. Prior 
to LIVE/DEAD assay, samples containing the microcylinders were placed in an 
incubator overnight, in order for the microcylinders to settle in the bottom of the 
wells. Cells cultured in the same conditions without microcylinders served as a 
positive control. For the negative control group, cells were maintained at the same 
condition as the positive control except that the culture medium was changed to 
70% v/v methanol in ddwater 30 minutes prior to performing the LIVE/DEAD 
assay. Additionally, cells were cultured with PLLA porous microcylinders (0.1, 
0.5, and 1.0 mg mL−1) in 24-well culture plates, and cell viability was evaluated 
by performing an AlamarBlue viability test (Molecular Probes, Invitrogen, 
Thermo Fisher Scientific, The Netherlands) per the manufacturer’s instructions 
to obtain quantitative data on cellular activity. Positive and negative controls 
were prepared as described for LIVE/DEAD assay.
2.5. Statistical Analysis.
Prism 6.01 software (GraphPad Software, Inc, USA) was used to perform all 
statistical calculations. Fiber diameter and microcylinders dimensions (length 
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and diameter) were estimated from the corresponding SEM images using ImageJ 
software (National Institutes of Health, USA). Twenty different measurements 
were taken from 5 different regions of each electrospun membrane or each 
microcylinders group (n = 100 for the fiber diameter and n = 100 for the 
microcylinders’ length and diameter). Data were reported as mean ± standard 
deviation (SD). Statistical analysis was carried out by using two-way analysis 
of variance (ANOVA) combined with a Sidak’s multiple comparison post-hoc 
test. The time of aminolysis and the morphology of fibers or microcylinders 
were considered as independent variables. Crystallite size data obtained by XRD 
from three samples (n = 3) and TNBS amines quantification data in triplicate 
(n = 3) were analyzed by a two-way ANOVA test combined with a Sidak’s 
multiple comparison post-hoc test, using the same variables. AlamarBlue data 
were assayed in triplicate (n ≈ 3) and analyzed using a one-way ANOVA test 
combined with a Tukey’s post-hoc comparison test. Differences were considered 
significant at p < 0.05.
3. Results and discussion
The electrospinning process resulted in the fabrication of two distinct types of 
fibers (Figure 1a and 1b). Morphologically, the use of HFIP (1,1,1,3,3,3-hexafluoro-
2-propanol) as a solvent resulted in fibers with a smooth surface. In contrast, 
PLLA fibers with a porous surface were obtained using a mixture of DCM and 
TCM as a solvent. The differences between these fibers have been described 
previously[27, 37] and are related to the volatility of the solvent used; HFIP is a 
less volatile solvent (vapor pressure of 16 kPa at 20 °C), resulting in uniform, 
dense, homogeneous fibers. DCM is a highly volatile compound (vapor pressure 
of 47.3 kPa at 20 °C) and evaporates quickly, leading to the presence of polymer-
rich and polymer-poor phases during electrospinning and resulting in the 
formation of surface porosity.[28, 29] The addition of TCM, which is less volatile 
than DCM (vapor pressure of 21.2 kPa at 20 °C), helped to avoid clogging of 
the nozzle during electrospinning due to drying of the polymeric solution. The 
fibers prepared with HFIP and the DCM/TCM mixture will be referred to as 
“smooth” and “porous”, respectively. Figure 1c shows that smooth fibers have 
a smaller diameter compared to the porous fibers (1.3 ± 0.20 versus 3.7 ± 1.14 
μm, respectively). As DCM is a solvent with lower electrical conductivity than 
HFIP, it was necessary to apply a higher voltage in order to achieve a stable mode 
of electrospinning. It is likely that this higher voltage increased the size of the 
electrospinning jet and hence the fiber diameter.[38] Figure 1d and 1e show the 
morphology of the smooth and porous microcylinders obtained using a 3 hours 
aminolysis procedure. Significant morphological changes to the fibers’ surface 
were not observed during the aminolysis procedure; smooth fibers formed 
smooth microcylinders, and porous fibers formed porous microcylinders. 
However, the microcylinders’ length showed differences; porous microcylinders 
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were longer than the smooth microcylinders (14.6 ± 5.77 vs 6.6 ± 3.24 μm after 
3 hours of aminolysis and 6.6 ± 3.57 vs 1.1 ± 0.19 μm after 5 hours of aminolysis, 
respectively), and aminolysis time had an inverse effect on length (Figure 1f). 
The differences in length between the two types of microcylinders are likely 
related to the different distribution of amorphous and crystalline regions in the 
developed fibers. In contrast, aminolysis time did not affect dramatically the 
diameter of the microcylinders, although a slight decrease of the diameter with 
the time of aminolysis could be observed (Figure 1c).
Figure 1. Representative SEM images of smooth fibers (a), porous fibers (b), and the resulting mi-
crocylinders after 3 hours of aminolysis (d and e, respectively). The average diameters and lengths of 
the fibers and microcylinders were measured from 100 different SEM images (c,f).**** p < 0.0001.
After 3 and 5 hours of aminolysis, the smooth microcylinders had average 
specific surface areas of 9.89 and 11.81 m2 g−1, respectively, while the porous 
microcylinders had average specific surface areas of 22.53 and 20.75 m2 g−1, 
respectively. As expected, the creation of a porous surface resulted in an increase 
in the specific surface area of the microcylinders.
DSC was used to study the thermal properties of the fibers and microcylinders. 
The curves obtained for the smooth and porous fibers and microcylinders 
were similar (Figure 2a and 2b, respectively). For both morphologies, the 
thermograms of untreated fibers presented a glass transition temperature (Tg) 
of PLLA at around 60 °C, consistent with results previously reported.[39] Also, 
the thermograms presented an exothermic peak at around 80 °C that can be 
attributed to a cold crystallization process, which accounts for the crystallinity 
developed during heating. Furthermore, the melting peak (Tm) at ~181 °C was 
preceded by a small exothermic signal, probably representing a second cold 
crystallization event.[40] The microcylinders showed the presence of a very small 
shift corresponding to the Tg and a second endothermic band related to the 
melting point of the polymer.
c)
f)
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a) b)
Figure 2. DSC curves for smooth fibers and microcylinders (a) and porous fibers and microcylin-
ders (b). Well-defined Tg and Tm peaks are observed for the untreated fibers. The microcylinders 
do not exhibit the same transitions, indicating a fundamental shift in crystallinity during amino-
lysis.
The degree of crystallinity (χc) for both smooth and porous fibers and microcyl-
inders was calculated based on the DSC results (Table 1). For electrospun fibers, 
the crystallinity was lower than 40%, which was lower than the crystallinity of 
the original polymer (χc = 59%). This significant reduction in crystallinity is pri-
marily due to the quick solidification of the polymer during jet formation in 
the electrospinning process, hindering the development of an ordered crystal-
line structure in the resulting fibers.[41] However, when the microcylinders were 
formed, the crystallinity increased to approximately 60%, which can be attribut-
ed to aminolysis-induced crystallization.[11] These results explain the absence of 
a peak related to the cold crystallization process at 80 °C in the DSC scans of the 
microcylinders. During aminolysis, the reactive amines group donor attacks the 
amorphous regions of the fibers, leading to the formation of microsized frag-
ments that possess a high degree of crystallinity and do not crystallize further 
upon heating during DSC.
Both the melting temperature (as measured by DSC; Table 1) and decomposi-
tion temperature (as measured by TGA; Figure S1) decreased with increasing 
times of aminolysis. This may be caused by the polymer molecular weight de-
crease during the aminolysis procedure.[11] As the aminolysis time increased, 
small fissures started to appear in the samples, as seen in Figure S2, although 
the main morphological features (a dense or porous surface) were maintained.
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Specific 
surface 
area
(m2 g -1)
Crystallite 
size (nm)
Degree of 
Crystallinity
(%)
Temperature 
of 
melting (°C)
Temperature
 of 
decomposition 
(°C)
Pristine 
polymer
----- ----- 58.85 ----- -----
Smooth fibers
untreated
----- amorphous 37.58 181.05 ± 2.26 311.47 ± 7.46
Smooth 
microcylinders
aminolysis 3 h
9.89 13.37 ± 1.55 63.36 154.10 ± 2.36 249.62 ± 16.92
Smooth 
microcylinders
aminolysis 5 h
11.81 18.20 ± 2.63 62.38 136.70 ± 0.45 239.34 ± 13.02
Porous fibers
untreated
----- amorphous 39.55 181.39 ± 0.04 286.80 ± 26.68
Porous 
microcylinders
aminolysis 3 h
22.53 14.97 ± 2.60 61.92 151.66 ± 0.71 260.37 ± 0.69
Porous 
microcylinders
aminolysis 5 h
20.75 18.70 ± 2.92 59.98 134.51 ± 0.25 240.94 ± 9.33
Table 1. Structural Properties of the Electrospun PLLA Fibers and the Microcylinders.
To develop a more thorough understanding of the effects of aminolysis on the 
crystalline properties of the microcylinders, XRD analyses were performed (Fig-
ure 3a and 3b). Independent of surface morphology, untreated fibers did not ex-
hibit any peaks throughout the 2θ range of 10−30°, showing only a broad bump 
of low intensity. This demonstrates the amorphous nature of the fibers. For the 
smooth and porous fibers that underwent aminolysis for 3 or 5 hours, distinctive 
peaks at 2θ = 16.5 and 18.9° were observed. These peaks are characteristic of the 
α-form of PLLA crystals.[42] The size of the crystallites was calculated according 
to the Scherrer equation [35] The crystallites showed similar sizes for both types 
of microcylinders, with a size ranging from 12 to 22 nm for porous microcylin-
ders and from 12 to 21 nm for smooth microcylinders (Table 1 and Figure 3c). 
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These results demonstrate that although the length of the microcylinders was 
dependent on aminolysis time, this process did not affect the crystallite units. 
Because there was no significant difference with respect to the size of the crys-
tallites between 3 and 5 hours of aminolysis, it can be concluded that after 3 
hours of aminolysis the PLLA crystallites seem not to be substantially affected 
by the chemical scission process and that the differences in length observed at 3 
and 5 hours of aminolysis were predominantly caused by the degradation of the 
amorphous regions of the fibers.
a) b)
c)
Figure 3. XRD spectra for smooth (a) and porous (b) fibers and microcylinders. (c) Crystallite 
dimensions for smooth and porous microcylinders at 3 and 5 hours of aminolysis; no statistical 
differences were observed across groups.
To further elucidate the mechanism of aminolysis, we studied the contributions 
of IPA and EtDA, the two components used to prepare the reactive solution, 
to the microcylinders’ formation. Electrospun PLLA fibers were immersed for 
1 hour in pure IPA, a 5% v/v solution of EtDA in ddwater, or a 5% v/v solution 
of EtDA in IPA (standard aminolysis solution). XRD spectra of the fibers after 
these treatments indicated that immersion in pure IPA or in a 5% v/v solution of 
EtDA in IPA substantially increased the crystallinity of the resulting microcylin-
ders, presenting characteristic peaks of PLLA crystals (Figure 4). This observa-
tion corroborates previous work, demonstrating a tendency of PLLA to crystal-
lize when it is immersed in a wide range of organic solvents.[43] However, EtDA 
alone appeared not to contribute to polymer crystallization. Interestingly, the 
combined use of EtDA and IPA showed a synergistic effect on polymer crystalli-
zation, as evidenced by the high intensity of the PLLA peak in the XRD spectra 
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(Figure 4). Further, when both the smooth and the porous fibers were immersed 
in IPA or 5% v/v EtDA in ddwater for 1 hour, no fiber degradation was observed 
in comparison with the cleavage of the fibers when immersed in 5% v/v EtDA 
in IPA (Figure S3). Therefore, the aminolysis-based preparation of microcylin-
ders can be regarded as an interplay between solvent induced crystallization and 
chemical cleavage of the amorphous regions of the fibers.
The DSC and XRD results suggest that during the microcylinders formation 
initially a solvent-induced crystallization occurs, which is followed by the EtDA 
preferential “cutting” of the amorphous regions within the polymer, resulting 
in an increase of the crystallinity. This mechanism is correlated with the theory 
proposed by Kim and Park.[11]
a) b)
Figure 4. XRD spectra for porous (a) and smooth (b) fibers subject to aminolysis for 1 hour.
Besides the fiber “cutting” effect, aminolysis is known to introduce amine groups 
at the surface of treated polymers.[15] These free amine groups render the micro-
cylinders suitable for further functionalization with therapeutic drugs or bio-
molecules. To monitor the amine groups at the microcylinders’ surface, ATR-IR 
analysis, a fluorescamine assay, and a TNBS colorimetric assay were performed. 
As expected, infrared analysis of the untreated fibers did not show any bands re-
lated to amine groups (Figure S4). However, the aminolysis procedure induced 
two new bands for microcylinders that can be assigned to an amide II N−H bond 
(~1540 cm−1)[13] and an amide I C=O bond (~1690 cm−1).[13, 14] Figure 5 shows 
the results obtained with the fluorescamine assay. This method is based on the 
specific attachment of the fluorescamine dye to primary amine groups. Micro-
cylinders prepared via aminolysis showed an intense blue fluorescent signal at 
their surface (Figures 5b and 5d). Although the presence of amines can be as-
sessed over the entire surface of the microcylinders, it is interesting to note that 
the edges present a higher fluorescence intensity (red arrows in Figures S5d and 
S5h). The untreated fibers did not show any fluorescent signal (Figures S5b and 
S5f). Such differences can be assessed more clearly when a fluorescence intensity 
map is created, showing that the extremities present a higher fluorescence in-
tensity when compared with other regions of the microcylinders (Figure 5c and 
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5f). The results obtained with the fluorescamine assay support our hypothesis of 
a transversal sectioning of the electrospun fibers and degradation of their more 
amorphous areas, presenting the extreme regions a more intense fluorescence.
c)
a) b)
c)
d) e)
f)
Figure 5. Smooth microcylinders after 3 hours of aminolysis (a, bright field; b, fluorescence; c, in-
tensity heatmap). Porous microcylinders after 3 hours of aminolysis (d, bright-field; e, fluorescence; 
f, intensity heatmap).
To quantify the amount of amine groups present at the surface of the micro-
cylinders, a TNBS colorimetric assay was performed. This test is based on the 
attachment of free amine groups to the TNBS reagent, resulting in the formation 
of a yellow chemical complex. A direct correlation between the aminolysis time 
and the number of the amine groups grafted to both smooth and porous micro-
cylinders could be observed (Figure 6). Porous microcylinders showed a larger 
average amount of amine groups compared to the smooth microcylinders that 
were subjected to similar aminolysis times, although there were no statistical 
differences between the groups.
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Figure 6. Amine group content for the smooth and porous microcylinders. ** p < 0.01; *** p = 
0.0001; **** p < 0.0001.
On the basis of these results, porous microcylinders present themselves as ideal 
candidates for local drug delivery purposes. The results obtained by DSC and 
XRD demonstrate that such structures are thermally stable and crystalline, 
increasing their chemical and physical stability. Furthermore, the increased 
specific surface area with the successful grafting of amine groups makes these 
microcylinders suitable for future use as therapeutic vehicles through the im-
mobilization of, for example, anticancer agents for tumor therapy.[44, 45] Alterna-
tively, immobilization of growth factors[46, 47] or biomolecules that mediate cellu-
lar adhesion[48] are options for the application of these microcylinders in tissue 
engineering and regenerative medicine.[30]
Biological evaluation of the microcylinders was performed by examining cell 
viability and cellular metabolic activity upon culture of human fibroblasts with 
the porous microcylinders (Figure 7). The LIVE/DEAD assay showed that hu-
man fibroblasts cultured with 0.5 mg mL−1 porous microcylinders presented vi-
able green fluorescent cells (Figure 7c). These data indicate that during LIVE/
DEAD assay only calcein was incorporated in the fibroblasts cultured with the 
porous microcylinders, which allows one to conclude that the microcylinders 
developed did not affect the integrity of the fibroblasts cellular membrane and 
hence no cytotoxic effect was observed. Figures 7d and 7e present the results 
obtained for the AlamarBlue viability test after 24 and 72 hours of incubation 
with the microcylinders, respectively. The fibroblasts viability was not affected 
by the presence of 0.1 mg mL−1 microcylinders. However, when fibroblasts are 
cultured with 1.0 mg mL−1 of microcylinders viability is significantly affected af-
ter both 24 and 72 hours of culture. Such results are related to the large number 
of microcylinders present at this concentration. Such a large number affect cell 
activity not only due to a possible high concentration of PLLA by-products in 
the medium but mostly due to the physical occupation of the well by the micro-
cylinders, affecting cellular proliferation over time (Figure S6).
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Figure 7. LIVE/DEAD assay for fibroblasts cultured with porous microcylinders (a) negative con-
trol; (b) positive control; and (c) 0.5 mg mL−1 porous microcylinders. AlamarBlue test for fibro-
blasts culture with porous microcylinders at different concentrations for (d) 24 and (e) 72 hours. *p 
< 0.05, **p < 0.01, ***p = 0.0001.
4. Conclusion
Electrospinning combined with an aminolysis chemical scission process led to 
the production of microcylinders of controllable dimensions, increased specific 
surface area, and with or without a surface porous morphology. The dimensions, 
crystallinity, specific surface area, and thermal stability of the structures were 
dependent on the experimental conditions used during fabrication, for example, 
the solvent chosen in electrospinning and the duration of aminolysis. In addi-
tion, amine groups were successfully introduced on the microcylinders’ surface, 
which can be used as reactive sites for the chemical immobilization of relevant 
compounds, such as therapeutic agents. The microcylinders showed biocom-
patible properties related to cell viability in vitro. This feature together with their 
increased specific surface area makes these structures appealing for future bio-
medical applications as local drug-delivery systems.
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Supplementary Information
Figure S1. a) TGA curve for smooth fibers and microcylinders after 3 hours and 5 hours of amino-
lysis b) TGA curves for porous fibers and microcylinders after 3 hours and 5 hours of aminolysis.
Figure S2. a) Smooth micro-cylinders after 5 hours of aminolysis b) Porous micro-cylinders after 5 
hours of aminolysis. Red arrows highlight the presence of small fissures in the structures.
c)
f)e)d)
b)a)
Figure S3. Smooth electrospun fibers immersed for 1 hour in a) isopropanol (IPA) b) 5% eth-
ylenediamine (EtDA) in ddwater c) 5% ethylenediamine (EtDA) in isopropanol. Porous electrospun 
fibers immersed for 1 hour in d) isopropanol (IPA) e) 5% ethylenediamine (EtDA) in ddwater f) 5% 
ethylenediamine (EtDA) in isopropanol. Cleavage of the fibers can be observed when immersed 
in 5% EtDA in IPA.
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Figure S4. ATR-IR spectra for porous untreated fibers and microcylinders after 3 hours and 5 hours 
of aminolysis.
Figure S6. Images obtained by optical microscope for fibroblasts cultured with a) 0.1 mg ml-1 of 
porous microcylinders b) 0.5 mg ml-1 of porous microcylinders and c) 1.0 mg ml-1 of porous mi-
crocylinders. Magnification of 10x.
Figure S5. Smooth electrospun fibers (a-bright field; b-fluorescence) and microcylinders after 3 
hours of aminolysis (c-bright field; d-fluorescence). Porous electrospun fibers (e-bright-field; f-flu-
orescence) and microcylinders after 3 hours of aminolysis (g-bright-field; h-fluorescence). Red ar-
rows indicate the areas with higher fluorescence.
a) b)
c) d)
f)
g)
e)
h)
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1. Introduction
 A calcium phosphate cement (CPC) is prepared from at least one type of 
calcium phosphate salt and a liquid phase. Mixing of these two phases triggers 
a precipitation reaction and results in the entanglement of precipitated calcium 
phosphate crystals to achieve the hardening of the cement, also known as setting.[1] 
CPCs are prepared from various calcium phosphate precursors, e.g. α-tricalcium 
phosphate (α-TCP), β-tricalcium phosphate (β-TCP), tetracalcium phosphate 
(TTCP) or combinations thereof. After completion of the precipitation reaction, 
either an apatite-rich CPC or a brushite-based CPC are formed, depending on 
the pH of the setting reaction.[2, 3] CPCs are highly attractive for bone regenerative 
applications due to their biocompatibility[4], similarity to the mineral phase of 
bone[5], possibility to be applied in an injectable form[6], and osteoconductivity.[7] 
During the past few years, CPCs have shown great potential for vertebroplasty 
procedures as well as treatment of osteoporosis-related fractures, maxillofacial 
defects and deformities.[1, 4]
Despite these advantageous properties, CPCs possess a major drawback: their 
mechanical properties are inferior to native bone. One of the main disadvantages 
of CPCs is their brittleness. CPCs can be deformed plastically to a very limited 
extent due to their low intrinsic resistance to crack propagation, which ultimately 
can lead to catastrophic failure.[8, 9] This drawback inhibits the application of 
CPCs at load-bearing anatomical sites.
Several strategies have been explored toward the enhancement of the mechanical 
properties of CPCs, for example by incorporation of titania, silica[10], carbon 
nanotubes and polymeric fibers.[11, 12] The addition of stiff and strong fibers for 
mechanical reinforcement of CPCs has become increasingly popular. In this way, 
loads can be transferred from the brittle matrix to the fibers, thereby improving 
the toughness and ductility of the resulting composite by mechanisms such as 
crack deflection, fiber bridging and frictional sliding.[13, 14] Synthetic polymeric 
fibers are widely used for reinforcement purposes due to their low cost, abundant 
availability and suitability for post-production modification.[15, 16] However, it is 
a challenge to incorporate long fibers into CPCs in a homogeneous manner. 
From a mixing perspective, short fibers are preferable.[17, 18] These fillers can be 
produced through several physical methods such as lithography[19], stretching[20] 
or sectioning[21] as well as chemical synthesis routes.[22] Recently, we reported 
the preparation of surface-porous micrometric fillers from poly(L-lactic acid) 
(PLLA) electrospun fibers.[23] This procedure is based on the incubation of 
polymeric fibers with a reactive amine donor that initiates a chemical scission 
process, resulting in transverse segmentation of the fibers.[24] Apart from the 
fiber cutting effect, aminolysis functionalizes the surface of the polymer with 
amine groups, hence increasing the hydrophilicity and enabling subsequent 
functionalization of the polymer.[25, 26]
Based on the aforementioned, we hypothesize that the introduction of 
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polymeric fillers can improve the toughness of CPCs provided that the fibers 
are mixed homogeneously throughout the cement matrix. Furthermore, we 
hypothesize that the presence of surface porosity on the polymeric micro-
fillers improves the mechanical properties of the resulting reinforced cement by 
means of micromechanical interlock.[27, 28] To test these hypotheses, we prepared 
PLLA micron-sized fillers (microcylinders) with either a smooth or porous 
surface. We incorporated the PLLA microcylinders into CPCs containing (or 
not) poly(lactic-co-glycolic acid) (PLGA) microparticles to render the CPC 
degradable.[29] Subsequently, the microcylinders distribution, as well as the 
morphology, cohesiveness, setting times and mechanical properties (in terms of 
flexural strength, flexural modulus and work-of-fracture) of the microcylinders 
reinforced cements were evaluated. PLLA microcylinders morphology and 
distribution together with CPCs morphology, cohesion, and initial and final 
setting times were examined. For mechanical evaluation, CPCs were subjected 
to a three-point flexural bending test to determine their flexural strength, 
flexural modulus, and work-of-fracture.
2. Materials and methods
2.1. Materials
Medical-grade PLLA (Purasorb PL65®) was obtained from Corbion-Purac (The 
Netherlands). 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) was purchased from 
Fluorochem (United Kingdom). Dichloromethane (DCM), trichloromethane 
(TCM), isopropanol (IPA), acetone and disodium hydrogen phosphate dihydrate 
(Na2HPO4·2H2O) were obtained from Merck (Germany). Ethylenediamine 
(EtDA) was obtained from VWR chemicals (France). Fluorescamine was 
obtained from Sigma-Aldrich (USA). CPC powder (α-tricalcium phosphate) 
and milled PLGA particles (Purasorb PDLG 5002A; average diameter of 48.65 
± 22.07 μm)[30] were provided by CAM Bioceramics (The Netherlands). For 
convenience, the samples made solely from CPC were named as CPC1 while 
the samples formed from CPC and milled PLGA particles were named as CPC2.
2.2. Electrospinning of PLLA
Continuous electrospun PLLA fibers were prepared according to a previously 
described method.[23] PLLA was dissolved at a concentration of 3% w/v in HFIP 
or in a 4:1 v/v mixture of DCM : TCM. A commercially available electrospinning 
apparatus (Advanced Surface Technology BV, The Netherlands) was used to 
create the electrospun fibers. Electrospinning of PLLA in HFIP was performed 
using the following parameters: feeding rate = 2.0 mL h−1; distance between the 
needle and the collector = 35 cm; voltage = 19.25 kV. Electrospinning of PLLA 
in the DCM : TCM mixture was performed using the following parameters: 
feeding rate = 2.0 mL h−1; distance between the needle and the collector = 35 cm; 
voltage = 35.00 kV. Fibers were collected on a stationary flat collector covered 
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with aluminum foil. Electrospun membranes were left to dry overnight in a 
fume hood to evaporate the solvent.
2.3. Production of PLLA microcylinders
PLLA microcylinders were fabricated as described previously.[23] First, the two 
different PLLA electrospun fibers were incubated in a 5% v/v EtDA solution in 
IPA at 37 °C for 3 hours. Subsequently, 4 cycles of centrifugation/washing with 
ddwater were performed to remove the EtDA solution in excess. Finally, samples 
were resuspended in ddwater, subjected to ultrasonication at 100% amplitude for 
40 seconds (UP50H; Hielscher - Ultrasound Technology; Germany) to disperse 
the PLLA micro-fillers, freeze-dried, and stored at -20 °C for further use.
2.4. Morphological evaluation of PLLA fibers and microcylinders
Scanning electron microscopy (SIGMA 300; Zeiss, The Netherlands) was 
performed at an acceleration voltage of 3.0 kV to study the morphology of PLLA 
fibers and microcylinders. The fiber mats and discrete microcylinders powders 
were fixed on aluminum stubs with carbon tape and coated with chromium 
(thickness≈10 nm) for subsequent observation.
2.5. Preparation of calcium phosphate cements
The cement samples were prepared by mixing the calcium phosphate base powder 
phase with an aqueous phase. The different compositions are described in Table 
1. For the groups including PLLA microcylinders, CPC1 or CPC2 powders were 
first mixed manually with 5% wt PLLA microcylinders. For the groups without 
PLLA microcylinders, only CPC1 or CPC2 were used as the powder phase. A 
4% w/v Na2HPO4·2H2O aqueous solution was then added to initiate the setting 
reaction. The liquid to powder (L/P) ratio for CPC1 and CPC2 based samples 
was 0.50 and 0.42, respectively.
Sample α-TCP/ wt% PLGA/ wt%
Smooth 
microcylinders/ 
wt%
Porous 
microcylinders 
/wt%
CPC1 100.0 ----- ----- -----
CPC1S 95.0 ----- 5.0 -----
CPC1P 95.0 ----- ----- 5.0
Table 1. Composition of the different CPCs
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2.6. PLLA microcylinders distribution
The spatial distribution of PLLA microcylinders throughout the CPCs was 
monitored using the fluorescent marker fluorescamine, which reacts with primary 
amines on the surface of aminolyzed fibers to form highly fluorescent products. 
To this end, 0.5 g PLLA microcylinders were incubated with 2 ml fluorescamine 
solution (50% v/v acetone/ddwater) for 1 hour at room temperature, conferring 
them a blue color when excited at λ=401 nm. The labeled PLLA microcylinders 
were freeze-dried and used for cement preparation by following the method 
described in the previous section. Samples were cross-sectioned with a scalpel 
for observation under a fluorescence microscope (Axioimager Z1; Zeiss, The 
Netherlands).
Backscatter SEM was performed at an acceleration voltage of 10.0 kV. Cements 
were broken, fixed to aluminum stubs with carbon tape, and examined as 
previously described.[31] 
2.7. X-ray diffraction analysis
X-ray diffraction (XRD; pw1830; Philips; The Netherlands) was performed to 
determine the crystallographic profile of the samples. Cements were incubated 
in SBF for 3 days, freeze-dried and grinded. Subsequently, as a powder, samples 
were placed in a copper holder and scanned. XRD spectra were registered at 40 
kV, 30 mA (Cu-Kα radiation with a wavelength of 1.54 Å), 2θ between 10° and 
60°and a step size of 0.005°.
2.8. Determination of porosity
Porosity was determined by a burn-out assay. First, cements were prepared, 
incubated in SBF for 3 days, freeze-dried and weighted. Subsequently a heating 
protocol was used to eliminate the organic components present in the cements. 
Briefly, samples were heated at a rate of 1.67 °C min−1 until the temperature 
reached 650 °C. Afterward, samples were maintained at this temperature for 3 
hours, and the temperature was decreased at a rate of 1.67 °C min−1 until reaching 
room temperature. Total porosity (1) and macroporosity (2) percentages were 
calculated according to the following formulas:[32] 
CPC2 60.0 40.0 ----- -----
CPC2S 58.0 37.0 5.0 -----
CPC2P 58.0 37.0 ----- 5.0
єtot = (1−mmacro /VρHAp) x 100 (1)
єmacro = (1–mmacro /mmicro) x 100 (2)
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where єtot is the total porosity (%), єmacro the macroporosity (%), mmacro is the mass 
of the samples after the thermal treatment and mmicro the mass of the samples 
after setting and freeze-drying.
2.9. Cohesion evaluation
The cohesion of CPCs was evaluated by visual examination. Immediately after 
mixing, the cement paste was immersed in PBS at 37 °C and the amount of debris 
present in the fluid examined. A score from 0 to 5 was applied, according to the 
visual examination. A value of 0 corresponds to a totally cohesive cement and 
a value of 5 to a large amount of debris in the medium (Table 2). Experiments 
were performed in triplicate (n=3).
Score Description
5 Large amount of debris in the medium
4 Moderate amount of debris in the medium
3 Small amount of debris in the mediums
2 Moderate amount of CPCs particles in the medium
1 Small amount of CPCs particles in the medium
0 Absence of debris/particles
Table 2. Grading table for cohesion evaluation
2.10. Setting time
The initial and final setting times of the CPCs were assessed using a Gillmore 
apparatus.[33] A bronze block containing six holes (6 mm in diameter, 12 mm 
in height) was used as a mold. The mold was placed in a water bath at 37 °C to 
mimic body temperature and afterward, the holes were filled with the different 
cement pastes. The initial/final setting times were defined as the times at which a 
light or heavy Gillmore needle failed to make a perceptible circular indentation 
on the surface of the cement (n=3).
2.11. Mechanical evaluation
After mixing, the cements were introduced into Teflon molds of 4×4×20 mm3 
and left to set overnight. The obtained samples were immersed in SBF for 3 
days at 37 °C, to achieve a complete conversion of α-TCP to hydroxyapatite. 
Afterward, the samples were subjected to a three-point flexural bending test 
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using a universal testing machine (858 mini bionix II; MTS, USA) with a load 
cell of 1 kN and a crosshead speed of 0.2 mm min−1 to evaluate the flexural 
strength, flexural modulus, and the work-of-fracture. The mechanical properties 
were determined according to the following equations:[14]
Flexural Strength: Sc = (3Pmax L)/(2bℎ2)
where Pmax is the maximum load on the load-displacement curve, L is the flexure 
span, b is the specimen width and ℎ the thickness.
Flexural Modulus: E = (mL3)/(4bℎ3)
where m is the slope of the tangent to the linear portion of the load-displace-
ment curve.
Work of fracture: WOF = A/bℎ
where A is the area under the load-displacement curve.
2.12. Morphological evaluation of CPCs
The set CPCs were cross-sectioned, fixed on aluminum stubs with carbon tape 
and examined by scanning electron microscopy as previously described.
2.13. Statistical analysis
Prism 6.01 software (GraphPad Software, Inc., USA) was used to perform 
all statistical calculations. PLLA microcylinders dimensions (length and 
diameter) were estimated from the corresponding SEM images using ImageJ 
software (National Institutes of Health, USA). Data were reported as mean ± 
standard deviation (SD) with n=100. Statistical analysis was effectuated by a 
Student’s t-test. Porosity calculations were performed using 3 samples of each 
composition (n=3) and data were reported as mean ± standard deviation (SD). 
Significance was analyzed using one-way ANOVA with a post-ℎoc Tukey’s 
multiple comparison test. Differences were considered significant at p < 0.05. 
For mechanical evaluation, ten specimens of each composition (n=10) were 
used for each of the mechanical tests and data were reported as mean ± standard 
deviation (SD). Results were statistically analyzed using one-way ANOVA 
with a post-ℎoc Tukey’s multiple comparison test. Differences were considered 
significant at p < 0.05.
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3. Results
3.1. PLLA fibers and micro-fillers visualization
Figure 1 shows the morphology of the smooth and porous fibers after 
electrospinning as well as the smooth and porous microstructures obtained 
after 3 hours of aminolysis. Morphologically, the use of HFIP as a solvent 
during electrospinning resulted in fibers with a smooth surface (Figure 1a). In 
contrast, porous PLLA fibers were obtained using a mixture of DCM and TCM 
(Figure 1b). Aminolysis resulted in micrometric cylindrical structures with two 
distinct morphologies, based on the surface morphology of the fibers: smooth 
microcylinders were created when smooth fibers were subject to aminolysis 
(Figure 1c), while aminolysis of porous fibers resulted in surface-porous 
microcylinders (Figure 1d).
Figure1. PLLA electrospun fibers. a) dense fibers b) surface porous fibers. PLLA microcylinders c) 
smooth microcylinders d) surface porous microcylinders. 10,000× magnification.
Figure 2 shows that the size of PLLA microcylinders was dependent on the 
electrospinning conditions resulting into a smaller length and diameter for 
smooth microcylinders as compared to the surface-porous microcylinders 
(average length of 6.6 ± 3.24 μm and 14.6 ± 5.77 μm, respectively, and average 
diameter of 1.3 ± 0.20 μm versus 3.7 ± 1.14 μm respectively). The aspect ratio 
was 5:1 for PLLA smooth microcylinders and 4:1 for PLLA surface-porous 
microcylinders.
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3.3. PLLA microcylinders distribution in CPCs
PLLA microcylinders distribution in the α-TCP matrix was evaluated by 
first labeling these with fluorescamine and then mixing with the remaining 
components of the CPCs. Figure 4 shows the results obtained when the different 
CPCs were observed by fluorescence microscopy. CPCs without microcylinders 
(Figure 4a and 4d) did not present any fluorescence. In contrast, CPCs containing 
Figure 2. Dimensions of PLLA microcylinders after 3 hours of aminolysis. a) diameter b) length. 
Student's t-test **** p < 0.0001.
3.2. Porosity evaluation
Figure 3 shows the values obtained for the macroporosity and total porosity of 
the different compositions. An increase in the percentage of macroporosity was 
observed when PLLA microcylinders were introduced (5.7 ± 0.02% for CPC1, 
9.8 ± 0.10% for CPC1S and 9.9 ± 0.13% for CPC1P). Samples containing PLGA 
presented higher values of macroporosity: 42.0 ± 0.48% for CPC2, 43.8 ± 0.26% 
for CPC2S and 42.4 ± 1.19% for CPC2P. Further, total porosity increased with 
the addition of the PLLA microcylinders, although samples containing PLGA 
presented higher levels of porosity: 60.2 ± 0.45% for CPC1, 63.3 ± 0.48% for 
CPC1S, 62.5 ± 0.24% for CPC1P, 79.1 ± 0.16% for CPC2, 79.7 ± 0.03% for CPC2S 
and 78.5 ± 0.79% for CPC2P.
Figure 3. Porosity of the prepared cements. a) macroporosity percentage b) total porosity percent-
age.* p < 0.05, *** p = 0.0001, **** p < 0.0001.
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Fig. 4. Fluorescamine assay a) CPC1 b) CPC1S  c) CPC1P d) CPC2 e) CPC2S f) CPC2P. 10× magnifi-
cation. Blue color indicates the presence of fluorescamine labeled PLLA micro-fillers.
Backscatter SEM was performed to observe the distribution of the PLLA 
microcylinders in the cement. Figure 5 presents the SEM images for CPC1, CPC1S 
and CPC1P compositions. A homogenous distribution of the PLLA smooth 
microcylinders can be observed for all samples, represented as small dark points 
in Figure 5b. Similarly, porous PLLA microcylinders showed a homogeneous 
distribution. Due to their higher dimensions, these microcylinders were more 
easily identified (Figure 5c).
either smooth or porous microcylinders showed overall blue areas which were 
homogenously distributed throughout the sample. However, due to resolution 
limitations, it was not possible to observe the individual PLLA microcylinders.
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Figure 5. Backscatter SEM a) CPC1 b) CPC1S c) CPC1P 1,000x magnification. Red arrows indicate 
the presence of smooth PLLA microcylinders. Yellow arrows indicate the presence of porous PLLA 
microcylinders.
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3.5. Cohesion evaluation
When in contact with PBS at 37 °C, released particles could be observed for all 
the CPCs, as shown in Figure 7. Qualitative analysis of the different composi-
tions did not reveal substantial differences (Figure 7g).
Figure 6. X-ray diffraction spectra for the prepared cements. Red lines delimited the regions where 
peaks are assigned to hydroxyapatite.
Figure 7. Immersion of the calcium-phosphate cements in PBS at 37 °C. a) CPC1 b) CPC1S c) CP-
C1P d) CPC2 e) CPC2S f) CPC2P g) Qualitative evaluation of the cement’s cohesion. Grading scale: 
0=absence of debris, 1=Small amount of CPCs particles in the medium, 2=moderate amount of 
CPCs particles in the medium, 3=small amount of debris in the medium, 4=moderate amount of 
debris in the medium, 5=large amount of debris in the medium. (n=3).
3.4. X-ray diffraction analysis
Figure 6 presents the XRD spectra for the different cements. All compositions 
show main peaks at 2θ of 26.1°, 31.7°, 32.2°, 39.8°, 46.7°, 49.6° and 53.3°, typical 
for hydroxyapatite.[34]
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Fig. 8. a) Initial setting times b) final setting times. One-way ANOVA. *p < 0.05, **p < 0.01.
3.7. Mechanical evaluation
Load-displacement curves (Figure S1) of cements containing smooth or porous 
microcylinders (CPC1S and CPC1P or CPC2S and CPC2P) presented similar 
curves to the CPC1 or CPC2 compositions, respectively. The incorporation of 
PLGA microparticles resulted in a significant increase in the displacement val-
ues for compositions CPC2, CPC2S and CPC2P.
Figure 9 shows the mechanical properties of the cements. Figure 9a represents 
the flexural strength for the different CPCs. No statistically significant differ-
ences were observed with average values ranging between 4 and 6 MPa for all 
groups. For both flexural modulus and work-of-fracture, the addition of either 
smooth or porous PLLA microcylinders did not show any effect. On the con-
trary, CPC2 groups either with or without PLLA microcylinders always present-
ed significantly lower flexural moduli (1 vs. 3 GPa; Figure 9b) and significantly 
higher values for the work-on-fracture (25 vs. 12 J m−2; Figure 9c).
3.6. Setting time
Figure 8 presents the initial and final setting times as determined with a Gill-
more apparatus. In general, CPC2 groups needed longer time to set (~4 minutes 
vs. 2 minutes of initial setting and ~18 minutes vs. 9 minutes of final setting for 
CPC2 and CPC1, respectively). On the contrary, the addition of PLLA micro-
cylinders had a limited effect on the setting time. PLLA microcylinders slightly 
shortened the setting times except for CPC1P and CPC2S formulations which 
revealed a prolonged final setting time compared with their counterparts with-
out PLLA fillers.
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Figure 9. Mechanical properties for the cements prepared a) flexural strength, b) flexural modulus 
and c) work-of-fracture. One-way ANOVA. **p < 0.01, ****p < 0.0001.
3.8. Morphological evaluation of the CPCs
The morphology of the CPCs sections was examined using SEM (Figure 10). 
The morphology of the calcium phosphate matrix was typical for this type of ce-
ramic materials as characterized by the presence of micrometric calcium-phos-
phate grains. For compositions with PLLA fillers, smooth or porous PLLA mi-
crocylinders (red and yellow arrows) were randomly distributed throughout the 
matrix (Figure 10b, 10c, 10e and 10f). No strong interfacial proximity could be 
observed between the calcium phosphate grains and the fillers. Instead, there 
were several voids and gaps between the two components
Fig. 10. SEM images for a) CPC1 b) CPC1S c) CPC1P d) CPC2 e) CPC2S f) CPC2P. 10,000× magni-
fication. Red arrows indicate the smooth microcylinders, yellow arrows indicate the surface porous 
microcylinders and blue arrows indicate the PLGA microparticles.
4. Discussion
The purpose of this study was to evaluate whether the addition of PLLA micro-
cylinders could be an efficient strategy for the reinforcement of calcium-phos-
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phate cements (CPCs). To this end, 5% wt PLLA microcylinders with either a 
smooth or porous surface were incorporated into the CPC and their effects on 
handling (i.e. cohesion and setting times) and mechanical properties (flexural 
strength, flexural modulus, and work-of-fracture) were assessed. It was observed 
that the microcylinders were uniformly distributed in the CPC matrix. The ini-
tial setting time was significantly reduced with the addition of the microfillers. 
The mechanical properties were not significantly affected by the incorporation 
of PLLA microcylinders.
Prior to mechanical evaluation, the different cements were immersed in SBF 
at 37°C for 3 days. As observed in Figure 6, this led to a total conversion of the 
α-TCP to hydroxyapatite. This suggests that cements with the incorporation of 
the PLLA microcylinders with or without PLGA microparticles would evoke a 
similar biological response compared to regular apatitic CPCs.[35] As already de-
scribed previously[36, 37], immersion of calcium-phosphate cements in phosphate 
containing buffers leads to a fast conversion of such materials into hydroxyapa-
tite. Besides mimicking more closely the bone mineral constituent, this conver-
sion has shown to enhance the mechanical properties through the formation 
of needle-like structures and to a decrease in the size of the residual pores.[38, 39] 
The lack of mechanical reinforcement efficacy for the produced PLLA micro-
cylinders can be attributed to several factors. Calcium-phosphate cements are 
inherently porous materials, containing mostly micropores. Figure 3 confirms 
this, with compositions CPC1, CPC1S and CPC1P possessing low values of mac-
roporosity and approximately 60% of total porosity. When PLGA microparticles 
were added, there was a large increase in macroporosity and also an increase in 
total porosity. A higher percentage of macropores for CPC2, CPC2S and CPC2P 
compositions was expected, since the PLGA particles are micron-sized and will 
occupy a large volume in the samples. After thermal degradation, this led to 
the creation of macropores. The addition of PLLA microcylinders increased the 
values of macroporosity for CPC1, CPC1S and CPC1P (Figure 3a). However, this 
increase did not have a deleterious effect on the mechanical properties of the 
cements. The fact that only 5% of the total weight is due to the presence of PLLA 
microcylinders can explain these results. Gaps and voids were observed between 
the microcylinders and calcium phosphate matrix, indicating that the interfa-
cial bonding between these two components was poor. Figure 4 and Figure 5 
demonstrate that the PLLA microcylinders were homogeneously dispersed 
throughout the cement. The micrometric size and hydrophilic nature (attribut-
ed to amine groups), when compared with non-treated PLLA materials[25, 40], 
might have contributed to this effect. Due to the limit of magnification it was 
not possible to observe the individual PLLA microcylinders in the cement by the 
fluorescamine assay, although the intense blue color through the CPC matrix 
indicates a homogeneous distribution of the PLLA microcylinders. Backscatter 
SEM enabled a better understanding of the distribution of the PLLA microcyl-
inders in the cements. Figure 5b and Figure 5c show that the microcylinders 
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are present through all the cement, being well dispersed in the ceramic matrix. 
It can be concluded that aminolysis led to an increase of hydrophilicity of the 
polymer and facilitated the mixing of the microcylinders with the other CPCs 
components. This treatment however, did not improve the interfacial bonding 
between the microcylinders and precipitated apatite crystals. The aspect ratio 
of the fillers might be a justification for the lack of mechanical improvement. 
When considering fiber reinforcement, mechanical properties are closely relat-
ed to the dimensions of the fibers used. Several studies have shown that mechan-
ical reinforcement increases with increasing aspect ratio of the fibers, although 
miscibility has been reported to decrease with increasing fiber length.[18, 41] To 
obtain a load transfer from the matrix to the fibers, the length of the fibers needs 
to be above the so-called critical length (lc). Possibly the PLLA microcylinders 
did not enhance the mechanical properties of CPCs because the fiber length was 
lower than the critical length, thereby not occuring load transfer upon tensile 
loading.[42, 43] An alternative approach to overcome the above-mentioned limita-
tions entailed the incorporation of microfillers with a porous surface. Such po-
rous surface, besides increasing the surface area of the PLLA microcylinders[23], 
could also create contact points for micromechanical interlock, thereby increas-
ing the friction at the surface of the microcylinders and consequently improving 
the mechanical properties of the CPCs.[44, 45] This mechanism was obviously not 
observed for the porous PLLA microcylinders (Figure 9). A third factor con-
tributing to the lack of reinforcing efficacy of PLLA microcylinders could be 
the weight fraction used. In this study a PLLA microcylinders amount of 5% wt 
was chosen since this amount did not affect the handling properties negatively. 
Increasing the amount of PLLA microcylinders used might have caused a more 
positive effect on the mechanical properties of the CPCs, albeit at the expense 
of the handling properties. The limitations discussed previously point out that 
different strategies need to be adopted in the future. A possible approach is the 
incorporation of residues which promote the mineralization[46, 47] or affinity to 
calcium of the PLLA microcylinders.[48, 49] 
Cohesion is another important aspect in the development of CPCs since debris 
will not flush out from cohesive cements when in contact with the body fluids, 
thereby confining the paste in the site of application.[5] The different cements 
prepared showed a similar cohesion to the pristine CPC1 composition (Figure 
7), indicating that the incorporation of PLLA microcylinders did not have a 
negative effect on cement cohesion.
CPCs are self-setting materials.[50] When an aqueous solution interacts with the 
calcium-phosphate powder precipitation and recrystallization processes are ini-
tiated, leading to the hardening of the cement. Setting time is an important pa-
rameter, affecting the handling and functionality of a cement: if set too rapidly, 
it will hinder the correct placement and reshape of the cement in the injured 
site, while in the case of a too slow setting the cement can be flushed out from 
the implanted site by blood and other body fluids. Figure 8 describes the results 
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obtained regarding initial and final setting times as measured using the Gillmore 
needle method. PLLA microcylinders decreased the initial setting time for all 
compositions. An explanation for this reduction in the initial setting time is the 
decrease in the liquid/powder (L/P) ratio: water from the cement paste can be 
absorbed by the PLLA microcylinders, thereby reducing the amount of water 
available for the cement hardening reaction.[8, 51] Incorporation of PLGA micro-
particles delayed the initial and final setting times considerably. This phenom-
enon was expected since CPC2 formulations contain a substantial amount of 
non-setting PLGA microparticles (40 %wt). Nevertheless, for all compositions 
the initial and final setting times were within the acceptable range for clinical 
usage.[52, 53]
CPC2 cements exhibit a lower stiffness and higher toughness (expressed as 
work-of-fracture) when compared with CPC1 compositions (Figure 9). CPC2, 
CPC2S and CPC2P cements contain 40% wt of PLGA microparticles. The de-
creased flexural modulus was related to the lower stiffness of PLGA when 
compared with α-TCP.[54, 55] The increased toughness was attributed to energy 
dissipation mechanisms associated with the more flexible nature of the PLGA 
microparticles.[16]
In the current work, homogeneous distribution of microcylinders in calci-
um-phosphate based cements was achieved, resulting in the maintenance of 
the handling properties characteristic of these biomaterials. The introduction of 
the PLLA microcylinders did not lead to improved mechanical properties, and 
so the clinical use of these materials remains limited to bone defects with only 
marginal load. However, the authors consider that by applying surface-func-
tionalization strategies, which promote the connection between the calcium 
phosphate matrix and the PLLA microcylinders, or by using tougher polymers, 
the presented strategy is a promising approach for the reinforcement of calci-
um-phosphate cements. 
5. Conclusion
PLLA microcylinders were incorporated into apatite-forming cements as a pos-
sible strategy to overcome their brittleness. The incorporation of the PLLA mi-
crocylinders resulted into a homogeneous dispersion throughout the cement 
and decreased initial setting times. However, no positive effects were observed 
on the mechanical properties of the cements, possibly due to their limited aspect 
ratio and lack of interaction with the ceramic matrix. Future functionalization 
strategies incorporating moieties able to promote a higher affinity for the calci-
um-phosphate matrix might lead to a more significant effect on the mechanical 
properties of CPCs.
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1. Summary
 Electrospinning has been used for a wide range of applications, including the 
development of filtration systems, production of substrates for chemical catalysis, 
development of photoluminescent materials, the creation of new textile fabrics, 
and for biomedical applications. Biomedical applications of electrospinning 
include the development of antimicrobial membranes, drug delivery systems, 
new gene therapy approaches and development of scaffolds for tissue healing 
and regeneration. Biodegradable synthetic polymers, e.g. poly(lactic acid) 
(PLA), poly(glycolic acid) (PGA) and poly(ε-caprolactone) (PCL), are prime 
candidate materials for the development of synthetic electrospun membranes. 
Biodegradable polymers have the advantage of avoiding a second surgery to 
remove the implant. However, the ideal scaffold, i.e. a “smart material” that 
is not only biocompatible, but also has an active role in cellular proliferation, 
cellular differentiation, and tissue regeneration or healing is still not available. 
Synthetic polymeric electrospun membranes are intrinsically hydrophobic and 
biologically inert, lacking a molecular structure that stimulates a desired cellular 
response. These drawbacks lead to the need to develop new methods for the 
functionalization of synthetic electrospun membranes, creating new biologically 
active materials.
What is the current state-of-the-art with respect to the functionalization of 
electrospun membranes for biomedical applications?
Chapter 2 entitled “Biofunctionalization of electrospun fibers for tissue 
engineering and regenerative medicine” focused on reviewing the most recent 
advances in the development, functionalization, and application of electrospun 
membranes for biomedical purposes. Different electrospinning techniques, 
including single-nozzle electrospinning, coaxial electrospinning, and emulsion 
electrospinning, were discussed, focusing on their advantages and limitations. 
The second part of the chapter focused on post-spinning functionalization 
of electrospun membranes. The main methodologies used for post-spinning 
functionalization were presented and discussed, being divided into non-
covalent and covalent modifications. A wide range of techniques was described, 
reaching from physical adsorption and layer-by-layer to energy-mediated 
functionalization and wet-chemistry functionalization techniques, such as 
surface-graft polymerization. The last section of this chapter was dedicated to 
the different applications of electrospun membranes for biomedical purposes: 
development of scaffolds for cellular adhesion, proliferation, and differentiation; 
delivery of biomolecules; gene therapy; development of drug delivery systems.
Can mechanical and biofunctional properties of PCL-based electrospun 
membranes be improved by the incorporation of silica nanoparticles?
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Chapter 3 described the development of a composite electrospun membrane 
for Guided Bone Regeneration (GBR). The pivotal step on GBR therapy is the 
insertion of a membrane for support and barrier functions. In Chapter 3, we 
studied the effect of silica nanoparticles (Si-NPs) incorporation in electrospun 
poly(ε-caprolactone) (PCL) membranes to improve the mechanical and 
osteoconductive properties of the membranes. To this end, Si-NPs were firstly 
synthesized and then suspended in PCL solutions containing a polar solvent 
(2,2,2-trifluoroethanol) and water with the addition of an anionic surfactant. 
Nanocomposite membranes were fabricated from the solutions through an 
electrospinning technique. Morphology, structure and chemical composition, 
and tensile properties of the membranes were analyzed. Membrane stability was 
determined by visual examination of the membranes after immersion in phosphate 
buffered saline (PBS). The effect of the materials on osteoblastic differentiation 
was evaluated by in vitro culture of the membranes with MC3T3-E1 osteoblastic 
cells. The results indicated that Si-NPs were successfully incorporated in the 
interior of the PCL electrospun fibers during the electrospinning process. 
Tensile modulus significantly increased for composition S50 and tensile strength 
significantly increased for compositions S25 and S50. Membranes containing Si-
NPs showed to be cytocompatible. The results obtained demonstrate that the Si-
NPs were homogeneously incorporated within the electrospun fibers, resulting 
in an improvement of the tensile properties of the prepared materials.
Can a thermal treatment lead to a more sustained release of the simvastatin 
incorporated in PLLA electrospun membranes, enabling their use as GBR 
electrospun membranes?
The incorporation of osteostimulatory compounds can improve the 
biofunctionality of electrospun membranes, making them active players toward 
bone regeneration. Simvastatin has shown to promote osteogenic differentiation 
both in vitro and in vivo. However, in most of these systems, simvastatin was 
quickly released, not matching the pace of bone regeneration. In Chapter 4 we 
developed poly(L-lactic acid) (PLLA) membranes containing simvastatin (SV) 
with an increased drug release rate, compatible with GBR applications. To this 
end, SV was mixed with PLLA and electrospun. The membranes were subjected 
to a thermal treatment to increase the crystallinity of PLLA. Morphological, 
structural and chemical properties of the electrospun membranes were 
characterized. The effect of the thermal treatment on the release profile of 
SV was evaluated by near physiological release experiments at 37 °C. The 
osteostimulatory potential was determined by in vitro culture of the membranes 
with rat bone marrow stromal cells (rBMSCs). The results confirmed that thermal 
treatment led to an increased polymer crystallinity and a more sustained release 
of SV. In vitro assays demonstrated cellular proliferation over time for all the 
membranes and a significant increase in ALP-activity expression for the cells 
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cultured with the membranes containing SV subjected to thermal treatment.
Can a layer-by-layer (LbL) strategy, based on the deposition of PAA and PLL, be 
used to functionalize PLLA electrospun fibers, facilitating the incorporation of 
small molecules?
In Chapter 5, post-spinning functionalization of PLLA electrospun membranes 
by a Layer-by-Layer (LbL) strategy was investigated. Electrospun poly(L-lactic 
acid) (PLLA) membranes are widely used for biomedical applications. A major 
drawback for such systems is PLLA lacking biological functionality, leading to 
the need of developing functionalization strategies that alter the physicochemical 
properties of PLLA, and hence enable the incorporation of reactive molecular 
groups or macromolecules on its surface. The aim of this study was to functionalize 
the fiber surface of electrospun PLLA membranes by LbL, creating a system 
that potentially finds application as a highly biocompatible substrate with the 
capacity to function as a reservoir for small molecules (e.g. pharmaceutical 
compounds). To this end, biocompatible polyelectrolytes, poly(L-lysine) (PLL) 
and poly(acrylic acid) (PAA), were used to functionalize PLLA electrospun 
membranes. Morphological and elemental examination of the membranes was 
performed. LbL functionalization was achieved, with a proportional increase in 
the amount of polyelectrolytes deposited with the number of immersion steps. 
Furthermore, two model drugs with a different surface charge at physiological 
pH (rhodamine B and clindamycin) were incorporated and their loading 
efficiency and release evaluated. Both drugs were incorporated, albeit with low 
loading efficiency. Rhodamine B was released after 8 hours of incubation in 
phosphate buffered saline (PBS) at 37 °C, while clindamycin release occurred up 
to 48 hours of incubation. Our data demonstrated the feasibility of the approach, 
but more studies are needed to improve drug loading efficiency and control drug 
release.
Can functionalized microcylinders be developed by a top-down modification of 
electrospun fibers?
Electrospinning is a versatile technique, which can be used not only to produce 
scaffolds and membranes but also for the development of new structures and 
components for composite biomaterials. In Chapter 6, we described a top-down 
approach for the development of new functionalized micrometric structures 
based on electrospun PLLA fibers, which can be used for the development of 
drug delivery systems or as building blocks for new biomaterials. A wide range 
of particles has been developed for different applications in drug delivery, tissue 
engineering, or regenerative medicine. In contrast to traditional spherical 
particles, non-spherical (e.g. cylindrical) particles possess several structural and 
morphological advantages that make them attractive for specific applications. In 
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Chapter 6, electrospun fibers were processed into micron-sized cylinders (i.e. 
microcylinders) with a high specific surface area and with or without surface 
porosity. To obtain these microcylinders, PLLA solutions were subjected to 
electrospinning, followed by an aminolysis-based chemical scission procedure. 
The morphology, structure, and chemical composition of the microcylinders 
were then characterized. Specific surface area and surface porosity of the 
microcylinders were controlled by the volatility of the solvents and their length 
was dependent on the duration of the aminolysis reaction. During aminolysis, 
the microcylinders became functionalized with amine groups, enabling potential 
further modifications by grafting with compounds containing desired chemical 
groups, e.g. carboxyl, carbonyl or hydroxyl functional groups. Additionally, 
the microcylinders showed in vitro biocompatible properties related to cell 
viability. These data demonstrate that PLLA microcylinders with a high specific 
surface area, optional surface porosity, amine-based functional handles granting 
additional functionalization, and cytocompatible properties are candidate 
materials for future biomedical applications.
Does the incorporation of PLLA microcylinders in calcium phosphate cements 
(CPCs) have a positive effect on their mechanical properties?
Chapter 7 focused on the potential application of the structures described in 
Chapter 6 as polymeric microfillers to improve the mechanical properties of 
calcium phosphate cements (CPCs). CPCs are excellent biomaterials for bone 
regeneration being biocompatible, resorbable, injectable and osteoconductive. 
However, the CPCs brittle nature limits their application only to no load-
bearing applications. The incorporation of long polymeric fibers can improve 
the mechanical properties of CPCs, but aggregation and heterogeneous 
distribution of the fibers are major problems. Instead, short polymeric fillers 
can be easily dispersed in the cement matrix. In Chapter 7, continuous 
PLLA fibers with a smooth or porous surface morphology were prepared 
by electrospinning. PLLA microcylinders were developed, by means of an 
aminolysis process (Chapter 6) and added to α-TCP or α-TCP/PLGA-based 
cements. Microcylinders distribution, as well as the morphology, cohesiveness, 
setting times and mechanical properties, were evaluated. PLLA microcylinders 
were homogeneously dispersed throughout the cement, while the handling 
properties were not significantly affected. A decrease in the initial setting times 
was observed when PLLA was added, while the mechanical properties were 
comparable to those of the α-TPC or α-TCP/PLGA compositions.
2. Closing remarks and future perspectives
In this thesis, we addressed the limited functionality inherent to synthetic 
polymeric membranes as applied for GBR procedures. Functionalization 
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techniques were applied to create new materials with improved mechanical 
properties or which could promote the osteogenic differentiation of pre-
osteoblastic cells. Although it was demonstrated that both pre-spinning 
and post-spinning functionalization strategies enable the production of i) 
membranes with improved tensile properties, ii) membranes which can be 
used as drug delivery vehicles iii) micrometric structures functionalized with 
reactive amine groups, several challenges still need to be addressed, namely the 
use of non-toxic solvents and the development of more precise approaches when 
electrospun materials are used as drug delivery systems.
Strong organic solvents are commonly used to dissolve the synthetic polymers 
prior to electrospinning. This is a major limitation for the definite translation 
of electrospinning to industry and the scale-up of this technology. The use of 
organic solvents on an industrial level presents several concerns: i) most organic 
solvents are highly flammable and volatile, which results in the need to adopt 
specific safety measures[1] ii) organic solvents are harmful to the environment, and 
special measures are needed for their storage and elimination[2] iii) conventional 
organic solvents are toxic and not suitable for the dissolution of biomolecules, 
limiting their use for biomedical applications.[3] New electrospinning 
methodologies, denominated as green electrospinning, which focus on more 
environmentally friendly approaches show promising results. The term green 
electrospinning is generally used when the dissolution of the polymers and 
subsequent electrospinning is performed using non-toxic and environmentally 
friendly solvents, mainly water or aqueous solutions. Water-soluble polymers as 
poly(ethylene oxide) (PEO), poly(vinyl alcohol) (PVA) or poly(vinylpyrrolidone) 
(PVP) have been electrospun by this approach.[4] However, water-insoluble 
polymers require the use of strong toxic organic solvents, as chloroform, 
dichloromethane or dimethylformamide. The development of suspension 
electrospinning and colloidal electrospinning is a recent green electrospinning 
strategy, where the production of electrospun fibers  is based on the dispersion 
of water-insoluble polymers or copolymers in an aqueous medium.[5, 6] A 
second alternative green approach is the electrospinning of thermo-responsive 
polymers, as poly(N-isopropylacrylamide) (PNIPAM). These polymers are 
water-soluble below their lower critical solution temperature (LCST), but when 
electrospun the fibers presented a good stability in aqueous environments.[7] 
Room temperature ionic liquids (RTILs) are also gaining increasing attention due 
to their high conductivity, low vapor pressure, high decomposition temperature 
and, the capability to chemically modify and recycle the ions.[8] Such properties 
make them especially attractive to be used as environmentally friendly solvents 
for electrospinning. Cellulose fibers have already been produced using RITLs[9] 
and efforts are being made to expand the use of ionic liquids for the production 
of non-cellulosic electrospun fibers.[10, 11]
The sustained delivery of pharmaceutical compounds and biomolecules from 
electrospun membranes also remains a challenge. The release of pharmaceutical 
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compounds or biomolecules incorporated in electrospun fibers by blending or 
coaxial electrospinning is mainly a passive phenomenon, being dependent on 
the diffusion of the drug or degradation/erosion of the polymeric fibers. On-
demand drug delivery systems, where a compound release occurs according 
to endogenous or exogenous stimuli and on a precise location are considered 
the next step in the development of drug delivery systems. Temperature, pH 
or enzyme-cleavable domains can be used to control and direct drug release. 
Stimuli-based responses can be developed based on the customization and 
modification of the polymeric backbone or by surface functionalization. 
Considering the polymeric backbone an interesting approach that should 
be explored in the future is the development of electrospun fibers based on 
block-copolymers. Temperature sensitive block-polymers as poly(N-isopropyl 
acrylamide)[12], poly(N,N-diethylacrylamide)[13], and PEG/PLGA[14] have been 
used in the development of temperature-sensitive nanoparticles. PEG-based 
block copolymers have been used for the development of pH-sensitive delivery 
systems.[15] Surface functionalization of electrospun fibers is also promising. 
Matrix metalloproteinase (MMPs) cleavable domains[16], thermo-responsive 
pamidronate[17], or pH-responsive dextran[18] and chitosan[19] have been used 
on the surface functionalization of nanoparticles and microparticles and 
are appealing strategies to be explored for the creation of new on-demand 
electrospun delivery systems.
In summary, in this thesis electrospinning combined with diverse functionalization 
techniques were used to develop new biomaterials with improved functional 
properties for GBR applications and bone tissue engineering. Diverse pre- 
and post-spinning strategies have led to the development of membranes with 
improved tensile properties which can potentially be used on GBR applications, 
and the development of new micrometric structures to be used for drug delivery 
purposes or as building blocks of new biomaterials. Electrospinning has all 
the potential to be an important technique in the development of the next 
generation of biomaterials. For that to occur i) low-cost and environmentally 
friendly electrospinning methodologies should be explored ii) stimuli-based 
drug delivery systems should be further investigated.
Summary, closing remarks and future perspectives
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1. Samenvatting
 Electrospinning wordt gebruikt voor een breed scala aan toepassingen, 
waaronder de ontwikkeling van filtratiesystemen, de productie van substraten 
voor chemische katalyse, de ontwikkeling van fotoluminescerende materialen, de 
creatie van nieuwe textielstoffen en voor biomedische toepassingen. Biomedische 
toepassingen van elektrospinning omvatten de ontwikkeling van antimicrobiële 
membranen, medicijnafgiftesystemen, nieuwe gentherapiebenaderingen en 
de ontwikkeling van scaffolds voor weefselgenezing en regeneratie. Biologisch 
afbreekbare synthetische polymeren, b.v. poly(lactic acid) (PLA), poly(glycolic 
acid) (PGA) en poly(ε-caprolactone) (PCL) zijn uitstekende kandidaat-
materialen voor de ontwikkeling van synthetische elektrospinmembranen. 
Biologisch afbreekbare polymeren hebben het voordeel dat een tweede operatie 
om het implantaat te verwijderen wordt vermeden. De ideale scaffold, d.w.z. een 
"slim materiaal" dat niet alleen biocompatibel is, maar ook een actieve rol heeft bij 
cellulaire proliferatie, cellulaire differentiatie, en weefselregeneratie of genezing 
is nog steeds niet beschikbaar. Synthetische polymere elektrospinmembranen 
zijn intrinsiek hydrofoob en biologisch inert, zonder een moleculaire structuur 
die een gewenste cellulaire respons stimuleert. Deze nadelen hebben geleid tot 
de noodzaak om nieuwe werkwijzen te ontwikkelen voor de functionalisering 
van synthetische elektrospinmembranen, waarbij nieuwe biologisch actieve 
materialen worden gevormd. 
Wat is de huidige state-of-the-art met betrekking tot de functionalisering van 
elektrospinmembranen voor biomedische toepassingen?
Hoofdstuk 2 getiteld "Biofunctionalization of Electrospun Fibres for Tissue 
Engineering and Regenerative Medicine", was gericht op het evalueren 
van de meest recente ontwikkelingen in de ontwikkeling, functionalisering 
en toepassing van elektrospinmembranen voor biomedische doeleinden. 
Verschillende elektrospinningtechnieken, waaronder elektrospinning met 
een enkel mondstuk, coaxiaal elektrospinnen en elektrospinnen met emulsie 
worden besproken, met de nadruk op hun voordelen en beperkingen. Het 
tweede deel van het hoofdstuk richt zich op post-spinning functionalisatie van 
elektrospun membranen. De belangrijkste methodologieën die worden gebruikt 
voor functionalisatie na spinnen worden gepresenteerd en besproken, verdeeld 
in niet-covalente en covalente modificaties. Een breed scala van technieken 
wordt beschreven, reikend van fysische adsorptie en laag-voor-laag tot energie-
gemedieerde functionalisering en wet-chemie functionalisatietechnieken, zoals 
oppervlakte-entpolymerisatie. De laatste sectie van dit hoofdstuk is gewijd aan 
de verschillende toepassingen van elektrospinmembranen voor biomedische 
doeleinden: ontwikkeling van scaffolds voor cellulaire adhesie, proliferatie 
en differentiatie; levering van biomoleculen; gentherapie; ontwikkeling van 
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medicijnafgiftesystemen.
Kunnen de mechanische en biofunctionele eigenschappen van PCL-gebaseerde 
elektrospinmembranen worden verbeterd door de opname van silicium 
nanodeeltjes?
Hoofdstuk 3 beschreef de ontwikkeling van een composiet elektrospun 
membraan voor Guided Bone Regeneration (GBR). De cruciale stap voor GBR-
therapie is het inbrengen van een membraan voor steun- en barrièrefuncties. 
In Hoofdstuk 3 hebben we het effect bestudeerd van siliciumdioxide 
nanopartikel (Si-NP) opname in electrospun poly(ε-caprolactone) (PCL) 
membranen om de mechanische en osteo-geleidende eigenschappen van de 
membranen te verbeteren. Hiertoe werden Si-NP's eerst gesynthetiseerd en 
vervolgens gesuspendeerd in PCL-oplossingen die een polair oplosmiddel 
(2,2,2-trifluorethanol) en water bevatten met de toevoeging van een anionische 
oppervlakteactieve stof. Nanocomposietmembranen werden vervaardigd uit 
de oplossingen door middel van een elektrospinningtechniek. Morfologie, 
structuur en chemische samenstelling en trekeigenschappen van de membranen 
werden geanalyseerd. Membraanstabiliteit werd bepaald door visueel onderzoek 
van de membranen na onderdompeling in phosphate buffered saline (PBS). 
Het effect van de materialen op osteoblastische differentiatie werd geëvalueerd 
door in vitro kweek van de membranen met MC3T3-E1 osteoblastische cellen. 
De resultaten gaven aan dat Si-NP's met succes werden opgenomen in het 
inwendige van de PCL-elektrospinvezels tijdens het elektrospinproces. De 
trekmodulus was significant verhoogd voor samenstelling S50 en de treksterkte 
nam significant toe voor de samenstellingen S25 en S50. Membranen die Si-
NP's bevatten, bleken cytocompatibel te zijn. De verkregen resultaten tonen 
aan dat de Si-NP's homogeen waren opgenomen in de elektrogesponnen vezels, 
hetgeen resulteerde in een verbetering van de trekeigenschappen van de bereide 
materialen.
Kan een thermische behandeling leiden tot een meer aanhoudende afgifte van 
simvastatine die is opgenomen in PLLA elektrospinmembranen, waardoor ze 
kunnen worden gebruikt als elektrospinmembranen van GBR?
De opname van osteostimulerende verbindingen kan de biofunctionaliteit 
van elektrospinmembranen verbeteren, waardoor ze actieve spelers worden 
in de richting van botregeneratie. Simvastatine heeft aangetoond dat het 
zowel in vitro als in vivo osteogene differentiatie bevordert. In de meeste van 
deze systemen werd simvastatine echter snel afgegeven, wat niet overeenkomt 
met het tempo van botregeneratie. In Hoofdstuk 4 ontwikkelden we poly(L-
lactic acid) (PLLA) membranen die simvastatine (SV) bevatten met een 
verhoogde medicijnafgiftesnelheid, compatibel met GBR-toepassingen. Voor 
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dit doel werd SV gemengd met PLLA en electrospun. De membranen werden 
onderworpen aan een thermische behandeling om de kristalliniteit van 
PLLA te verhogen. Morfologische, structurele en chemische eigenschappen 
van de elektrospinmembranen werden gekarakteriseerd. Het effect van de 
thermische behandeling op het afgifteprofiel van SV werd geëvalueerd door 
bijna fysiologische vrijgave-experimenten bij 37 °C. Het osteostimulatoire 
potentieel werd bepaald door in vitro kweek van de membranen met beenmerg 
stromale cellen van de rat (rBMSCs). De resultaten bevestigden dat thermische 
behandeling leidde tot een verhoogde polymeerkristalliniteit en een meer 
aanhoudende afgifte van SV. In vitro testen vertoonden cellulaire proliferatie in 
de loop van de tijd voor alle membranen en een significante toename in ALP-
activiteit voor de cellen gekweekt met de membranen die SV onderworpen aan 
thermische behandeling bevatten.
Kan een layer-by-layer (LbL) -strategie, gebaseerd op de depositie van PAA en 
PLL, worden gebruikt om PLLA elektrospinvezels te functionaliseren, waardoor 
de integratie van kleine moleculen wordt vergemakkelijkt?
In Hoofdstuk 5 werd post-spinfunctionaliteit van PLLA elektrospinmembranen 
door een Layer-by-Layer (LbL) strategie onderzocht. Electrospun poly(L-
lactic acid) (PLLA) membranen worden veel gebruikt voor biomedische 
toepassingen. Een belangrijk nadeel voor dergelijke systemen is PLLA zonder 
biologische functionaliteit, wat leidt tot de noodzaak van het ontwikkelen van 
functionaliseringsstrategieën die de fysisch-chemische eigenschappen van 
PLLA veranderen en vandaar de opname van reactieve moleculaire groepen 
of macromoleculen aan het oppervlak mogelijk maken. Het doel van deze 
studie was om het vezeloppervlak van elektrospun PLLA-membranen door 
LbL te functionaliseren, waardoor een systeem wordt gecreëerd dat mogelijk 
toepassing vindt als een zeer biocompatibel substraat met het vermogen 
om te functioneren als een reservoir voor kleine moleculen (bijvoorbeeld 
farmaceutische verbindingen). Voor dit doel werden biocompatibele 
polyelektrolyten, poly(L-lysine) (PLL) en poly (acrylic acid) (PAA) gebruikt om 
PLLA elektrospinmembranen te functionaliseren. Morfologisch en elementair 
onderzoek van de membranen werd uitgevoerd. LbL-functionalisering werd 
bereikt, met een evenredige toename in de hoeveelheid poly-elektrolyten 
afgezet met het aantal onderdompelingsstappen. Verder werden twee 
modelgeneesmiddelen met een verschillende oppervlaktelading bij fysiologische 
pH (rhodamine B en clindamycine) opgenomen en hun ladingsrendement 
en afgifte beoordeeld. Beide geneesmiddelen werden opgenomen, zij het met 
lage ladingsefficiëntie. Rhodamine B werd vrijgegeven na 8 uur incuberen in 
phosphate buffered saline (PBS) bij 37 °C, terwijl de afgifte van clindamycine 
optrad tot 24 uur incubatie. Onze gegevens hebben de haalbaarheid van de 
aanpak aangetoond, maar er zijn meer studies nodig om de efficiëntie van de 
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medicijnbelading te verbeteren en de afgifte van geneesmiddelen te beheersen.
Kunnen gefunctionaliseerde microcilinders worden ontwikkeld door een top-
down modificatie van elektrospun vezels?
Electrospinning is een veelzijdige techniek, die niet alleen kan worden gebruikt 
voor het produceren van steigers en membranen, maar ook voor de ontwikkeling 
van nieuwe structuren en componenten voor composiet biomaterialen. 
In hoofdstuk 6 hebben we een top-down benadering beschreven voor de 
ontwikkeling van nieuwe gefunctionaliseerde micrometrische structuren op basis 
van elektrospun PLLA-vezels, die kunnen worden gebruikt voor de ontwikkeling 
van medicijnafgiftesystemen of als bouwstenen voor nieuwe biomaterialen. 
Een breed scala aan deeltjes is ontwikkeld voor verschillende toepassingen in 
medicijnafgifte, weefseltechniek of regeneratieve geneeskunde. In tegenstelling 
tot traditionele bolvormige deeltjes bezitten niet-sferische (bijvoorbeeld 
cilindrische) deeltjes verschillende structurele en morfologische voordelen die 
hen aantrekkelijk maken voor specifieke toepassingen. In Hoofdstuk 6 werden 
elektrospinvezels verwerkt tot micro-maat cilinders (d.w.z. microcilinders) 
met een hoog specifiek oppervlak en met of zonder oppervlakteporositeit. Om 
deze microcilinders te verkrijgen, werden PLLA-oplossingen onderworpen 
aan elektrospinning, gevolgd door een op aminolyse gebaseerde chemische 
splijtingsprocedure. De morfologie, structuur en chemische samenstelling van 
de microcilinders werden vervolgens gekarakteriseerd. Het specifieke oppervlak 
en de porositeit van het oppervlak van de microcilinders werden geregeld door 
de vluchtigheid van de oplosmiddelen en hun lengte was afhankelijk van de duur 
van de aminolysereactie. Gedurende de aminolyse werden de microcilinders 
gefunctionaliseerd met aminegroepen, hetgeen mogelijk verdere modificaties 
mogelijk maakt door enten met verbindingen die gewenste chemische groepen 
bevatten, b.v. carboxyl, carbonyl of hydroxyl functionele groepen. Bovendien 
vertoonden de microcilinders in vitro biocompatibele eigenschappen met 
betrekking tot cellevensvatbaarheid. Deze gegevens toonden aan dat PLLA-
microcilinders met een hoog specifiek oppervlak, optionele oppervlakporositeit, 
op amine gebaseerde functionele handvatten die additionele functionalisatie 
verschaffen, en cytocompatibele eigenschappen kandidaat-materialen zijn voor 
toekomstige biomedische toepassingen.
Heeft de opname van PLLA-microcilinders in calciumfosfaatcementen (CPC's) 
een positief effect op hun mechanische eigenschappen?
Hoofdstuk 7 richt zich op de mogelijke toepassing van de structuren beschreven 
in Hoofdstuk 6 als polymere microfillers om de mechanische eigenschappen 
van calciumfosfaatcementen (CPC's) te verbeteren. CPC's zijn uitstekende 
biomaterialen voor botregeneratie die biocompatibel, resorbeerbaar, 
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injecteerbaar en osteoconductief zijn. De brosheid van de CPC's beperkt hun 
toepassing echter alleen tot toepassingen zonder belasting. De opname van 
lange polymeervezels kan de mechanische eigenschappen van CPC's verbeteren, 
maar aggregatie en heterogene verdeling van de vezels zijn grote problemen. 
In plaats daarvan kunnen korte polymere vulstoffen gemakkelijk in de 
cementmatrix worden gedispergeerd. In Hoofdstuk 7 werden continue PLLA-
vezels met een gladde of poreuze oppervlaktemorfologie bereid door middel 
van elektrospinning. PLLA-microcilinders werden ontwikkeld, door middel 
van een aminolyseproces (hoofdstuk 6) en toegevoegd aan op α-TCP of α-TCP/
PLGA gebaseerde cementen. Microcilinders distributie, evenals de morfologie, 
cohesie, uithardingstijden en mechanische eigenschappen, werden geëvalueerd. 
PLLA-microcilinders werden homogeen door het cement gedispergeerd, terwijl 
de hanteringseigenschappen niet significant werden beïnvloed. Een afname van 
de initiële instellingstijden werd waargenomen wanneer PLLA werd toegevoegd, 
terwijl de mechanische eigenschappen vergelijkbaar waren met die van de 
α-TPC of α-TCP / PLGA-samenstellingen.
2. Slotopmerkingen en toekomstperspectieven
In dit proefschrift hebben we ingegaan op de beperkte functionaliteit inherent 
aan synthetische polymeermembranen zoals toegepast voor GBR-procedures. 
Functionalisatietechnieken werden toegepast om nieuwe materialen te creëren 
met verbeterde mechanische eigenschappen of die de osteogene differentiatie van 
pre-osteoblastische cellen zouden kunnen bevorderen. Hoewel werd aangetoond 
dat zowel pre-spinning als post-spinning functionaliseringsstrategieën de 
productie mogelijk maken van i) membranen met verbeterde trekeigenschappen, 
ii) membranen die kunnen worden gebruikt als drugsafgiftedragers iii) 
micrometrische structuren gefunctionaliseerd met reactieve aminegroepen, 
verschillende uitdagingen moet nog steeds worden aangepakt, namelijk 
het gebruik van niet-toxische oplosmiddelen en de ontwikkeling van meer 
precieze benaderingen wanneer elektrospunmaterialen worden gebruikt als 
medicijnafgiftesystemen.
Sterke organische oplosmiddelen worden gewoonlijk gebruikt om de synthetische 
polymeren op te lossen voorafgaand aan elektrospinnen. Dit is een belangrijke 
beperking voor de definitieve vertaling van elektrospinning naar de industrie en 
de opschaling van deze technologie. Het gebruik van organische oplosmiddelen 
op industrieel niveau levert verschillende bezwaren op: i) de meeste organische 
oplosmiddelen zijn licht ontvlambaar en vluchtig, wat resulteert in de noodzaak 
om specifieke veiligheidsmaatregelen te nemen[1] ii) organische oplosmiddelen 
zijn schadelijk voor het milieu en speciale maatregelen zijn nodig voor hun opslag 
en eliminatie[2] iii) conventionele organische oplosmiddelen zijn toxisch en niet 
geschikt voor het oplossen van biomoleculen, waardoor het gebruik ervan voor 
biomedische toepassingen wordt beperkt.[3] Nieuwe elektrospinningmethodieken, 
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die worden aangeduid als groene elektrospinning, en die zich richten op 
milieuvriendelijkere benaderingen, laten veelbelovende resultaten zien. De term 
groene electrospinning wordt over het algemeen gebruikt wanneer het oplossen 
van de polymeren en daaropvolgende elektrospinning wordt uitgevoerd met 
behulp van niet-toxische en milieuvriendelijke oplosmiddelen, voornamelijk 
water of waterige oplossingen. Water-oplosbare polymeren als poly(ethylene 
oxide) (PEO), poly(vinyl alcohol) (PVA) of poly(vinyl pyrrolidone) (PVP) 
zijn elektrogesponnen door deze benadering.[4] Wateronoplosbare polymeren 
vereisen echter het gebruik van sterke toxische organische oplosmiddelen, 
zoals chloroform, dichloormethaan of dimethylformamide. De ontwikkeling 
van elektrospinning met suspensie en colloïdale electrospinning is een 
recente groene elektrospinningstrategie, waarbij elektrospinvezels worden 
geproduceerd op basis van de dispersie van wateronoplosbare polymeren 
of copolymeren in een waterig medium.[5, 6] Een tweede alternatieve groene 
benadering is de elektrospinning van thermoresponsieve polymeren, zoals 
poly(N-isopropylacrylamide) (PNIPAM). Deze polymeren zijn in water 
oplosbaar onder hun lagere kritieke oplossingstemperatuur (LCST), maar bij 
elektrospin gaven de vezels een goede stabiliteit in waterige omgevingen.[7] Ook 
ionische vloeistoffen op kamertemperatuur (Room temperature ionic liquids; 
RTIL's) krijgen steeds meer aandacht vanwege hun hoge geleidbaarheid, lage 
dampspanning, hoge ontledingstemperatuur en de mogelijkheid om de ionen 
chemisch te modificeren en te recyclen.[8] Dergelijke eigenschappen maken 
ze bijzonder aantrekkelijk om te worden gebruikt als milieuvriendelijke 
oplosmiddelen voor elektrospinning. Cellulosevezels zijn al geproduceerd met 
behulp van RITL's[9] en er worden inspanningen geleverd om het gebruik van 
ionische vloeistoffen voor de productie van niet-celluloseachtige elektrospun 
vezels uit te breiden.[10, 11]
De aanhoudende levering van farmaceutische verbindingen en biomoleculen uit 
elektrospinmembranen blijft ook een uitdaging. De afgifte van farmaceutische 
verbindingen of biomoleculen opgenomen in elektrospunvezels door mengen of 
coaxiaal elektrospinnen is hoofdzakelijk een passief fenomeen, dat afhankelijk is 
van de diffusie van het geneesmiddel of afbraak / erosie van de polymeervezels. 
On-demand medicijnafgiftesystemen, waarbij een afgifte van een verbinding 
plaatsvindt volgens endogene of exogene stimuli en op een precieze locatie, worden 
beschouwd als de volgende stap in de ontwikkeling van medicijnafgiftesystemen. 
Temperatuur, pH of door enzym afsplitsbare domeinen kunnen worden 
gebruikt voor het reguleren en richten van geneesmiddelafgifte. Op stimulansen 
gebaseerde responsen kunnen worden ontwikkeld op basis van de aanpassing 
en modificatie van de polymere hoofdketen of door oppervlaktefunctionalisatie. 
Gezien de polymere hoofdketen is een interessante benadering die in de 
toekomst moet worden onderzocht de ontwikkeling van elektrospinvezels op 
basis van blokcopolymeren. Temperatuurgevoelige blokpolymeren zoals poly(N-
isopropylacrylamide)[12], poly(N,N-diethylacrylamide)[13] en PEG/PLGA[14] 
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zijn gebruikt bij de ontwikkeling van temperatuurgevoelige nanodeeltjes. Op 
PEG gebaseerde blokcopolymeren zijn gebruikt voor de ontwikkeling van pH-
gevoelige afgiftesystemen.[15] Oppervlaktefunctionalisatie van elektrospinvezels 
is ook veelbelovend. Matrix-metalloproteinase (MMP's) knipbare domeinen[16], 
thermoresponsief pamidronaat[17], of pH-responsief dextran[18] en chitosan[19] zijn 
gebruikt voor de oppervlaktefunctionalisatie van nanodeeltjes en microdeeltjes 
en zijn aansprekende strategieën om te verkennen voor het creëren van nieuwe 
on demand demandingsystemen voor elektrospun.
Samengevat, in dit proefschrift werd elektrospinning gecombineerd met diverse 
functionalisatietechnieken gebruikt om nieuwe biomaterialen te ontwikkelen 
met verbeterde functionele eigenschappen voor GBR-toepassingen en 
botweefselengineering. Diverse pre- en post-spinning strategieën hebben geleid 
tot de ontwikkeling van membranen met verbeterde trekeigenschappen die 
mogelijk kunnen worden toegepast op GBR-toepassingen, en de ontwikkeling 
van nieuwe micrometrische structuren die kunnen worden gebruikt voor 
medicijnafgifte of als bouwstenen voor nieuwe biomaterialen. Electrospinning 
heeft alle potentie om een belangrijke techniek te zijn in de ontwikkeling van de 
volgende generatie biomaterialen. Om dat te laten gebeuren, moeten i) goedkope 
en milieuvriendelijke methoden voor elektrospinning worden onderzocht; ii) 
op stimuli gebaseerde systemen voor toediening van geneesmiddelen moeten 
verder worden onderzocht.
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